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Abstract
The problem of increasing rates of antibiotic resistance has become a global concern, particularly
among multidrug resistant Gram-negative nosocomial pathogens. These organisms display non-
susceptibility to the majority of routinely used antibiotics, causing infections which are more
difficult to treat and increase the duration of patient recovery. Due to the plethora of resistance
determinants and the molecular machinery which facilitates their dissemination, new strategies are
required to investigate the mechanisms that confer antibiotic resistance. Proteomic techniques
allow the global analysis of the expressed proteome, providing a more holistic view of the current
physiological state of the bacterial cell. The techniques used in this investigation cover the
separation, quantification and identification of proteins present in cellular extracts from resistant
organisms. These included the use of 2-D electrophoresis, DIGE and LC-MSIMS mass
spectrometry applied to multidrug resistant Escherichia coli, Klebsiella pneumoniae, Enterobacter
cloacae, Serratia marcescens and Acinetobacter baumannii. In summary, these investigations
revealed that the Tol-Pal membrane protein system and susceptibilities to polymyxin antibiotics
and biocides are altered upon acquisition of a resistance plasmid in E. coli. Furthermore, it revealed
that non-carbapenemase-mediated carbapenem resistance in K. pneumoniae involved the loss of
fimbriae proteins, the increased expression of OmpK26 and the resistance proteins EmrA and
APH(3"), in addition to OmpK35/36 porin loss. The upregulation of a multi drug efflux pump in E.
cloacae, A. baumannii and S. marcescens involved the differential regulation of many proteins,
spanning a broad range of functional classes, including the MinCDE cell division inhibitors, iron
acquisition proteins such as FepA and FhuA and proteins involved in biofilm and LPS formation
such as PapC, LptD and GmhA. Overall this project has highlighted the complex and dynamic
changes in protein expression upon acquisition of a resistance phenotype and the importance of
using genetically related isolates when undertaking proteomic analyses. This work also emphasised
the advantages of using proteomics for profiling the expression of resistance proteins, including the
detection of specific enzymes, such as CTX-M ESBLs.
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1. Introduction
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1.1 Antibiotics and antibiotic resistance
The implementation of modem antimicrobial therapy (1940s - post-world war II) changed the face
of medicine, patient care and has had a profound impact on our society. Modem procedures rely on
the use of antibiotics for surgery, organ transplants, care of premature neonates and infection
management to allow successful patient rehabilitation and treatment of infections in the
community. The use of antimicrobials has removed infectious disease as a top priority healthcare
concern in the western world, displaced with diabetes, heart disease, and cancer. However,
infectious diseases remain the leading causes of mortality in low-income countries and the third
highest cause of mortality worldwide (World Health Organisation, 2011).
The term antibiotic originally described compounds naturally produced by microorganisms and
which inhibited the growth of bacteria at very low concentrations (Waksman, 1972). However, the
treatment of bacterial infections is hampered by resistance to antibiotics, first observed in
Flemings' lab shortly after his discovery of penicillin (Fleming, 1945). Fleming himself stated:
" ...There is probably no chemotherapeutic drug to which in suitable circumstances the bacteria
cannot react by in some way acquiring 'fastness' [resistance] .... " (Fleming, 1947), noting that low
levels of penicillin or short treatment cycles would induce resistance in bacteria.
The detection of resistance to antibiotics continued throughout the golden age of antibiotic
discovery (said to be the 1950s; see Table 1.1) where many new drugs and drug classes were
discovered to keep up with the increasing rates of resistance. For instance, the incidence of
penicillin-resistant staphylococci increased throughout the 1950s until methicillin was developed
and released in 1960, however methicillin-resistant Staphylococcus aureus (MRSA) isolates
rapidly appeared within a year (Johnson 2011). After the discovery of transmissible resistance
factors (R factors) in Japan (Mitsuhashi et al. 1960), these R factors were detected in isolates in
Britain and later in Greece, with the first confirmed detection of TEM ~-lactamase (Datta &
Kontomichalou, 1965). Around this time, there was a surge in drug discovery, albeit most 'new'
antibiotics were modified structures of existing agents e.g. latter generations of cephalosporins. The
19
evolution of resistant strains continued to catch up with these new agents at an alarming rate.
Resistance is now a concern that is increasing both nationally and worldwide (Livermore et al.
2008; Rossolini & Mantengoli, 2008) and agents that physicians have come to rely on are being
labelled as inadequate. These include antibiotics such as ampicillin and trimethoprim, successful
agents which used to have widespread activity, but now E. coli isolates recovered from urinary
tract infections (UTIs) show resistance rates of 55% and 40% for ampicillin and trimethoprim,
respectively (Bean et al. 2008).
Class Year discovered
Sulfonamides
Penicillins
Polymyxin
Chloramphenicol
Tetracyclines
Cephalosporins (four generations)
Aminoglycosides
Vancomycin
Clindamycin
Rifamycin
Trimethoprimlsulfamethoxazole
Carbapenems
Monobadams
Linezolid
Daptomycin
Synercid
1937
1940
1947*
1949
1953
1953
1957
1958*
1966
1971
1973
1976
1982
1987*
1987*
1992*
*Recently reintroduced
Table 1.1. List of antimicrobials and their date of discovery. Taken from: (Davies 2006).
20
1.1.2 How do we define resistance?
Bacteria are principally defined as susceptible or resistant to an antibiotic based on the value of
their minimum inhibitory concentration (MIC) and epidemiological cut-off value (ECOFF). An
MIC is the lowest concentration of an antibiotic at which bacterial growth is inhibited, and the
extent of any resistance is determined by whether it falls above or below decided concentrations or
breakpoints, which vary across bacterial species and antibiotic classes. Breakpoints are decided on
the basis of many factors, particularly susceptibility distribution, pharmacological properties of the
antibiotic and data on the clinical outcomes of the antibiotic (Macgowan & Wise, 2001). An
ECOFF is an MIC value identifying the upper limit of the wild type population for a given species
and distinguishes wild-type isolates from those with reduced susceptibility. ECOFFs are
determined by visual inspection of MIC histograms for a given species, or through statistical
calculation (Tumidge et al. 2006). They are used as an indicator of resistance prevalence in
surveillance studies. Breakpoint MICs are standardised by organisations such as the British Society
for Antimicrobial Chemotherapy (BSAC) (Andrews & Howe, 2011), whose guidelines are used in
this thesis, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the
Clinical and Laboratory Standards Institute in the US (CLSI).
1.1.3 Resistance on the rise
Resistance to multiple agents was originally commonly documented in nosocomial isolates, which
is unsurprising given the selection pressures present, although there were also reports of Shigella
isolates from dysentery patients which were resistant to streptomycin, tetracycline and
chloramphenicol (Watanabe 1963). In modem times, the first probable report in 1998 of an ESBL-
producing E. coli isolate initiated a rise to prominence (Cormican et al. 1998) and since then,
resistance detection on community acquired infections has increased steadily (Pitout et al. 2005).
For example, in the US in 2005, it was found that 13.7% of methicillin-resistant Staphylococcus
aureus (MRSA) infections originated from the community (Klevens et al. 2007). While the general
public is aware of the threat of highly publicised increases in MRSA infection, resistant Gram-
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negative infections have been increasing also, but have gone somewhat unnoticed (Livermore,
2004). This problem was highlighted in a report on multiresistant Enterobacteriaceae isolates from
the community, where many of the patients visited general practices and had no prior hospital
exposure (Woodford et al. 2004).
Multiple studies have drawn attention to the inappropriate prescribing of antibiotics to treat
infection as a contributing factor to the rise of resistance. Lai et al. saw links with increased
prescription and resistance rates in Gram-negative bacteria, although it was antibiotic and
organism-dependant. Similarly they found that resistance rates also dropped with the reduced use
of certain antibiotics (Lai et al. 2011). Hsu et al. also noted similar observations, such as the
increasing rates of both fluoroquinolone prescription and ciprofloxacin-resistant E. coli, and the
association of prescription of carbapenems and imipenem-resistant Acinetobacter baumannii (Hsu
et al. 2010).
1.2 Are we running out of antibiotics?
Whether appropriately prescribed or not, with the estimated production of antibiotics in the
hundreds of thousands of tonnes per year worldwide (Nikaido, 2009), it is unsurprising that
resistance is so widespread and frequently documented. But despite the rising rates of resistance
and the critical need for novel antibiotics, the number of new agents coming on to the market is
falling e.g. 16 agents were approved for use between 1983-87 but only seven were approved
between 1998-2002 (Spellberg et al. 2004). Furthermore, drugs with novel modes of action, which
are vital as cross-resistance to existing drugs is unlikely, are even fewer in number e.g. only
linezolid and daptomycin had novel mechanisms of action (approved between 1998 and 2003),
while the remainder were merely modified structures of existing agents (Spellberg et al. 2004).
Lower still is the number of agents designed for use against Gram-negative pathogens, possibly due
to the lower political and media attention they receive in contrast to, for example,MRSA, which is
a problem well-known to the public and may have driven the focus on anti-Gram-positive agents
(Theuretzbacher, 2009). This has caused a delay in the discovery and approval of new anti-Gram-
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negative agents and is a cause for concern among clinicians, particularly with respect to treating
ESBL-producing Gram-negative pathogens in the community (Livermore, 2009). These are among
the reasons that the World Health Organisation recognises antibiotic resistance as a worldwide
threat to human health (World Health Organisation, 2012).
A major problem of novel antibiotic development is that many drug companies see it as an
unattractive financial risk. This is due to huge production costs for compounds which require
relatively small doses and short treatment cycles to be effective and which may not have a long
clinical shelf life (Kraus, 2008). Many 'Big Pharma' are focusing their efforts on compounds used
in long-term treatment plans, for chronic illnesses, obesity and quality of life drugs, all of which are
more likely to return greater profit than antibiotics (Kraus, 2008). However, many governments and
international agencies are aware of the situation and measures are being taken to raise awareness of
prescribing and misuse of antibiotics, such as the Stemming the Tide of Antibiotic Resistance
(STAR) protocol, which promotes appropriate antibiotic prescription in the UK (Simpson et al.
2009). There is also the implementation of antibiotic stewardship programs to provide guidance to
healthcare professionals on antibiotic prescribing (Charani et al. 2010).
The current situation of antibiotic resistance has renewed interest In antibiotic
development, although the research and development of novel antibiotic compounds is increasingly
being carried out in academia and smaller biotech companies rather than 'Big Pharma' (Kneller,
2010). There is also a large initiative by the Infectious Diseases Society of America (IDSA), "10 x
20" which aims to promote and sustain an R&D enterprise to develop 10 new antibacterial drugs by
2020 (Gilbert et al. 2010). In the UK, there is "Antibiotic Action", an initiative launched by the
British Society for Antimicrobial Chemotherapy (BSAC) which has the aim of making resistance a
public issue, by gathering parties from government, research, industry and charity to identify and
implement solutions for the discovery and development of future antibiotics (http://antibiotic-
action.coW
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1.3 Mechanisms of antibiotic resistance
There are many methods by which bacteria can become resistant to antibiotics, but the current scale
of the problem and the number of resistances against drugs across different classes is
unprecedented (Levy & Marshall, 2004). Listed here are a few major examples of clinically-
relevant resistance mechanisms in three categories: (i) drug inactivation/modification (section
1.3.1), (ii) reduced accumulation (via reduced permeability or enhanced efflux) (section 1.3.2), (iii)
target modification (section 1.3.3) and (iv) alteration of metabolic pathways (section 1.3.4). The
resistances investigated in this thesis are summarised in Table 1.2, presented in Figure 1.1 and
focus on Gram-negative bacteria.
Figure 1.1 A simplified schema illustrating some of the major mechanisms of antibiotic resistance
used by bacteria. Taken: from Levy & Marshall, 2004.
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1.3.1 Drug inactivation
The mechanism of action of an antibiotic may be disrupted either through degradation or chemical
modification of the agent, leading to changes in binding affinity and a reduction in efficacy. An
obvious example is the hydrolysis of ~-lactam antibiotics by ~-lactamase enzymes, probably the
most common resistance mechanism in Gram-negative bacteria (Bush & Jacoby, 2010). The ~-
lactams encompasses a vast collection of antibiotics, all with the characteristic ~-lactam ring
structure (Fig. 1.2). Their mechanism of action is to inhibit the enzymes involved in late stage
synthesis of cell wall peptidoglycan, leading to reduced integrity of cell wall and eventually,
cytosolic leakage and cell death. Paralogues (genes duplicated in the same organism) of these
peptidoglycan enzymes were detected, which were able to hydrolyse and cleave the ~-lactam ring,
leading to loss of antibiotic activity. These enzymes are known as ~-lactamases and number in the
hundreds (Bush & Jacoby, 20 10). Later, variants were detected that could hydrolyse more than one
sub-class of ~-lactam, so called extended-spectrum 13-lactamases (ESBLs), see multidrug
resistance, section 1.6.
(a)
/~gH 05R, .~
o * N # ~
COOH
Figure 1.2 Core structures of (a) cephalosporins; (b) penicillins and structure of (c) cefotaxime.
The beta-lactam ring is the square structure which simulates an amide bond. Taken from Bompard-
Gilles (2000).
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While many mechanisms of resistance exist for aminoglycoside antibiotics, chemical
modification is by far the most prevalent (Ramirez & Tolmasky, 2011). There are multiple
modifications documented which lead to the inactivation of aminoglycosides, through modification
of their hydroxyl and amino groups, which are required to interact with the ribosomal machinery.
The modifications which mediate aminoglycoside inactivation include N -acetylation e.g. the
enzyme AAC(6')-Ib, phosphorylation e.g. APH(3') and adenylation e.g. ANT(6) (Ramirez &
Tolmasky, 2011). Each enzyme has a specific spectrum of activity and as many of these enzymes
are plasmid-encoded, organisms have been documented carrying multiple aminoglycoside-
modifying enzymes (Davies & Wright, 1997).
1.3.2 Reduced drug accumulation
An obvious way to reduce the accumulation of an antibiotic is to prevent entry to the cell
altogether. By reducing the expression of the outer membrane porins, cells can restrict the entry of
a variety of compounds. Porins are outer membrane proteins which cross the outer membrane and
act like a channel through which molecules may pass e.g. metabolites (in) or toxins (out)
(Martinez-Martinez, 2008). As porins have different sized pores, bacteria can prevent entry of
antibiotic molecules while still allowing other nutrients free passage across the outer membrane
through selective porin regulation. For instance this can occur in E. coli, through reduction of
Ompf: or OmpF expression while not reducing OmpA (Tenover, 2006). This is a common strategy
for bacteria, particularly against carbapenem antibiotics, and has been documented in Pseudomonas
aeruginosa, Enterobacter cloacae and Klebsiella pneumoniae (Doumith et al. 2009; Jacoby et al.
2004).
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An alternative method of reducing antibiotic accumulation is to increase the efflux of
antibiotics from the cell. Efflux as a mechanism for antibiotic resistance was first described by
Mcmurry et al. (Mcmurry et al. 1980) who demonstrated that efflux pumps were responsible for
tetracycline resistance. Now the view is that efflux pumps are widely distributed across all domains
oflife and serve a variety of functions in the life cycle of bacteria to interact with their environment
(Martinez et al. 2009). There are many types of efflux pump, three of which confer multidrug
resistance (MDR; see section 1.6) phenotypes in Gram-negative bacteria: the major facilitator
superfamily (MFS), the ATP-binding cassette (ABC) superfamily and the resistance-nodulation-
cell division (RND) superfamily (Piddock, 2006). Here the focus will be on the RND-type family
as these are the pumps most-often associated with resistances of clinical significance. For instance,
they include: AcrAB- ToIC, present in many Enterobacteriaceae such as E. coli, Salmonella
typhimurium and Enterobacter cloacae (Perez et al. 2012). The MexXY -OprM and MexAB-OprM
pumps in P. aeruginosa, which provide inherent non-susceptibility to many compounds, including
fluoroquinolones, tetracyclines, aminoglycosides, macrolides and chloramphenicol (Tenover,
2006), also the AdeAB-ToIC pump in Acinetobacter baumannii (Homsey et al. 2010a). These
RND pumps consist of three subunits, in the case of AcrAB-ToIC; AcrB acts as the transporter or
efflux protein, located on the cytoplasmic membrane. AcrA is the periplasmic linker subunit
(known as a membrane-fusion protein) which spans the periplasmic space. In this pump TolC is the
outer membrane protein (OMP) channel used to extrude the molecule, although many proteins may
be used as OMP channels depending on the specific pump. AcrABC binds substrates from the inner
membrane or the cytoplasm and transports them to the extracellular medium (Piddock, 2006).
1.3.3 Target modification
Antibiotic targets may be modified either through natural chromosomal mutation or changes which
lead to chemical modification by host enzymes. Examples of antibiotic targets which mediate
resistance through modification include daptomycin, an anti-Gram-positive agent which was the
first in the novel class of lipopeptides. Its mechanism of action, though not entirely understood,
involves binding and subsequent calcium-dependent insertion into the bacterial cell wall. This
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disrupts the cell membrane, causing ion efflux, closely followed by loss of the ion concentration
gradient and depolarisation of the membrane, disrupting macromolecule synthesis and leading to
cell death (Beiras-Fernandez et al. 2010). There are many potential genes in which mutations could
give rise to daptomycin non-susceptibility, including mprF, )ycG, rpoB and rpoC (Friedman et al.
2006). The association of MprF with daptomycin resistance has been well documented in S. aureus
and is involved in the synthesis of the phospholipid precursor phosphatidylglycerol (Oku et al.
2004, Kristian et al. 2003). MprF catalyses the transfer of a lysine residue onto
phosphatidylglycerol to yield lysylphosphatidylglycerol, the incorporation of this into the
membrane increases the overall positive charge and repels Ca2+ ions, which are required for
daptomycin activity, rendering the organism resistant (Thedieck et al. 2006). This resistance
mechanism also confers resistance to a variety of cationic antimicrobial peptides, found both in the
environment e.g. soil, and in mammalian hosts as part of the immune system. This resistance
mechanism may confer a more virulent phenotype and increase the difficulty of organism clearance
during treatment.
Target modification is one method of resistance utilised against the fluoroquinolone
antibiotics. Although the accumulation of mutations in the target proteins are most common (Poirel
et al. 2012), other methods include reduced accumulation and plasmid-encoded proteins which
prevent quinolone activity. These agents act on the essential bacterial enzymes DNA gyrase
(primary target in Gram-negative bacteria) and DNA topoisomerase IV (primary target of Gram-
positive bacteria), large complex enzymes involved in the positive and negative supercoiling of
DNA. This is an important process in all aspects of nucleic acid maintenance and metabolism
including the replication, transcription, recombination, and repair of DNA (Jacoby, 2005). The
enzymes also have endonuclease properties, required to break double stranded DNA (dsDNA) and
ligate it with incorporated supercoils. The quinolones exploit this activity and trap the enzymes
when bound to dsDNA, causing unchecked breaks in the DNA to occur, leading to cell death.
Mutations in the DNA-binding domain of the genes encoding gyrase (gyrA) and topoisomerase IV
(pare) have been shown to decrease the binding affinity of quinolones, inhibiting their activity and
conferring resistance (Piddock, 2002).
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1.3.4 Alteration of metabolic pathwav
The alteration of a metabolic pathway (or metabolic bypass) to confer resistance to an antibiotic
involves acquiring a novel variant of an antibiotic-susceptible enzyme and using it in place of the
existing enzyme, 'bypassing' the metabolic susceptibility. This process can involve the addition of
whole operons rather than just single gene transfer. Examples include sulphonamide resistance: the
sulphonamides, while not the first antimicrobials discovered, were the first to be used in large scale
treatment of infections. They act upon the essential tetrahydrofolate biosynthetic pathway,
specifically they are competitive inhibitors of dihydropteroate synthase (DHPS), which starves the
bacteria of folate and leads to eventual cell death. Bacteria have circumvented the effects of this
agent by replacing DHPS with a sulphonamide-resistant variant, either sulI or sulII, effectively
bypassing the enzyme susceptible to antibiotic action (Wise & Abou-donia, 1975). There are few
available variants due to the constraints imposed upon the enzyme to retain normal activity as well
as sulphonamide resistance. However, due to their efficient vehicles for dissemination, such as the
transfer and acquisition of resistance plasmids (see section 1.5), these enzymes are widespread and
account for the vast majority of sulphonamide resistance in Gram-negative bacteria (Skold, 2001).
A similar mechanism is employed for resistance to trimethoprim, another synthetic antibiotic which
acts on the same pathway as the sulphonamides, but on the enzyme dihydrofolate reductase
(DHFR), which inhibits the synthesis of tetrahydrofolate. Plasmid-encoded dfr genes express
trimethoprim-resistant forms of the enzyme to confer resistance to trimethoprim and unlike the
sulphonamides, there are numerous forms of the enzyme (Skold, 2001).
The best characterised example is probably recruitment of the mecA gene by methicillin-
resistant Staphylococcus aureus (MRSA). S. aureus has a variety of penicillin-binding proteins
(PBPs) involved in peptidoglycan turnover of the cell wall e.g. PBP2 has transpeptidase and
transglycosylase activities. Normally, the presence of p-Iactams would inhibit the PBPs and lead to
eventual cell death due to loss of cell wall integrity. However, PBP2a encoded by the mecA gene
and transported on a mobile genetic element called the staphylococcal cassette chromosome
(SCCmec) is not susceptible to most p-Iactams and provides transpeptidase activity unhindered
(Fuda et al. 2005). The result is that MRSA isolates have resistance to most ~-lactam antibiotics.
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1.4 Phvsiological role of resistance components: resistance in the environment
Given the number of resistances across different drug classes and the speed with which bacteria
acquire resistance to agents with novel mechanisms of action, many investigators have turned to
the environment to seek out sources of resistance or reservoirs of resistance mechanisms. Indeed,
there are obvious animal sources of drug resistance, such as from the farming of animals for meat
and poultry. Here antibiotics were routinely used (and still are in developing countries) as growth
promoters to produce much larger animals, allowing the energy and nutrient resources previously
used to fight off infections to be used to increase animal growth and prevent loss oflivestock due to
illness (Dibner & Richards, 2005). Antibiotics are also heavily used in agriculture, administration
of antibiotics can boost product yield by preventing disease and pests although this is a practice
which is diminishing e.g. in 2006 the EU placed a ban on the feeding of all antibiotics to farm
animals for growth purposes (upgraded from a partial ban placed in 1998) (Martinez, 2009).
For a time it was believed that these human-influenced environmental sources of
antibiotics were solely responsible for the rise in resistance, however mechanisms of resistance
have been discovered in the natural environment far away from human-populated areas. For
example, E. coli resistant to tetracyclines, ampicillin, chloramphenicol and streptomycin were
detected in 92% of the remote, high-altitude community of Peruvian Amazonas, far-removed from
modem antibiotic exposure (Bartoloni et al. 2009). There have also been reports of bacteria from
the pre-antibiotic era possessing resistance enzymes e.g. Song et al. recovered bacteria from deep
ocean sediments (c. 10,000 years old) and found that a small number carried ESBLs highly similar
to TEM ESBL (Song et al. 2005). D'Costa and colleagues reported on the detection of resistance
genes in bacteria sampled from ice cores over 30,000 years old and detected, among others,
aminoglycoside resistance protein AAC(3), tetracycline protection protein TetM, a member of the
TEM ~-lactamases and vanX, a component from the vancomycin resistance operon (D'Costa et al.
2011).
Hence, resistance to antibiotics, and the dissemination of resistance, is not a novel phenomenon. As
Allen et al. discuss, resistance genes in the natural environment are extremely prevalent (Allen et
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al. 2010). Enzymes conferring drug resistance often have natural roles in bacteria, some are
variants of proteins possessing essential functions in cellular physiology e.g. penicillin-binding
proteins were originally involved in the maintenance and modification of cell wall peptidoglycan.
Furthermore, CTX-M p-lactamases originated from a variant of penicillin-binding proteins in
Kluyvera sp. (Canton et al. 2012) and TetX genes found to confer tetracycline resistance in soil-
dwelling Bacteroides fragilis, were originally used as monooxygenase enzymes (Volkers et al.
2011). Efflux pumps are involved in many natural processes, from reduced accumulation of toxic
compounds from environment, such as heavy metals, to the extrusion of signal molecules
mediating cellular communication (Martinez et al. 2009).
There is an abundant natural source of potential resistance genes providing a repository
from which pathogenic bacteria could draw on. This was recently highlighted by D'Costa, who
showed that even for daptomycin, one of the few novel classes of antibiotic for years, multiple
resistance mechanisms were found in environmental actinomycetes, including ring hydrolysis and
acetylation of the hydrophobic tail (D'Costa et al. 2012). As we come to understand more of the
microbial biosphere, it seems that the reservoir of resistance that many are searching for may be
bacteria themselves (Forsberg et al. 2012). While this may answer how bacteria may rapidly
become resistant to even novel agents without requiring previous exposure, it does not explain how
specific- and multidrug-resistances have become so widespread.
1.S Molecular spread of resistance
The most obvious method of resistance transmission would be to pass on the gene directly from
mother cell to daughter cell i.e. the vertical spread of resistance. An increase in the prevalence of a
resistance mechanism is often aided by the expansion of successful bacterial lineages or clones
(descendants of a common strain). Examples of successful clones include ST131 E. coli. which
often carry CTX-M-15, ST258 Klebsiella pneumoniae, which often carry KPC carbapenemase and
the OXA-23 clone 1Acinetobacter baumannii (Woodford et al. 2011).
As described in section 1.4, resistance to a variety of antibiotics has existed in the
environment for millennia, it is likely that the means to spread these resistance determinants
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between bacteria have been around just as long e.g. horizontal gene transfer (HGT). The ease of
resistance transmission combined with successful clones, can result in the rapid spread of a
resistance mechanism. There are three main molecular mechanisms of HGT and resistance
dissemination in bacteria: bacteriophages; transposable genetic elements; and plasmids (see Fig.
1.3); (i) bacteriophages are bacterial viruses which infect prokaryotic cells and deliver their genetic
material from a protein capsid. These genes code for proteins to make more viruses, utilising the
host's replication machinery to copy their DNA and express capsid proteins to make more phage
particles (Frost et al. 2005). When packing the phage particle with DNA, bacterial chromosomal
material adjacent to the phage may be excised also, packaged with the prophage and upon infecting
a new host, integrated it into the new chromosome. Sometimes there may be no phage genes at all
and the defective virion serves only to transfer bacterial DNA from one cell to another (Brussow et
al. 2004). Bacteriophages are important for bacterial pathogenesis, pathogens such as
Corynebacterium diptheriae, Clostridium botulinum and Streptococcus pyogenes all contain phage-
encoded toxins (Brussow et al. 2004) and are also known to play a role in the dissemination of
antibiotic resistance genes (Fancello et al. 2011).
(ii) Transposable genetic elements, including: insertion sequences (ISs), transposons and
integrons within. The transposases (enzymes which carry out the insertion and excision activities)
encoded by transposons and ISs are believed to be the most abundant proteins in nature (Aziz et al.
2010), highlighting the fundamental role this widely used process plays in the evolution and
ecology of all forms of life.
ISs are the simplest transposable genetic elements, they consist of only genes encoding
transposition activity, usually flanked by inverted repeat sequences and do not carry other
accessory genes e.g. antibiotic resistance genes. They are able to insert themselves into a DNA
molecule through the transposase, which has the potential to cause mutations e.g. insertional
inactivation, and promotes bacterial genetic diversity (Toleman & Walsh, 201l). ISs are frequently
found on plasmids and are often linked with antibiotic resistance genes e.g. ISEcpl and ISCRI
enable the mobilisation of blacrxu genes (Canton & Coque, 2006).
Transposons are similar to IS in that they contain a transposase flanked by inverted repeats,
however some transposons also carry a repressor to regulate transposition. They regularly carry
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accessory genes between the inverted repeat regions and transfer them to other locations on the
chromosome or to different cells (Frost et al. 2005).
Integrons are based on a platform that incorporates genes by site-specific integration and
all contain three basic elements: the intI gene, encoding an integrase; a promoter Pc and a specific
recombination site attl, which allows the recombination of various resistance gene cassettes,
encoding resistance determinants to almost every type 0 f antibiotic (Stalder et al. 2012).
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Fig. 1.3 A schema describing the potential molecular mechanisms which promote dissemination of
resistance genes. I) Transduction 2) Conjugation 3) Transposition. Taken from: Frost (2005)
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(iii) Plasm ids are (usually) circular molecules of DNA that can replicate independently
from the chromosome and provide extra genes, which may provide an advantage to the host e.g.
they may code for toxins, metabolic proteins and antibiotic resistance determinants. Plasmids differ
from the previously mentioned elements in that they may carry many genes and it is quite usual to
see resistance plasm ids of more than 100 kb (Karisik et al. 2006). They may be either conjugative,
that is, encoding the proteins required to facilitate cell-to-cell DNA transfer and can have a range of
hosts, or they may be non-conjugative, that is, they do not have the machinery for cell-to-cell
transfer but still contain enzymes to transfer individual genes (Bennett, 2008). In Gram-negative
bacteria, this machinery is known as a sex pilus such as the F pilus of E. coli, similar to type IV
secretion apparatus which acts to pull two bacterial cells together, fuse their membranes and allow
exchange of cytoplasmic material (Bennett, 2008). Conjugation has played an important role in the
dissemination of resistance genes between and within many bacterial pathogens, as there is
minimal energy cost to the host, replication is host-independent and no recombination is necessary
for genetic insertion (Carattoli, 2009).
1.6l\1ulti-drug resistance (MDR)
Given the variety of potential mechanisms that exist for antibiotic resistance, and the fact that the
genetic determinants for these resistance mechanisms are able to mobilise and transfer freely from
one organism to another, it is unsurprising that sometimes organisms pick up more than one. Most
of the previously mentioned mechanisms of antibiotic resistance (section 1.3) were single
determinants of resistance, allowing tolerance of one particular compound or group of compounds.
However, combinations of these mechanisms (or alone for some mechanisms e.g. drug efflux) can
lead to multi drug resistance or MDR. An MDR organism is defined as one that is simultaneously
resistant to several (more than three) structurally and functionally different drugs (Magiorakos et
al. 2011). It was originally described by Watanabe referring to strains of Shigella dysenteriae
which harboured transferable resistance determinants for streptomycin, tetracycline and
sulphonamides in Japan (Watanabe, 1963).
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MDR organisms are resistant to agents crossing different drug classes, possibly without the
need for prior exposure, and in some cases can spread intra- and inter-specially with great rapidity
due to the aforementioned molecular mechanisms promoting dissemination (Canton & Coque
2006; Smillie et al. 2010). Combined with the numerous molecular methods of resistance
dissemination, the spread of MDR bacteria is a key threat to global health and the reason for this
study.
Mechanisms of resistance that confer MDR phenotypes include: Ci) Effiux pumps, which were
mentioned previously in section 1.3.2, but given that RND effiux pumps can extrude many
different chemicals and chemical classes non-specifically, it follows that this molecular mechanism
is capable of conferring MDR to a variety of antibiotics. Although effiux pumps do not naturally
confer MDR phenotypes, a simple mutation in a promoter/repressor to upregulate the pumps, may
lead to MDR (Keeney et al. 2007; Homsey et al. 20l0a; Ruzin et al. 2005). An example of an
efflux pumps conferring MDR has been demonstrated by Homsey et al. who showed that treatment
of E. cloacae with ciprofloxacin caused upregulation of the AcrAB-ToIC pump, conferring
resistance to ciprofloxacin and also tigecycline (Homsey et al. 2010b).
(ii) The term extended-spectrum ~-lactamases CESBLs) was first coined to describe
variants of the TEM and SHY ~-lactamases. The criteria were: (i) high catalytic rates for the
oxyimino-cephalosporins and (ii) extended spectrums of activity compared to their parent enzymes
(Livermore, 2008). The term now includes many enzymes which only have to meet either one of
the criteria (Livermore, 2008). There are now multiple classes of ESBL with hundreds if not
thousands of members e.g. Class A (CTX-M ESBL), Class B [metallo-ji-lactamases), Class C
(AmpC ESBL) and Class D (OXA ESBL).
Class B includes many of the carbapenemase enzymes, which represent the most versatile
family of ~-lactamases and one with the greatest spectrum of activity. Although called
carbapenemases, many of these enzymes have activity against the majority of ~-lactams but
without the susceptibility to ~-lactamase inhibitors e.g. clavulanic acid (Queenan & Bush, 2007).
The class B enzymes contain zinc metal in their catalytic sites rather than serine, which is utilised
by other clinically problematic carbapenemases including KPC, originally from Klebsiella
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pneumoniae, and the OXA carbapenemases, a problem commonly associated with Acinetobacter
baumannii (Woodford et al. 2006). More recently NDM-1 was discovered, amid much controversy,
and was found to confer resistance to almost all available beta lactam antibiotics, including the
clinically important carbapenems. As it has the potential to disseminate in a similar manner to the
CTX-M and carbapenemase enzymes before it, it represents a global threat in the treatment of
MDR infections (Kumarasamy et al. 2010).
(iii) These mechanisms may be exacerbated when combined with porin deficiency, as it
widens the resistance profile of the organism. For example, chromosomal AmpC in combination
with porin deficiency in Enterobacter cloacae gives resistance to 4th generation cephalosporlns
(Paterson, 2006). ESBL-producing K. pneumoniae with reduced porin expression can potentially be
resistant to carbapenems (Martinez-Martinez, 2008). It is thought that although ESBLs have poor
rates of hydrolysis of carbapenems, the reduced accumulation conferred by alterations in porin
expression allows the degradation of carbapenems at low levels (Nikaido, 2009).
(iv) As mentioned previously in section 1.5, resistance plasmids are capable of carrying
many genes (>100) and can be very large (>100 kb). Examples of MDR plasmids include
incompatibility group IncF, which often carry the blaCTx_Mgenes e.g the blacTx-M-J5gene is often
associated with blawf-J, blaox4-J and aac(6 ,)-Ib-cr genes (Carattoli, 2009). Today there are
plasmids harbouring multiple resistance determinants covering different classes, capable of
conferring MDR with just one plasmid transfer. This contributes heavily to explain why bacterial
pathogens whose treatment was once straightforward are now resistant to many or all of the
treatment options (Rossolini & Mantengoli, 2008). This is exemplified by the rise of MDR Gram-
negative pathogens resistant to all routinely-prescribed agents, which are an increasing concern
(Livermore, 2004). The organisms selected for investigation in this thesis are all MDR Gram-
negative pathogens and represent resistances of public health concern.
37
1.7 Resistances investigated in this thesis
1.7.1 ESBL-producing Escherichia coli
Extended-spectrum ~-lactamases (ESBLs) hydrolyze a wider range of p~lactam antibiotics and
were first reported in the 1980s as variants of the classical SHY and TEM p-Iactamases. CTX-M
enzymes have subsequently established themselves as the dominant ESBLs worldwide (Bonnet,
2004; Canton & Coque, 2006). Their name is derived from their ability to hydrolyse cefotaxime
(CTX) and they are defined by a weaker activity against the related compound ceftazidime
(Woodford et al. 2004). CTX-M-15 is the most successful CTX-M ESBL in the UK and globally, it
has a greater activity against ceftazidime when compared to most CTX-M enzymes (Poirel, 2002).
The CTX-M ESBL-encoding genes are thought to have been captured from the chromosome of
Kluyvera spp. on conjugative plasmids, which helped mediate their dissemination (Canton &
Coque, 2006; Rossolini &Mantengoli, 2008).
CTX-M-15 ESBL is usually encoded on large multi-resistance plasmids, with E. coli now
the main host species (Canton & Coque, 2006). This is a problem in itself as E. coli is a highly
prevalent organism and the most frequent causative agent of bacteraemia and urinary tract
infections (UTIs) (Livermore et al. 2008). These plasmids not only facilitate the spread of ESBLs
but they can also harbour a range of unrelated antibiotic resistance genes, seriously reducing the
treatment options of plasmid-containing organisms. For example, the plasmids found in successful
UK clones contain genes for resistance to trimethoprim, tetracycline, chloramphenicol and
aminoglycosides (Bonnet, 2004; Karisik et al. 2006). These additional resistances also aid the
spread of CTX-M ESBLs via indirect selective antibiotic pressure i.e. selection pressure with an
antibiotic on the same plasmid as a CTX-M enzyme could select for CTX-M-producing strains
even though the organism was never exposed to cefotaxime.
Different strains harbouring defined resistance plasmids/genes are endemic in countries
across the world (Canton & Coque, 2006). The CTX-M enzymes are thought to be so widely
disseminated in part due to the spread of pandemic uropathogenic clones and partly because of the
accumulation of highly transmissible genetic elements on successful plasmids. These elements
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include insertion sequences, transposons and integrons, some of which act as promoters for the
resistance genes themselves (Dhanji et al. 2011).
1.7.1.2 Escherichia coli
Escherichia coli is a natural commensal Gram-negative organism and is one of the most
extensively studied bacterial species. However, some strains have diverged to form pathogenic
variants, able to cause disease within the intestine (diarrheagenic E. coli) or outside it
(extraintestinal pathogenic E. coli or ExPEC). These pathogenic strains have subtypes or
pathotypes, possessing similar virulence factors and displaying similar disease outcomes (Wiles et
al. 2008). The pathotypes have distinct sites of infection, but one of the most commonly
encountered is uropathogenic E. coli (UPEC). Although they are extraintestinally pathogenic,
UPEC isolates still reside in the gut, which is thought to be a reservoir for these pathogens (Sivick
& Mobley, 2010). About 70-95% of community urinary tract infections (UTls) and about 50% of
nosocomial UTls involve UPEC isolates, which often involve recurring infections (Wiles et al.
2008). It is known that specific clonal isolates of E. coli have participated in the global
dissemination of CTX-M enzymes, such as ST131 which is associated with CTX-M-15 carriage.
Also, the majority of E. coli which make up these pathogenic clones are UPEC isolates (Canton et
al. 2012). As UTls are one of the most common human infections, it becomes clear that this is a
model for resistance dissemination which is worth investigating to probe ways of preventing global
dissemination of resistance determinants. Although the resistance determinants on the plasmids
used in this study have been well characterised previously (Dhanji et al. 2011; Karisik et al. 2007),
this study utilises proteomics to probe deeper into the physiological changes in the cell.
1.7.2 Carbapenem resistant Klebsiella pneumoniae
1.7.2.1 Carbapenems and carbapenemases
Carbapenems have the broadest activity of all p-Iactam antibiotics and are often the agents of last
resort to treat serious infections caused by Gram-negative bacteria (Kattan et al. 2008). The
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carbapenems are a relatively recent addition to the antibacterial arsenal; imipenem and meropenem
were the first agents to be released (1984 and 1995, respectively) and resistance has been sparse.
However, when ertapenem, a new agent was licensed in 2001, cases of resistance were reported
relatively rapidly as ertapenem has decreased activity as compared with other carbapenems against
bacteria that produce ESBLs (Kattan et al. 2008). There have also been cases where treatment of
an infection with imipenem has actually selected for ertapenem resistance (Lartigue et al. 2007).
Although as cell impermeability was a factor, this may just have been class-wide cross-resistance.
More recently, production of a carbapenemase has become one of the main mechanisms of
resistance to carbapenems. Most of these diverse enzymes have an extremely broad substrate range
and are able to hydrolyse many ~-lactam antibiotics (Kattan et al. 2008). At the same time, many
are unaffected by ~-lactamase inhibitors (Queenan & Bush, 2007). Other mechanisms of
carbapenem resistance have been described, such as reduced membrane permeability (often
through reduced expression of outer membrane porins), up-regulated efflux pumps (which expel
the antibiotic e.g. ertapenem, from its site of action) or a combination of mechanisms (Szab6 et al.
2006). For instance, E. coli isolates that hyperproduce an AmpC ~-lactamase or ESBL and also
have decreased permeability through down-regulated expression of outer membrane proteins
(OMPs; e.g. OmpC/OmpF), are resistant to ertapenem (Mammeri et al. 2008; Poirel et al. 2004).
While there is concern regarding the wider dissemination of carbapenemases, the genes encoding
them can be detected by PCR. However, non-carbapenemase-producing isolates pose problems for
reference laboratories, where isolates such as K. pneumoniae present high carbapenem MICs but
are negative for any carbapenemase (Woodford et al. 2007).
1.7.2.2 Klebsiella pneumoniae
K. pneumoniae is a commensal organism and is also present in the environment, it is however an
opportunistic, Gram-negative pathogen capable of causing severe disease in humans and animals. It
is a prominent nosocomial pathogen that frequently causes respiratory infections, bacteraemia and
UTIs (Brisse et al. 2009). Carbapenems are one of the last remaining treatment options for MDR
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ESBL-producing K. pneumoniae. Now carbapenem-resistant K. pneumoniae are on the rise
worldwide, with endemic situations in some countries (Nordmann et al. 2009). As with other MDR
Enterobacteriaceae isolates, there are high mortality rates (c. 40%) associated with this organism
and debilitated patients with prior antibiotic treatment are at the greatest risk (Nordmann et al.
2009).
While much attention has been given to carbapenemase-producing Enterobacteriaceae, the
combination of reduced permeability and ESBL production still occurs (Webster et al. 2010) and
can give erroneous results in antibiotic resistance assays e.g. a non-carbapenemase-producing
isolate with reduced porin expression and an ESBL would give MICs similar to carbapenemase
producers. For example in a recent study conducted in Chile, 61 carbapenem resistant
Enterobacteriaceae isolates were tested for carbapenemase and all returned as negative (Wozniak
et al. 2012). For non-carbapenemase-producing K. pneumoniae, it was found that porin alteration
was the most important factor in carbapenem resistance rather than presence of an ESBL (Wozniak
et al. 2012).
Although the underlying changes resulting from this resistance mechanism are poorly
defined, it is probable that they will involve changes to the bacterial proteome. Utilising a
proteomic approach may help to elucidate these changes and the potential causes of them such as
direct changes in the genes, or their regulatory sequences or indirectly through changes in global
regulatory loci. For instance changes in the mar locus of E. coli can produce a multi drug resistance
(MDR) phenotype via up-regulation of the AcrAB-ToIC tripartite efflux system (Alekshun & Levy,
2007; Randall & Woodward, 2002). The carbapenems have been referred to previously as agents of
last resort or 'silver bullets'. but with resistance on the rise, there is the potential that carbapenems
may be rendered ineffective in the future. Therefore, investigation into these mechanisms of
resistance is of high importance to public health.
Using proteomics to analyse the changes in protein expression profile between
carbapenem-susceptible and -resistant non-carbapenemase-producing isolates may elucidate other
proteins which have a role in the resistance mechanism, a protein marker for reduced porin
expression or even a protein which may serve as a novel antimicrobial target.
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1.7.3 Tigecvcline resistance
Tigecycline is a semi-synthetic derivative of minocycline and is a member of the novel
glycylcycline class of antibiotics, based on the tetracycline molecular frame (Fig 1.4) (Kelesidis et
al. 2008). Tigecycline retains activity against isolates carrying the tet genes encoding tetracycline
efflux and ribosomal-protection resistance mechanisms (Fritsche et al. 2005). Tigecycline has a
broad range of in vitro activity across many Gram positive species such as MRSA (Fritsche et al.
2005) and anaerobes such as Bacteroides, Prevotella and Clostridium sp. (Nagy & Dowzicky,
2010).
(a) H~'N""'O:I"3
H :.,: OH
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Figure 1.4 Chemical structures of a) tetracycline b) minocycline and c) tigecycline. Taken from
Livermore et al. (2005).
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Tigecycline also had in vitro activity against many members of the Enterobacteriaceae and
particularly against ESBL-positive MDR E. coli and Klebsiella sp. isolates (Kelesidis et al. 2008)
and also MDR and non-MDR A. baumannii (Karageorgopoulos et al. 2008). However,
Pseudomonas aeruginosa and the Proteae are inherently resistant due to the possession of multiple
RND efflux pumps (Livermore, 2005). This same resistance mechanism is also possible in other
Gram-negative pathogens, the upregulation of RND efflux pumps as a mechanism for tigecyc1ine
resistance has been documented in organisms such as Klebsiella pneumoniae (Ruzin et al. 2005),
Acinetobacter baumannii (Homsey et al. 20 lOa; Peleg et al. 2007), Enterobacter cloacae
(Homsey et al. 2010b; Keeney et al. 2007) and Serratia marcescens (Homsey et al. 2010c).
There are very few agents to which tigecycline-resistant MDR pathogens remain
susceptible, often the last antibiotics available for tigecycline-resistant organisms are the
polymyxins (e.g. colistin and polymyxin B). These agents were never widely used due to their
toxicity, but have seen a resurgence in interest in recent years due to ever-increasing numbers of
MDR pathogens (Zavascki et al. 2007).
Three organisms of public health importance were selected from the AMRHAI collection
for the investigation into efflux-mediated tigecyc1ine-resistance in MDR Gram-negative pathogens.
1.7.3.1 Tigecycline resistance in Adnetobacter baumannii
The Acinetobacter spp. first came to prominence in the 1970s as nosocomial pathogens, with the
majority of isolates displaying susceptibility to commonly used antibiotics (Towner, 2009). The
most clinically important species is Acinetobacter baumannii and multidrug-resistant (MDR)
strains have emerged in the past two decades as nosocomial pathogens affecting severely
debilitated patients and often giving rise to outbreaks (Hanlon 2005, Dijkshoom et al. 2007) where
it can be difficult to eradicate.
A. baumannii has a plethora of potential body sites it may colonise, with infections
including bacteraemia, pneumonia, meningitis, urinary tract infections and wound infections
(Maragakis & Perl, 2008) but the most clinically important is in ventilator associated pneumoniae
(Livermore, 2009). Mortality from Acinetobacter infections has been reported as high and ranges
43
from around 52% (Dijkshoom et al. 2007) to 75% (Smith et al. 2007). But as many A. baumannii
infections are in immunocompromisedldebilitated patients, little is known about this organisms'
pathogenicity and mortality figures are the subject of much debate (Dijkshoom et al. 2007).
A. baumannii has become notoriously resistant to antibiotics, for instance, the cell
membrane is much less permeable than in E. coli and compared even with P. aeruginosa,
cephalosporin permeability is 5-fold less in A. baumannii (Vila et al. 2007). When combined with
the expression of several efflux pumps, these features make A. baumannii a particularly difficult
pathogen to treat. Common treatment options for Acinetobacter infection used to include
carbapenems imipenem and meropenem, but these have become less effective due to increasing
prevalence of MDR A. baumannii with OXA- or metallo-carbapenemases (Livermore, 2009). Other
options include aminoglycosides, which are still used in combination therapy for Acinetobacter
infections and the J3-lactamase inhibitor sulbactam which has unusual intrinsic activity against
Acinetobacter and is also used in combination with other agents (Dijkshoom et al. 2007).
However, there are even fewer therapeutic options for patients infected by the rising
numbers of carbapenem-resistant strains, which are often susceptible only to polymyxins and
tigecycline, but with resistance sometimes noted even against these agents (Peleg et al. 2007,
Moffatt et al. 2010). A. baumannii is known for its pandrug resistance (PDR) potential (Falagas &
Bliziotis, 2007), that is, resistant to all routinely tested antibiotics (Magiorakos et al. 2011) and
although PDR is rarely reported, it has important public health implications.
AMRHAI has previously reported on a pair of MDR A. baumannii isolates belonging to the UK
epidemic strain, OXA-23 clone 1 collected from a patient in intensive care before and after a week
of tigecycline therapy. Tigecycline-resistance in the post-therapy isolate resulted from AdeS-
mediated up-regulation of the AdeAB-ToIC efflux pump (Homsey et al. 2010a). This mechanism
for tigecycline resistance has been described in other isolates (Ruzin et al. 2007). It remains
unclear, however, whether the up-regulation of the AdeAB-ToIC efflux pump is the only event in
the acquisition of tigecycline resistance or whether it is one of a series of global changes with
broader effects on resistant isolates.
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While proteomics has been used before to investigate consequences of antibiotic resistance
in A. baumannii (Fernandez-Reyes et al. 2009; Vashist et al. 2010; Yun et al. 2008), no proteomic
studies have been carried out involving tigecyc1ine resistance.
1.7.3.2 Tigecvcline resistance in Enterobacter cloacae
Enterobacter cloacae is an important nosocomial pathogen, particularly in neonatal and paediatric
intensive care units (ICUs) where it often causes outbreaks (Dalben et al. 2008). It is a versatile
pathogen, as infection can manifest through lower respiratory tract infections, urinary tract
infections, bacteraemia, meningitis, endocarditis and skin and soft tissue infections (Sanders &
Sanders 1997). Like A. baumannii, it causes opportunistic infections in debilitated patients and
mortality from these infections is potentially high (Liu et al. 2004).
Treatment of E. cloacae infections can be problematic, owing in part to chromosomal
AmpC ~-lactamases, which can be induced by ~-lactam exposure and confer intrinsic resistance to
certain antibiotics e.g. cephalosporins (Paterson, 2006). In combination with decreased
permeability, AmpC de-repression can confer resistance to a broader range of antibiotics including
many 4th generation cephalosporins and even carbapenems (Doumith et al. 2009). Resistance to the
latter is steadily increasing, leaving few effective therapeutic options available except polymyxins
and tigecycline (Livermore et al. 2008).
Tigecycline has good in vitro activity against many Enterobacteriaceae (Hope et al. 2010),
although multi-resistant Enterobacter spp. are among the least susceptible, often with MICs close
to the current susceptible breakpoint (lmg/L) (Andrews & Howe 2011). Also, the broad substrate
ranges of many efflux pumps can complicate the choice of appropriate treatment regimens.
Furthermore, full resistance to tigecycline has been reported to be conferred by the RamA-mediated
up-regulation of the AcrAB-ToIC efflux pump (Keeney et al. 2007).
AMRHAI has previously reported on a tigecycline-susceptible and -resistant pair of clinical E.
cloacae isolates from a single patient (Homsey et al. 20l0b). They were recovered before and after
ciprofloxacin therapy, which may have selected for the up-regulated AcrAB expression that was
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responsible for tigecycline resistance. While this resistance mechanism has been previously
described in other isolates (Perez et al. 2007) and investigations into efflux-mediated resistance in
E. cloacae have been reported (Keeney et al. 2007; Perez et al. 2012). No known studies have
attempted to use proteomics to further probe and characterise the proteins involved in this
tigecycline resistance mechanism.
1.7.3.3 Tigecvcline resistance in Serratia marcescens
Serratia marcescens is an important opportunistic nosocomial pathogen, it is ubiquitous in the
environment and has a broad host range including plants and both vertebrates and invertebrates
(Van Houdt et al. 2007). S. marcescens is capable of causing infections in a broad range of sites
including: bloodstream infections, conjunctivitis, pneumonia, urinary tract infections, meningitis,
otitis externa and gastroenteritis (Hertle, 2005; Voelz et al. 2010). S. marcescens is also frequently
associated with outbreaks, particularly in neonatal units, where this organism is a problematic and
increasingly reported pathogen (Voelz et al. 2010). Like the two previous organisms selected for
investigation of tigecycline resistance, S. marcescens also has a high mortality rate in debilitated
patients, particularly in neonates (Maragakis et al. 2012).
Treating S. marcescens infections can be problematic due to the inherent resistance to
many antibiotics, including members of the quinolones, ~-lactams, macrolides, tetracyclines and
polymyxins (Fritsche et al. 2005; Mahlen, 2011). S. marcescens also produces chromosomal AmpC
~-lactamase which confers resistance to an even wider range of p-lactams. If these enzymes are de-
repressed, the potential consequences can include resistance to carbapenems, which are frequently
used as agents of last resort (David et al. 2006). Aside from the carbapenems, often the only
remaining therapeutic option is tigecycline, which has reasonable activity against S. marcescens,
although it is less susceptible than other Enterobacteriaceae (Livermore et al. 2008). Efflux-
mediated resistance is also known to cause elevated MICs for members of the Enterobacteriaceae
(Homsey et al. 20l0b; Ruzin et al. 2005) and since S. marcescens possesses multiple efflux pumps
(Begic & Worobec, 2008; Homsey et al. 20l0c), it is capable of conferring resistance to a wide
variety of unrelated compounds. The broad substrate ranges of many efflux pumps can complicate
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the choice of appropriate treatment regimes and in an intrinsically resistant species such as this,
efflux-mediated resistance to multiple antibiotics could make it an extremely difficult infection to
clear.
AMRHAI has previously reported a S. marcescens clinical isolate, SM346, with resistance
to tigecycline (MIC = 16 mgIL) attributed to up-regulation of the SdeXY-HasF tripartite efflux
pump (Homsey et al. 2010c). Comparative, quantitative proteomics techniques were employed to
compare the proteome of SM346 against the S. marcescens type strain NCTC 10211 with the aim
of characterising the proteins associated with this efflux-mediated resistance mechanism.
1.8 Detecting and interpreting antibiotic resistance
Understanding the molecular mechanisms responsible for antibiotic resistance is imperative in
adapting patient treatment. It can help in the identification of new drug targets and hence lead to the
discovery of novel antibiotics. Alternatively, it can provide the means to inactivate/circumvent
resistance mechanisms and grant renewed activity to formerly ineffective drugs. For example,
combination therapies have proved very successful in circumventing ESBL-mediated resistance
with the use of ~-lactamase inhibitors e.g. clavulanate with ampicillin or tazobactam with
piperacillin (Lee et al. 2003). To aid this understanding of resistance mechanisms, we must know
more about the proteins involved in resistance. For instance drug design and resistance mechanism
determination are often based around the crystal structures of proteins e.g. efflux pumps and porins,
antibiotic-modifying enzymes (Simmons et al. 2010).
Mechanisms of antibiotic resistance may be inferred from the results of classical
susceptibility testing methods, such as disc diffusion and minimum inhibitory concentration (MIC)
assays (Andrews & Howe, 2011). These techniques give a resistance phenotype and allow
mechanisms of resistance to be inferred through 'interpretative reading' (Livermore et al. 2001), a
strategy which analyses the susceptibility of an isolate to a range of compounds and compares the
patterns of different classes to elucidate underlying mechanisms of resistance. The inferred
mechanism allows healthcare professionals to advise the appropriate antibacterial regimen for
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patient treatment based on the determined susceptibilities. It also allows laboratories to monitor the
prevalence and spread of resistance, but it can be time consuming and remains an inexact science.
There have been recent advances in MALDI-TOF mass spectrometry which allow rapid
detection (1-2 hours) of carbapenemase enzymes in bacteria (Burckhardt & Zimmermann, 2011).
But the precise mechanism of resistance can still be elusive and further tests must be done to
determine the resistance phenotype of the organism. For example, isolates with reduced porin
expression would give a negative result for carbapenemase production, but are still resistant to the
antibiotic (Wozniak et al. 2012).
To provide more information on these mechanisms, certain proteomics techniques may
reveal more than conventional assays and could prove useful in furthering understanding of
resistance mechanisms and allow more accurate interpretation of resistance phenotypes. Current
molecular approaches to dissect out mechanisms of antibiotic resistance include, among others:
PCR screening for resistance genes (simplex, multiplex or Real-Time PCR), DNA sequencing,
micro arrays and other hybridisation technologies (Woodford & Sundsfjord, 2005). However,
DNA-based methods only provide information on the presence of a resistance gene and are limited
by the availability of DNA sequence information, Even quantitative RT -PCR, which can generate
data on the levels of mRNA transcribed from a resistance gene, does not give reliable data e.g.
mRNA levels are not a direct reflection of translated protein content in the cell (Graves &
Haystead, 2002). The study of proteins also gives the advantage of quantification, the expression
levels of individual proteins may be measured in response to environmental stimulation e.g.
addition of an antibiotic. Despite this, DNA-based techniques are still required, as mechanisms of
resistance require information on both the genotype and phenotype to be fully understood.
Proteomics may provide an alternative, but complementary approach to elucidate mechanisms of
antibiotic resistance.
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1.9 Proteomics
1.9.1 Complexity ofthe Proteome
The term 'Proteome' was coined by Marc Wilkins in 1994 as an analogy to the entire PROTEin
complement encoded by a genOME. Proteomics encompasses the extraction, separation, analysis
and eventual identification of proteins expressed in the cell/organism of interest under a defined set
of conditions (Wasinger et al. 1995). The proteome of a cell is highly dynamic and complex, the
expression levels of proteins will fluctuate over time as the bacterium, in this case, continually
adapts to changes in its environment. By visualising and identifying components of the proteome, a
vast wealth of information may be acquired not only on the effects of an environmental change
(e.g. expression of a resistance enzyme in response to an antibiotic), but how this change affects
other parts of the cell (e.g. effect of antibiotic on bacterial cell wall synthetic pathways) (Graham et
al. 2011). In what is termed comparative proteomics, comparing two extracts of the same isolate
under two different conditions will return two lists of proteins. The differences in these lists may be
assigned to the condition that prompted their expression (e.g. high osmolarity), allowing the
elucidation of which proteins are important or required for the condition (e.g. outer membrane
porins) and the characterisation of the physiological response.
Furthermore, proteomics techniques enable users to study the expression levels of proteins,
something which cannot be inferred from DNA· sequence analysis. There are transcriptomics
techniques available to study gene expression (Croucher & Thomson, 2010), but mRNA levels are
known to correlate poorly with protein expression levels (Laurent et al. 2011). This is because
mRNA transcription is only the first step in protein synthesis, proteins can have many isoforms and
can be further regulated by protein turnover, secretion and truncation. Often proteins are regulated
with post-translational modifications (PTMs) such as phosphorylation, acetylation, ubiquitylation,
glycosylation, although the potential number of modifications could be up to several hundred
(Graham et al. 2011). This level of complexity needs to be directly investigated, as the analysis of
proteins gives the closest indication of the organisms' phenotype which cannot be reliably
predicted from nucleic acid data.
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1.9.2 Proteomics techniques
The modem approach to proteomics consists of two basic elements: separation of the complex
mixture of proteins and identification of the individual proteins by mass spectrometry (MS). The
techniques discussed in this section are summarised in Table 1.3. Separation techniques are either i)
gel-based methods or ii) gel-free methods. Gel-based methods include sodium dodecyl sulphate-
polyacrylamide electrophoresis (SOS-PAGE). This well-established technique uses the detergent
SOS to denature and negatively charge proteins, which allows them to move in the same direction
under an electric current. Running the proteins through a porous polyacrylamide gel allows
separation on the basis of molecular mass and staining with e.g. coomassie blue, silver stain or
SYPRO ruby, allows visualisation of the separated proteins. SOS-PAGE is simple to perform, is
reproducible and can separate a wide range of molecular weights (10-300 kDa) (Graves &
Haystead, 2002). SOS-PAGE also acts as a preliminary separation step in the proteome-wide
identification of proteins. For example, one may cut out the protein profile and slice it into sections
which are digested to peptides and eluted to give a fractionated mixture of peptides, allowing easier
analysis by Le-MS. This method is known as Gel.C bottom-up proteomics (Graham et al. 2007).
Isoelectric focusing (IEF) separates the proteins from complex mixtures based on their
native charge by employing a ployacrylamide gel with an immobilised pH gradient (IPG), where
the pH gradient is fixed into place by charged ampholytes. Under an electrical current, the proteins
will migrate until they reach a pH which negates their surface charges (e.g. on residues like lysine
and arginine) leaving the protein with a net surface charge of zero, known as the isoelectric point
(PI) of a protein. IEF is an established method for the classification ofbeta-lactamases, comparing
enzymes from clinical isolates with known beta-lactamases and reading the pI from these
comparisons. While once the gold standard for ESBL identification, it has now been superseded by
peR-based methods as many ESBLs have identical pIs and are more difficult to distinguish
(Sharma et al. 2010).
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Two-dimensional gel electrophoresis (2DGE) combines the two previously described
techniques to increase separation of all proteins in a sample. It was successfully used by O'Farrell
(O'Farrell, 1975) and works by placing a focused IPG gel on top of a larger SDS-PAGE gel, the
bands of focused proteins will be again separated further by molecular weight, leaving distinct
'spots'. The aim is to separate individual proteins from the mixture, although this is not always
possible as some spots may contain one or more proteins with a similar pI and molecular weight.
However, these unknown spots can be excised and analysed by matrix-assisted laser
desorption/ionisation-time of flight (MALDI-TOF) MS; the resulting spectral 'fingerprint' can be
searched against online databases to identify the proteins (Aebersold & Mann 2003).
Major shortcomings of 2DGE include the poor representation of basic and membrane
proteins, as well as limited dynamic range and the potential for 'hidden' proteins. 2DGE spots may
be made up of more than one protein (two or more may have similar pIs and molecular weights)
(Wittmann-Liebold et al. 2006). These disadvantages of 2DGE demonstrate the choice of method
depends heavily on the type of sample and its complexity and thus sometimes, gel-based methods
may not be applicable.
There are also various gel-free methods to analyse complex mixtures of proteins, a major
advantage of gel-free methods is that a greater number of proteins can be detected and the sample
preparation time is reduced (although the data analysis time may be greater). Liquid
chromatography (LC) is a method of sample separation so that individual compounds may be
identified from a mixture. This can be achieved by exploiting the hydrophobic/hydrophilic
properties of the compounds to be separated. By passing these compounds through a gradient of
organic solvent (referred to as the mobile phase) over a polar coating (the stationary phase) i.e. the
more hydrophobic a molecule is, the quicker it will travel along with the gradient. There are
increasing applications for this technique due to its ability to analyse large fragile molecules such
as intact proteins (Zhou et al. 2012). The most common approach to protein identification is via
bottom up proteomics, which involves digesting the proteins to peptides, separating these via LC
and directly injecting into a mass spectrometer. LC-MS may be used to produce a peptide
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fingerprint or Le-MSIMS (tandem mass spectrometry) is used to derive the amino acid sequence of
detected peptides (Frese et al. 2011).
For a greater degree of peptide separation, sometimes required for biological mixtures
where their complexity is too great even for highly sensitive MS equipment, one may use
multidimensional-Lfl, This technique simply utilises two or more consecutive Le separation
methods to further separate complex mixtures. It is required for the analysis of labelled protein
mixtures e.g. iTRAQ experiments (see quantification section 1.9.4). Also, reversed-phase Le (RP-
LC) and strong cation exchange Le (SCX-LC) may be employed in 2D-LC separations to increase
separation and decrease sample complexity (Edelmann, 2011).
1.9.3 Mass Spectrometry
1.9.3.1 Ionisation
Mass spectrometry is a highly sensitive, high-throughput technique which is used to detect the
molecular weight and even the amino acid sequence of a protein and/or peptide. In order to detect
molecules and calculate their molecular mass, the sample must be ionised and in the gaseous phase.
Mass spectral analysis of proteins may be either 'top-down', referring to the analysis of intact
proteins; or 'bottom-up' referring to the analysis of digested peptides. The bottom-up approach is
most commonly used, but with rapid advances in instruments and software, top-down proteomics is
becoming more widely-used (Becker & Bern, 2011). A revolutionary development in MS for the
analysis of peptides came with the advent of matrix-assisted laser desorption ionisation (MALDI)
and electro spray ionisation (ESI). Both of which allowed the ionisation of peptides by loss of
protons in the gaseous phase (Graves & Haystead, 2002). MALDI acquires data through repeated
laser shots and ion detection to give an acceptable signal-to-noise level for the rapid identification
of proteins. The disadvantages are that there is low reproducibility between these laser shots and
results are strongly influenced by sample preparation methods (Yates et al. 2009). ESI produces
ions from solution by spraying droplets of mixed solvent-analyte towards the inlet of the mass
spectrometer. As they are formed, the droplets rapidly evaporate (due to high temperature of
capillary) to leave behind charged ions in the gaseous phase. (Yates et al. 2009).
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1.9.3.2 Mass analvsis
Ionisation is coupled to mass analysers which calculate the mass/charge ratio (mlz) of an ion and
return its molecular mass. Popular mass analysers include the time of flight (TOF) type of
instrument, which measures the mlz by determining the time it takes for the ion to travel the length
of the flight tube (Aebersold & Mann, 2003). Combined with MALDI ionisation, the MALDI-TOF
is one of the best-known and well-used mass spectrometers for protein/peptide mass analysis
(Albrethsen,2007).
Quadrupole mass analysers are a common mass analyser consisting of four parallel metal
rods which generate an electric field. Ions are transmitted through this electric field by ascending
mlz or they can be selectively held back allowing the quadrupole to filter ions of a certain mlz,
acting as ion traps (March, 2009).
The orbitrap mass analyser consists of two electrodes, an outer barrel-like chamber and an
inner spindle-like central axis. The ions are injected into the chamber and electrostatically attracted
to the inner electrode but their centrifugal force stabilises them into a regular oscillation along the
spindle electrode. Ions of a specific mlz will have specific frequency of oscillation (it is inversely
proportional to the square root of mlz), so the oscillation frequency can be used to calculate the mlz
of an ion with a high degree of accuracy with a high dynamic range (Hu et al. 2005). The obitrap is
suited for proteomics due to its high resolution, high sensitivity and high mass accuracy, while its
dynamic range and fast scan rate are also advantageous. The result is a fast, sensitive and accurate
instrument, with good reproducibility and range of applications (Yates et al. 2009).
1.9.3.3 MS to analvse peptides
Mass spectrometry analysis e.g. by a MALDI-TOF, can generate a peptide mass fingerprint (PMF),
a reproducible spectra (an average of many taken) of mass peaks for a given peptide. This PMF is
searched against a database of many peptides (or against genomic data) and generates a match
based on the peaks in the PMF (Park et al. 2003). However the searching assumes that the peptides
come from one protein, so peptide mixtures can return poor results (Shevchenko et al. 1996).
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Two mass analysers can be used in tandem to perform MSIMS analysis, for example
quadrupole mass analysers can be used in combination e.g. triple-quadrupole MS, these
instruments use one quadrupole to trap and analyse ions, the second for fragmentation of the
analyte and the third for trapping and analysing the fragmented ions or product ions (Graves &
Haystead, 2002). This analysis returns two mass spectra (hence tandem MS) and the comparison of
both allows more accurate identification of the analyte. MSIMS instruments are able to ascertain
the amino acid sequence of a peptide by fragmenting the molecule about its amide (or peptide)
bonds via bombardment withinert gas molecules, such as nitrogen or argon (Seidler et al. 2010).
The ion fragments (product ions) are designated a, b, c or x, y, z ions depending on whether they
contain the N- or C-terminus of the original peptide (precursor ion). Because of this designation,
different sequences are generated depending on which direction the molecule is fragmented e.g.
from the N- or C-terminus, akin to the 3' or 5' direction in nucleic acid analysis. From the
compilation of all possible fragments of the peptide it is possible to calculate the sequence allowing
incredible accuracy when assigning protein identifications (Seidler et al. 2010).
1.9.4 Quantitative proteomics techniques
To add an additional layer of information to the results of proteomics identifications, various
techniques may be employed to measure protein abundance. The measured abundances can be
compared between experiments to determine expression changes related to virulence, adaptive
responses, antibiotic resistance or any other condition under investigation. For example, this
approach allows identification of proteins that are present in both isolates and expression of these
proteins may be affected by the addition of an antibiotic. This could include proteins which have
important roles in resistance, but are present in both sensitive and resistant organisms, such as OM
porins. There are two main approaches for the quantification of protein levels, label-based methods
and label-free methods, for which examples are given below.
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1.9.4.1 Label-based methods
In terms of gel-based protein separation, difference in-gel electrophoresis (DIGE) which utilises
fluorescent tagging of two different protein samples using two different dyes, is currently the best
method of quantification and once was considered the gold standard in quantitative proteomics
(lung et al. 2005). The labelled protein samples are pooled together and run in the same gel, which
eliminates the reproducibility issues associated with 2DGE. After image acquisition, software is
utilised to create a superimposed image of the two gel profiles, to compare the two samples. This
specialist software can also interpret changes in the CyDye-labelled protein spot size and intensity
and give a ratio of the difference in protein expression between the two samples. DIGE does have
its disadvantages, for instance sample preparation procedures must be identical, as biological
variation accounts for most of the gel-to-gel variation observed (Zech, et al. 2011). Also many
proteins (e.g. membrane proteins and high pI proteins) are not soluble in polyacrylamide gels.
However, this technique has been used with great success (Alteri et al. 2009; Fernandez-Reyes et
al. 2009; Madeira et al. 2011) and despite its shortcomings, is still widely used today.
An important means of quantifying proteins in mixtures via LC/MS analysis has been to
use stable isotope probe labelling, which allows gel-free separation and analysis of proteins.
Examples of this include; isotope-coded affinity tags (ICAT), which consist of; a reactive group to
label the cysteine side chain, an isotopically coded linker and a tag for the isolation of tagged
peptides. Two samples are labelled with ICAT reagents (usually a heavy tag and a light tag), then
mixed and digested together. Upon MS analysis, the ratio of the two labelled tags is used to
relatively quantify levels of tagged peptides (Becker & Bern, 2011). A drawback of this technique
is that only cysteine-containing peptides can be quantified.
Later, this technique gave rise to isobaric tags for relative and absolute quantification
(iTRAQ), which uses a set of isobaric reagents to multiplex up to four, six or eight samples.
Labelling of the samples with four different mass-tags generates molecules with similar or exact
molecular weights and shows as one large peak in MS scans. Upon fragmentation e.g. with a
higher-energy collisional dissociation (HCD) cell, the low-molecular weight reporter ions
generated all have different masses and their ratios can be calculated to allow quantification of the
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proteins they labelled (Pichler et al. 2010). While iTRAQ offers high sensitivity and no amino acid
bias (no specific requirement for cysteine or arginine), the reporter ions generated could be iTRAQ
reagents or just peptide fragments and this ambiguity only worsens with sample complexity, so
quantification is not absolute, nor 100% accurate (Wu et al. 2009).
There is also metabolic labelling e.g. using radiolabelled CI31H2-arginine, known as stable
isotope labelling with amino acids in culture (SILAC). It is a commonly used approach to
quantification but is limited by the need to grow cultures in a specific media. However, Vogels and
colleagues showed the advantages of SILAC in an epithelial cell model of Salmonella typhimurium
infection, where both host and pathogen protein levels could be quantified, revealing host proteins
that have a role in infection (Vogels et al. 2011).
1.9.4.2 Label-free methods
Label-free method of protein quantification are currently gaining momentum as they do not require
complicated sample preparation steps (such as labelling) and are therefore relatively inexpensive
and applicable for any sample. However, while label-free methods show a better degree of
reproducibility than labelled methods, quantification is more reliable using protein labelling (Li et
al. 2012). Label-free methods may estimate the relative or absolute protein abundance, for peptides
in a mixture, they include techniques such as: sample spiking, an approach which yields relative
quantification data by adding an internal standard of known concentration into the peptide mixture
prior to MSIMS analysis (Porteus et al. 2011). Spectral counting is an increasingly utilised strategy
which measures protein abundance from the spectral count data, essentially the number of peptide
MSIMS spectra determined for a given protein, it also correlates well with sample spiking
techniques (Porteus et al. 2011). The main drawback of this approach is that both data analysis and
methodologies are still under development, particularly with regards to the quantification of low-
abundance proteins.
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1.10 Proteomics to investigate bacteria and microbial physiology
While modern MS-based proteomics is still a growing field, it has already proven to be a powerful
approach for the characterisation of microbial physiology. Even now, where DNA sequencing
technologies are ubiquitous, studies have shown that proteomics is still able to fill important
knowledge gaps. For instance, using whole genome sequencing once took years to complete an
assembled genome, now it takes merely a few hours. Despite the advances, one major caveat that
has persisted since the introduction of whole genome sequencing, is that vast numbers of ORFs are
poorly characterised, leaving regions of the genome annotated as functionally unknown. In a study
by Kolker, roughly one third of all proteins listed in NCB! were labelled as hypothetical (Kolker et
al. 2004). Proteomics is helping to address this continued ambiguity through studies targeting a
particular protein or set of proteins labelled as 'hypothetical' and attempting to assign their
functions through proteomics and bioinformatics techniques e.g. Zhang et al. assigned functions to
20 hypothetical proteins in Desu/fovibrio vulgaris (Zhang et al. 2006).
For decades now, scientists have attempted to use proteomics techniques for the taxonomic
classification of bacteria, from SOS-PAGE profiles (Costas et al. 1990) to 2DGE spot maps or
reference maps (Encheva et al. 2006). More recently, proteomics techniques are experiencing a
surge of attention in the clinical setting due to the rapid nature and ease of use ofMALDI-TOF MS
for the identification of bacterial pathogens, which requires very little sample preparation and can
return a result in minutes (Croxatto et al. 2011). Other groups are looking forward to using more
advanced, sensitive instruments such as LC-MSIMS to identify bacteria through peptide
biomarkers (Al-Shahib et al. 2010; Misra et al. 2012).
The interactions of pathogen and host can also be probed using proteomics e.g. eukaryotic
cells infected with bacteria could be subjected to comparative proteomics. For example, Schmidt et
al. managed to quantify proteins of S. aureus recovered from infection of an epithelial cell culture
(Schmidt et al. 2010), studies such as this could give further insights into the process of
pathogenesis by highlighting which host factors are required by the pathogen and which ones will
prevent infection.
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Examples of recent use of proteomics techniques to aid in the understanding of bacterial
pathogenicity and physiology include: Alteri & Mobley, who analysed the changes in the E. coli
proteome from growth in human urine compared to growth in LB broth. They identified a number
of proteins that were expressed only upon growth in urine, providing a host of factors which may
be required for UTI pathogenicity e.g. six different iron scavenging proteins and an array of
attachment/adhesion proteins were expressed upon growth in urine (Alteri & Mobley, 2007).
Soares et al. used 2DGE and iTRAQ combined with LC-MS/MS to analyse the proteome of A.
baumannii under different states of growth: exponential, and early and late stationary phase. They
found that A. baumannii is able to tolerate high amounts of free radicals in its later growth stages
and also shows tolerance to hydrogen peroxide due to increased expression of oxidative stress
defence proteins. These heightened stress defence systems may aid in the tolerance of antibiotics
(Soares et al. 2009).
Proteomics has been used to investigate bacterial responses to many changes in the
environment, including antibiotics. Often proteomics has the potential to further characterise
mechanisms of antibiotic resistance, through elucidation of the previously unseen proteins and
protein interactions which constitute the resistance mechanism.
1.11 Proteomics to investigate antibiotic resistance
In contrast to proteomics, DNA-based techniques offer little insight into the effects of resistance
gene expression on cellular processes, as the genome does not definitively indicate which proteins
are expressed under the conditions being studied. This project aims to evaluate whether proteomic
methodologies can be applied to enhance our understanding of antimicrobial resistance. The aim is
to provide a more comprehensive overview of resistance and how it impacts on the bacterial cell.
This could lead to the development of novel molecular methods to screen for resistance, resulting
in better patient management and more rational use of antibiotics. It might even highlight targets
for further antibacterial research.
Although a relatively new concept, using proteomics to study antibiotic resistance is an
increasingly attractive approach and has been proven effective in previous studies. For example,
59
Zhang (Zhang et al. 2008) and Xu (Xu et al. 2006) investigated tetracycline resistance and
ampicillin resistance, respectively, in E. coli through characterisation of membrane proteins that
showed differential expression upon addition of antibiotics. Coldham (Coldham et al. 2006) used
celllysates of Salmonella enterica to study fluoroquinolone resistance and Yun (Yun et al. 2008)
investigated the outer membrane proteins involved in A. baumannii tetracycline resistance.
The resistances to be investigated in this project have key public health importance
(Livermore et al. 2008) yet to date, no work has been published on them using a proteomics-based
approach.
1.12 Aims and objectives
The overall aim of this study is to characterise the proteins involved in the selected resistance
mechanisms from clinically-important pathogens, using proteomics approaches such as gel
electrophoresis, quantitative labelling and mass spectrometry. It is hoped that these approaches will
help to elucidate novel mechanisms, or aspects of resistance, which hitherto have been difficult to
define using traditional molecular methods. In doing so will provide a global overview of the
processes that are affected in the cell upon exposure to antimicrobials. This may lead to new
molecular tests for complex resistance mechanisms, with implications for improved patient
management and rational antibiotic use.
Three key resistances will be investigated:
1) Plasmid-mediated multidrug-resistance in E. coli
2) Non-carbapenemase-mediated carbapenem resistance in K. pneumoniae
3) Efflux-mediated tigecyc1ine resistance in A. baumannii, E. cloacae and S. marcescens
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2. Materials and Methods
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2.t Materials and reagents
All reagents listed were from the Plus One range purchased from GE Healthcare
(Buckinghamshire, UK) unless otherwise stated.
2.2 Bacteria and culture conditions
All isolates used in this work were from the collection held by ARMRL, HPA and were cultured in
Lysogeny Broth (LB) media and on nutrient agar plates at 37 DCunless otherwise stated.
The three isolates of Escherichia coli used were strain J53 (NCTC 50165) and two
transformed J53 derivatives carrying antibiotic resistance plasmids pEK.204 (lncIl plasmid; 94kb,
containing blaTEM-1and blacrxscs ) and pEK499 (IncF1A1FII fusion plasmid; 117kb, containing
blaTEM_h blacTX-M-15,blaoXA-h aac6'-lb-cr, mph(A), catB4, tet(A), dfrA7, aadA5 and sull )
(Woodford et al. 2009). These transformants were referred to as J204 (NCTC 13452) and J499
(NCTC 13451) respectively and their remaining resistance genes are listed in Table 2.1.
Four isolates of Acinetobacter baumannii were used; a pre- and post-tigecycline therapy
pair of clinical isolates designated AB210 (tigecycline-susceptible, MIC 0.5 mgIL) and AB211
(tigecycline-resistant, MIC 16 mgIL); a laboratory-selected tigecycline-resistant mutant of AB210
(designated AB210-6, MIC 64 mgIL); and a tigecycline-susceptible gene-knockout mutant of
AB211 (designated AB211~adeB, MIC 0.5 mgIL) (Homsey et al. 2010a). The MICs of these
isolates are displayed in Table 22.
Three isolates of Enterobacter cloacae were used; a pre- and post-tigecycline therapy pair
of clinical isolates, designated TGC-S (tigecycline-susceptible, MIC 0.5 mgIL) and TGC-R
(tigecycline-resistant, MIC 4 mgIL) and a tigecycline-susceptible gene-knockout mutant ofTGC-R
referred to as TGC-MacrB (tigecycline susceptible, MIC 0.125 mgIL) (Homsey et al. 2010b).
The five isolates of Serratia marcescens used were: a tigecycline-resistant clinical isolate,
SM346 (MIC 16 mgIL): the type strain, NCTC 10211 (MIC 0.25 mgIL): a tigecycline-resistant
laboratory mutant, 10211-10 (MIC 64 mgIL): and two tigecycline-susceptible gene knockout
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mutants generated from 10211-10, designated 10211-l0~deY (MIC 0.125 mg/L) and 10211-
lO~hasF(MIC 0.125 mgIL) (Homsey et al. 20l0c).
Four isolates of Klebsiella pneumoniae were used: a pre- and post-meropenem therapy
clinical pair, lA and lB (ertapenem MICs of 0.125 and 16 mgIL respectively); the K. pneumoniae
type strain ATCC 13883 and a porin deficient isolate K2 (no expression of ompK35 or ompK36;
Doumith et al. 2009) were used as comparators for SDS-PAGE OMP analysis.
Plasmid pEK204 pEK499
Size 94kb 117 kb
Incompatibility group IncH IncFIA-FII fusion
Number of predicted proteins 96 139
Number of resistance genes 2 10
blatos-: blateu.:
blactxu-: blacrxwss
blaoXA-l
aac6 '-/b-cr
mph(A)
Resistance genes present
catB4
tet(A)
dfrA7
aadA5
sull
Table 2.1 Features of the two multiresistance plasmids used to transform E. coli J53 into its
resistant derivatives.
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2.3 Susceptibility testing
E-tests (AB Biomerieux, Basingstoke, UK) were used to test antimicrobial sensitivity m
accordance with the manufacturer's instructions. Briefly, bacteria grown overnight on ISO nutrient
agar were suspended in ISO nutrient broth to a density equivalent to a 0.5 McFarland standard
(equivalent to the absorbance of a solution of 0.05 ml of 1.175 % barium chloride and 9.95 mlof
I% sulphuric acid at 625 nm; (Andrews & Howe, 2011). This suspension was used to inoculate
ISO agar plates. An E-test strip was carefully applied to the agar plate to avoid air bubbles forming
under the strip and plates were incubated at 37°C overnight. Organisms were designated resistant if
their MIC exceeded the breakpoints set by BSAC (Andrews & Howe, 2011).
2.4 Phenohpe Microarravs (P:\fs)
PM tests 1-20 were performed in accordance with manufacturer's instructions (Biolog, via
Technopath, Co Tipperary, Ireland) and as described previously (Bailey et al. 2008; Zhou et al.
2003). Bacteria were grown overnight at 37°C on BUG+B agar plates (Biolog) and used to
inoculate 15 ml of inoculating fluid (IF) IF-Oa. The cell density was adjusted to 42 % transmittance
(T) on a Biolog turbidimeter (equivalent to an O.Ds4Onmof c. 0.38) and then diluted with 75 ml of
IF-Oa to give a density of 85 % T (an O.DS4Orunof c. 0.08).
Plates PMI and PM2 (measuring carbon utilisation phenotypes) were directly inoculated
with 22 ml of the 85 % T suspension. Disodium succinate and ferric citrate were added to 66 ml of
the 85 % T suspension to give final concentrations of 20 mM and 2 11M respectively, this solution
was used to inoculate PM3-PM8 which measure nitrogen, phosphorus and sulphur utilisation and
auxotrophic phenotypes (by way of nutrient supplement utilisation). 600 III of the remaining 85 %
T suspension was diluted to 120 ml with IF-lOa and used to inoculate PM9-PM20 which measure
sensitivity to salt and pH stress as well as antimicrobials and antimetabolites. All plates were
inoculated with 100 III cell suspension per well.
All plates were incubated at 37°C in an Omnilog incubator (Biolog) and were repeated in
duplicate. The data were recorded as RA, a unitless value of respiration activity calculated from the
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reduction of the tetrazolium dye present in each test (Bochner et al. 2001). Plates were monitored
automatically for colour changes caused by the reduced dye every 15 min for 48 h, these timepoint
entries were recorded and collated into curves of RA (respiration) over time. Curves for different
strains were then compared using the Omnilog-PM software (version 2.1).
2.4.1 Analysis ofP:\1 data
The data from all plates were exported to Microsoft Excel 2003 and the RA values from each
individual isolate used to create a minimum cut-offvalue, applied to distinguish 'growth' from 'no
growth'. Substrates that permitted bacterial growth in both the test and control isolates were then
selected for comparison with respect to difference in RA values e.g. test isolate vs. control isolate.
New minimum cut-offs were generated to differentiate between a significant difference in growth
vs. insignificant difference in growth i.e. whether the compound gave either isolate a growth
advantage. Substrates that did not permit growth of either isolate or failed to show a difference in
growth between isolates were omitted from further analysis.
Cut-off values were calculated in a similar manner to Morales et al., using averaged RA
values from negative control wells of PM plates plus the standard deviation of the RA values of the
control wells; an RA above this value was considered a sign of growth (Morales et al. 2005). All
values from all substrates deemed 'significant' were zeroed and averages were taken from
duplicate readings. A student's t-test was applied to the data to confirm that any differences
observed were statistically significant. Any differences >2-fold or <2-fold with p values of <0.05
were considered to reflect significant changes in phenotype. The substrates associated with these
changes were compiled and those that were deemed biased were removed e.g. if a test isolate
possessed a p-Iactarnase, all p-Iactam substrates were disregarded from analysis.
2.5.1 Protein extraction from agar plates
Bacteria were harvested from four plates of nutrient agar using plastic loops and suspended in 1 ml
of standard lysis solution containing 7 M urea, 2 M thiourea, 4 % 3-[(3-
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cholamidopropyl)dimethylammonio]-I-propanesulfonate (CHAPS - Melford, Ipswich, UK) and 40
mM dithiothreitol (DTT). The suspension was thoroughly mixed, then 300 III of glass beads
(Sigma, Gillingham, UK) were added and the cells were mechanically disrupted using a FastPrep
homogeniser (MP Biomedicals, Cambridge, UK). The suspension was pulsed for 5 cycles of 60 s at
a speed of 4 mis, followed by 60 s on ice between cycles to cool the homogenate and prevent
chemical modification of proteins. This crude extract was centrifuged for 30 min at 21,000 x g at 4
°C (Thermo) to remove glass beads and cell debris. The supernatant was removed and stored at -20
°C until required.
2.5.2 Protein extraction from liquid culture
A starter culture of 10 ml LB broth was inoculated with a single colony from NA plates and grown
overnight, with the addition of an appropriate antibiotic disc to maintain pressure for resistant
strains. This was used to inoculate 100 ml of LB broth 1:100, where bacteria were grown to log
phase at 37°C with shaking at 175 rpm (Orbital shaker, New Brunswick Scientific, USA) until an
OD550nm of 0.7-0.8 was reached. Cells were harvested by centrifugation at 10,000 x g for 10 min at
4°C in a HERMLE Z36 HK centrifuge (Labortechnik, Wehingen, Germany). The cell pellet was
resuspended and washed three times in I ml of 100 mM phosphate-buffered saline (PBS), then
resuspended in 900 III of standard lysis solution (see protein extraction from agar plates). To reduce
protein degradation, 100 III of lOx Complete Protease Inhibitor Cocktail (Roche, Burgess Hill, UK)
was added to the lysis buffer mix. 300 IIIof glass beads (Sigma) were added and the cells were
disrupted using a FastPrep homogeniser (MP Biomedicals) using the same settings as for the agar
plate extractions. Suspensions were kept on ice between cycles to cool the homogenate and prevent
chemical modification of proteins. Crude extracts were centrifuged for 30 min at 21,000 x g at 4 DC
(Thermo) to remove glass beads and cell debris. The supernatants were removed and stored at -20
°C until required.
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2.6 Bradford Assav of protein concentration
To test the protein concentration of bacterial lysates, a standard curve was created using bovine
serum albumin (BSA; Sigma) over eight different concentrations; 0, 0.05, 0.1, 0.2, 0.4, 0.6, 0.8 and
1 mg/ml using the standard lysis solution (or whatever the protein samples were solubilised in) to
dilute BSA to the appropriate concentration. 5 III of each standard concentration was added in
triplicate to a 96-well plate and 5 III of each sample was added in duplicate at two different
dilutions (1:10 and 1:20, or 1:1 and 1:5 for dilute samples). 250 III of Bradford reagent (Bio-Rad,
Hemel Hempstead, UK) was added to each well, the plate was left for 2 mins and the absorbance
read by an ELx808 spectrophotometer (Biotek, Bedfordshire, UK) at 595 nm. The absorbance
values of each extract were converted into protein concentrations using the gradient of the BSA
standard curve, all duplicate values were averaged and a final concentration was recorded.
2.7 Membrane fractionation
2.7.1 Large volume method
10 ml LB broth was inoculated with a single bacterial colony and incubated at 37 °C overnight, 1
ml of this starter culture was inoculated into 1 L of LB broth and propagated overnight to log
phase. Cells were collected via centrifugation in a Sorvall evolution RC large volume centrifuge
(Thermo, Loughborough, UK) by spinning at 10,000 x g and 4 °C for 10 min. The cell pellets were
resuspended in PBS, split between five tubes and washed and disrupted with the FastPrep
homogeniser (MP Biomedicals) as above to yield crude protein extracts. Crude extracts were
transferred to 32.4 ml Optiseal ultracentrifuge tubes (Beckman, High Wycombe, UK) and diluted
with 100 mM sodium carbonate when pelleting both inner and outer membranes or with 2 % (w/v)
sodium sarcosinate (sarkosyl, Fluka: as part of Sigma) when pelleting the outer membrane only.
The diluted extracts were incubated at room temperature with agitation for 30 min, then transferred
to a 70Ti ultracentrifuge rotor (Beckman) and centrifuged at 115 000 x g for 90 min at 4 °C on an
optima L-100 XP ultracentrifuge (Beckman). Membrane pellets were washed three times in
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sarkosyl and the final pellets were resuspended in 50-100 ~I standard lysis solution and frozen at-
20 QCuntil required.
2.7.2 Rapid membrane fractionation (ROMP method)
A rapid protocol for OMP isolation was carried out according to Carlone et al. (Carlone et al.
1986). Briefly, 10 ml LB broth was inoculated with a single bacterial colony and incubated at 37 QC
overnight. Resistant isolates were cultured in the presence of appropriate antibiotic discs to
maintain selection pressure. Bacteria were pelleted at 5,000 x g for 10 min at 4 QCand resuspended
in 1 ml of cold (4 QC) 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES _
Sigma) pH 7.4. Cells were washed by centrifugation at 15,600 x g for 2 min at 4 QC(Thermo) and
lysed with a FastPrep homogeniser (MP Biosciences) and glass beads (Sigma) for 5 cycles of 60 s
at 4 mls. Cell debris was removed by centrifugation at 15,600 x g for 2 min at 4 QC,the supernatant
was transferred to a fresh tube and centrifuged at 15,600 x g for 2 min at 4 QCto pellet cell
membranes. The supernatant was discarded and the cell membrane pellet resuspended in 0.2 ml of
10 mM HEPES buffer. The cytoplasmic membranes were solubilised by the addition ofO.2 ml2 %
sarkosyl in 10 mM HEPES buffer and incubated at room temperature for 30 mins with mixing. The
outer membranes were pelleted by centrifugation at 15,600 x g for 30 min at 4°C, washed once in
0.5 ml IO mM HEPES buffer and finally resuspended in 20 ul 10 mM HEPES buffer and stored at
-20°C until required.
2.S Biotin labelling
The biotin labelling and neutravidin capture protocols were based on the methods of Smither and
Peirce (Peirce et al. 2004; Smither et al. 2007). Bacteria were grown to log phase and harvested as
before (section 2.5.2), then cells were washed three times in Borate Buffered Saline (BBS),
containing 10 mM boric acid, 2.3 mM sodium tetraborate, 115 mM sodium chloride, pH 8.1. The
cell pellet was resuspended in 1 ml BBS containing 0.5 mg/ml Sulfo-NHS-SS-Biotin (Pierce, via
Thermo Fisher, Northumberland, UK). Labelling took place on ice for 30 min with gentle agitation
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and the reaction was quenched by addition of 1 M Tris pH 7.5 in BBS. The labelled cells were
washed three times in Tris-BBS to ensure that all unbound biotin had been removed. The cells were
lysed as described previously (see section 2.5.2) on a FastPrep Homogeniser (MP Biomedicals) and
cell debris was removed by centrifugation (Thermo) at 1,000 x g for 30 min at 4°C. Crude protein
extracts were then ultracentrifuged to pellet the labelled outer membrane proteins at 115,000 x g for
90 min at 4 °C and on an optima L-100 XP ultracentrifuge (Beckman) and the pellet was washed in
PBS three times. The final pellet was re-suspended in PBS and the amount of protein quantified
using the Bradford assay.
2.8.t Neutravidin capture
The required amount of neutravidin resin (1 ml neutravidin resin per 5 mg protein) was packed into
assembled spin columns (Pierce, Northumberland, UK) and centrifuged at 1,000 x g for 1 min to
remove the liquid from the resin (2 ml neutravidin solution = 1 ml settled resin). The resin was
washed three times in buffer A (25 mM Tris-HCI, 0.15 M NaCl, 0.5 % NP-40, 0.5 % sodium
deoxycholate, 0.05 % SDS, pH 7.5) discarding the wash each time. The resin was then re-pelleted
as above, the spin column capped and the labelled OMP lysates fraction was added (5 mg protein
per ml resin). The resin was incubated for 1 h at room temperature with gentle mixing and then
removed by centrifugation at 1,000 x g for 1 min. The resin was washed twice with buffer B 1 (25
mM Tris-HCI, 0.65 M NaCl, 0.1 % NP-40, pH 7.5) and once in buffer B2 (25 mM Tris-HCI, 1.15
M NaCl, 0.1 % NP-40) to remove any non-specifically bound proteins. To elute the labelled
proteins, the resin was incubated in 50 mM DTT in PBS for 10 min to reduce the disulfide linker
and sever the link to the biotin molecule. The resin was centrifuged at 1000 x g for 2 min at 4 °C
and the eluant was transferred to a clean tube. This step was repeated to ensure all biotin-tagged
protein was removed; the eluant was then quantified and stored at -20°C.
70
2.9 Sample clean-up
2.9.1 GE Healthcare clean-up kit
300 III of the 'precipitant' reagent was added to 100 pg protein, which was vortexed and incubated
for 15 min (all incubations in this procedure are carried out on ice). 300 III of the 'co-precipitant'
reagent was added and vortexed, then the proteins were pelleted by centrifugation (Thermo) at
maximum speed for 5 min. The supernatant was decanted and the pellet briefly centrifuged to
remove all trace of liquid. Then, 40 III of the 'co-precipitant' reagent was overlayed onto the pellet
and left for 5 min. The tube was then centrifuged for 5 min, the supernatant discarded and the pellet
was dispersed with 25 III distilled water and vortexing. 1 ml of the 'wash buffer' solution (pre-
chilled to -20°C) and 5 III of the 'wash additive' solution were added and the pellet was vortexed
until completely dispersed. Protein samples were incubated at -20°C for at least 30 min with
intermittent vortexing (roughly every 10 min), then centrifuged for 5 min. The supernatant was
discarded and the pellet air-dried (for 1 min) before being re-solubilised in standard lysis solution.
Preparations were either used immediately or stored at -20°C.
2.9.2 Acetone precipitation
Proteins were transferred to a clean tube and precipitated with five times the sample volume of ice
cold acetone (pre-chilled at -20°C). The tubes were mixed and left at -20 DC for 1 h with
intermittent mixing every 20 min. The protein precipitate was then pelleted in a microcentrifuge at
21,000 x g for 10 min at 4 °C and was resuspended in standard lysis solution. Protein
concentrations were calculated using the Bradford assay (see section 2.6) before the samples were
stored at -20 DC.
2.10 DIGE labelling
Proteins prepared for DIGE analysis were extracted in a modified standard lysis solution that
included 30 mM Tris to raise the pH to 8.5, the optimal pH required for DIGE-labelling with
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CyDye minimal dyes (GE Healthcare). The pH of protein extracts was checked with pH indicator
strips (Sigma) and 50 mM hydrochloric acid and 50 mM sodium hydroxide to adjust extracts to pH
8.5. 50 ug of each protein extract used in the experiment was labelled with 400 pmol of CyDye
minimal Dye Cy3 or Cy5, along with 50 ug of an internal standard labelled with Cy2 (containing
equal amounts of each protein extract used in the DIGE experiment; see Figure 2.1). The CyDyes
were randomised when labelling an experiment consisting of biological replicates e.g. three
replicate extracts of each bacterial isolate were labelled alternately with Cy5/Cy3/Cy5 or
Cy3/Cy5/Cy3 to check for preferential labelling. Random labelling of all samples ensures no bias
towards anyone dye. All incubation steps involving the CyDye compounds were carried out in a
sealed polystyrene tub, away from light as they are highly photosensitive. Proteins were incubated
with CyDyes for 30 min on ice and the reaction was then quenched by addition of I ul of 10 mM
lysine per 400 pmol of CyDye and incubation for 10 min on ice. Extracts were pooled together and
adjusted to ISO ul with DIGE rehydration solution (7 M urea, 2 M thiourea, 2 % CHAPS, 20 mM
DTT and 0.5 % immobilised pH gradient (IPG) buffer), then immediately analysed by IEF.
Biological replicates of
Unlabelled sample
D=Cy2
.=Cy3
.=Cy5
Gel1 Gel2 Gel3
Labelled samples
combined with
equal amounts of
internal standardiii
Internal
standard:
contains equal
amounts of every
extract
Samples are alternately
labelled with Cy3/Cy5 to
ensure no bias in sample
labelling
Figure 2.1 Overview of the DIGE protein-labelling process.
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2.11 SDS-PAGE
2.11.1 Lab-cast gels
The OMP fractions of each isolate were boiled for 10 min in 2x sample buffer containing 125 mM
Tris-HCI (pH 6.8), 20 % (v/v) glycerol, 4 % (w/v) SDS and 10 % p-mercaptoethanol (v/v). The
OMPs were separated in gels containing 12.5 % acrylamide, 0.35 % bisacrylamide and 0.1 % SDS.
Gels were run at 60mA for 1 h in SDS running buffer (1.5 M Tris-HCI, pH 8.8 and 0.4% SDS),
stained with Coomassie Brilliant blue (Sigma) in a 45 % methanol/IO % acetic acid mixture
overnight and destained by washing with the same solution for at least 1 h.
2.11.2 Nu-PAGE gels
Nu-PAGE gels (Invitrogen, Paisley, UK) were run according to manufacturer's' instructions; 5 ug
of each protein extract was mixed with 1 III of 10x reducing solution (500 mM DTT) and 2.5 1l14x
sample buffer (including glycerol and lithium dodecyl sulphate at pH 8.4). This mixture was made
up to 10 III with distilled H20 and heated at 70°C for 10 min. Ten III of Novex sharp unstained
protein standard (Invitrogen) was used as a marker and gels were run in Nu-PAGE MES SDS
running buffer with 500 III antioxidant added to the upper chamber at 200 V for 50 min. Gels were
fixed in 40 % methanol for 1 h and stained overnight in either SYPRO ruby stain (Invitrogen) or
Colloidal G Brilliant BIue Stain (Sigma) in 25 % methanol. Gels were destained for 1 h in 10 %
methanol before being scanned in an Ettan DIGE imager (GE Healthcare) for fluorescent gels or in
a ProPic II scanner (Digilab, Huntingdon, UK) for colloidal gels.
2.12 2-Dimensional gel electrophoresis
2.12.llst Dimension: IEF on pH 4-7 strips
Immobilised pH gradient (IPG) strips of pH 4-7 were re-hydrated overnight in a Drystrip re-
swelling tray CGEHealthcare) with 340 III re-hydration solution containing 7M urea, 2M thiourea,
2 % CHAPS, 20mM DTT, 2 % IPG buffer (pH 4-7) and 0.002 % bromophenol blue. Strips were
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overlayed with mineral oil to prevent dehydration and urea crystallisation. 100 ug of protein extract
was diluted with rehydration solution to a final volume of 150 ~l and added to the IPG strip via
cup-loading at the anode. Paper wicks were dampened with 150 ul of deionised water to carry
current from the electrodes to the strips. Samples were focused using a universal focusing program
(Table 2.3) and all focusing was carried out using a current of 50 ~A per strip. After focusing, the
second dimension was run immediately or the strips were stored at -80°C until required.
Voltage application Voltaze Time
1 Step and hold 300V 3h
2 Gradient IOOOV 6h
3 Gradient 8000V 3h
4 Step and hold 8000V 3h
5 Step and hold 8000V 5h
Table 2.3 Universal IEF program used for all strips of pH 4-7 and 3-10.
2.12.2 1RDimension; IEF on pH 6-11 strips
IPG strips of pH 6-11 were rehydrated overnight in a Drystrip re-swelling tray (GE Healthcare)
with 340 ~l re-hydration solution containing 7M urea, 2M thiourea, 2 % CHAPS, 2 % IPG buffer
(pH 4-7) and 0.002 % bromophenol blue. To prevent protein streaking at the cathode, 12 III
DeStreak solution (GE Healthcare) was added per ml of rehydration solution. 100 ug of protein
extract was diluted with rehydration solution containing 7M urea, 2M thiourea, 2 % CHAPS,
IOmM OTT, 0.5 % IPG buffer (PH 6-11) and 0.002 % bromophenol blue to a final volume of 150
III and added to the IPG strip via cup-loading at the anode. Anodic paper wicks were dampened
with deionised water while cathodic wicks were dampened with water containing 12 III DeStreak
solution per ml. Samples were focused using a program designed for pH 6-11 strips (table 2.4) after
focusing, the second dimension was run immediately or the strips were stored at -80°C until
required.
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Voltage application Voltage Time
1 Step and hold 300V 2h
2 Gradient IOOOV 8h
3 Gradient 8000V 3h
" Step_and hold 8000V 2h
Table 2.4 UniversallEF program used for all strips of pH 6-11
2.12.3 Gel Casting
The polyacrylamide gels used for the second dimension of 20 GE contained 12 % acrylamide. To
make six gels, 187 ml LC-grade water was added to 140 ml40 % acrylamide.bis-acrylarnide 19:1
(Bio-Rad) and 112.5 ml 1.5 M Tris-HCl pH 8.8 and stirred. To this mixture was added 4.5 ml of 10
% SOS solution (Gibco), with 5 milO % ammonium persulfate (APS) and 125 111of N,N,N,N'-
tetramethylethane-l,2-diamine (TEMEO) to catalyse polymerisation. The gels were cast using an
Ettan OALT 6 casting box (GE Healthcare) and overlayed with 80 % isopropanol. After 4 h of
polymerisation, the gels were covered with gel storage solution (0.1 % SOS, 375mM Tris-HCl pH
8.8) and left overnight to continue to polymerise. Gels were either used immediately the next
morning or kept in short-term storage (1-4 days) at 4 CCwrapped in wet paper towels.
2.12.4 1PG strip Fgllilihration
If the strips were frozen, they were allowed to equilibrate to room temperature for roughly 45 min.
Each focused strip was then incubated in 4 ml equilibration solution containing 6 M urea, 75mM
Tris-IICI pH 8.8, 30 % (v/v) glycerol, 2 % (v/v) SOS, 0.002 % bromophenol blue and 1 % OTT at
room temperature for 20 min to reduce the side chains of cysteine amino acids. Strips were then
incubated in 4 ml of the same solution for 20 min with 2.5 % iodoacetamide replacing the OTT to
alkylate or 'cap' the reduced cysteine side chains. This reduction and alkylation prevented re-
oxidation of the reduced proteins during electrophoresis.
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2.12.5 rd Dimension
Equilibrated IPG strips were placed on top of 12 % polyacrylamide gels and overlayed with 1.5 ml
agarose sealing solution containing lx TGS running buffer (25 mM Tris, 192 mM Glycine, 0.1 %
SOS at pH 8.8; Bio-rad), 0.002 % bromophenol blue and 0.5 % low melting-point agarose (GE
Healthcare). A molecular weight marker was prepared by adding 25 III of novex sharp unstained
protein standard (Invitrogen) to 25 III of agarose-sealing solution, mixing and pipetting into a well
moulded into the agarose layer. Gels were immersed in 1 x TGS running buffer in the lower buffer
chamber while the upper buffer chamber contained 2 x TGS running buffer. Gels were run
overnight at 80 V, 10 rnA per gel and 1W per gel until the dye front had reached the bottom of the
gel (about 22 h).
2.12.6 Protein staining
After proteins had been separated, gels were fixed in 40 % methanol for 1 h and then stained
overnight with either Brilliant blue colloidal G stain (Sigma) in 25 % methanol or in the dark with
SYPRO ruby fluorescent stain (Invitrogen). The next day gels were rinsed twice with distilled
water and de-stained with 10 % methanol for 1 h before imaging.
2.13 Gel imaging
For CyDye labelled gels, once the second dimension was completed they were imaged
immediately without the need for fixing or staining. Gels were scanned on an Ettan OIGE scanner
(GE Healthcare) with all three CyDyes scanned simultaneously at a resolution of 100 pixels.
Colour images of DIGE gels were collated using ImageQuant software tools (GE Healthcare).
SYPRO-stained gels were scanned with the Ettan DIGE imager after destaining at a resolution of
100 pixels and colloidal-stained gels were scanned with a ProPic II spot-picker (Digilab,
Huntingdon, UK). Image exposure was adjusted to ensure that there was no signal saturation from
any stained spots (resulting in unreliable gel analysis downstream). Using ImageQuant tools (GE
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Healthcare) software, noise and artefacts on the gel surface were removed from the image and files
were converted from .gel to .TIFF images. After scanning, gels were stored in 25 % ammonium
sulphate at 4 °C until required for spot-picking.
2.14 SameSpots software for 2DGE analysis
Once all the extracts had been tested, they were labelled with the CyDyes and separated using the
2DGE protocol on gradients of pH 4-7. The .GEL image files of the separated proteins were
transferred into Progenesis SameSpots software (version 3.3) where the gels were checked for
image saturation (image saturation occurs when the background is measured as higher than it
actually is, due to e.g. image exposure too high. This results in loss of information on spot area and
intensity, leading to inaccurate analysis) and dynamic range (the range of potential pixels actually
used in the gel image: a low dynamic range means less precision in the representation of spot
intensity, therefore less precise quantification). One of the gels was selected to be a reference
image, based on the resolution and quality of the gels, which gave the best representation of all gels
in the experiment, on which, the spot positions would be mapped out on for the rest of the
workflow. SameSpots then assigned spot positions and numbers according to what it believed to be
protein spots. But, there was an opportunity to manually check assignment of spot numbers and
positions, to ensure that as many as possible non-protein spots (artefacts) were disregarded. This
included cropping areas that were not of interest (sides and bottom of gel) and removing very low-
volume spots (caused by e.g. dust). When all protein spots were mapped, the proteins 'of interest'
were taken forward for picking and identification. Proteins were considered to be 'of interest' if
they displayed a difference in expression between isolates of 2-fold or greater and also had p < 0.05
(using a one-way ANOVA test) of displaying a false positive expression difference.
Spots that also appeared novel to one isolate i.e. a protein that was present in one isolate
but not another, were also selected as 'unique' spots of interest. These were tentatively selected
however, as the absence of a protein spot may not mean that it wasn't expressed, it may be present
at a low level, it may have undergone post-translational modifications or an isoform with a
different pI may have been expressed instead. Without other data e.g. a sequenced genome to
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confirm the presence of a gene and the 'uniqueness' of these spots, no finn conclusions may be
drawn from them.
Once the proteins of interest were selected, a protein "pick list" was generated from
SameSpots software, consisting of an image of the DIGE reference gel annotated with spot
numbers and areas, with a table detailing expression levels, p values and expression ratios between
the two samples. This list of proteins was manually entered into the ProPic spot picking robot and
overlaid onto an image of the picking gel. The proteins of interest were automatically picked and
deposited into a 96-well plate, after which the picking gel was overlayed onto a I: 1 paper image of
the gel to visually check all spots had been picked that were selected. The gel was re-imaged to
ensure that all the right proteins had all been picked. A note was made of the pick numbers and
how they corresponded to the positions in the 96-well plate. Although it would have been
preferable to electronically transfer the report list into Propic rather than have the operator
manually select spots, it was not possible at the time due to compatibility issues between the
software packages used. Once picked, all proteins of interest were then digested as in methods
section 2.16 and the peptides were submitted for identification by LC-MSIMS.
2.15 Spot picking
Gels were scanned into the ProPic 2 (Digilab) spot-picker and pick-lists were compiled by
manually selecting proteins of interest for picking according to the picking list generated by
SameSpots. Distilled water was used to draw in, expel and store the excised spots in a 96-well
plate. Protein spots were excised at a diameter of 1.2 mm, placed into a 96-well plate and either
frozen at -80 °C or immediately digested.
2.16 Protein digestion
Excised gel plugs were washed three times and incubated for 20 min in I00 ~l of 50 % methanol in
50mM ammonium bicarbonate (AmBic - Fluka), then dehydrated with 100 ~l acetonitrile (Fisher
Scientific). Ten ~l of 10mM DTT was added to each gel plug and the plate was incubated at 60 °C
78
for 30 min. The gel plugs were again dehydrated with acetonitrile and alkylated with 10 III 50mM
iodoacetamide in the dark at room temperature for 45 min. Once alkylated, the plugs were washed
three times with 25 mM AmBic solution, dehydrated with acetonitrile and incubated with 20 III of
20 ng/ml modified sequencing-grade trypsin (Promega, Southampton, UK) overnight at 37 DC.The
next day the plate was centrifuged at 4000 x g for 10 min at 4 DCon a Haraeus Megafuge II plate
centrifuge (Thermo) and the peptides were extracted with 20 III of 0.1 % tri-fluoroacetic acid (TFA
- Fluka) at room temperature for 1 h with shaking at 300 rpm on a Thermomixer (Eppendorf,
Cambridge, UK). The plate was centrifuged as above and peptides were transferred to a clean plate
and stored at -80 DCuntil required.
2. t 7 Zip-tip concentration and clean-up of peptides
Peptide extracts were de-salted and concentrated using C18 Zip-tips (Millipore, Watford, UK). The
C 18 column was activated by the aspiration of 10 III acetonitrile with the retention of enough liquid
to cover the column throughout the procedure, thus preventing air bubbles entering the column.
The tip was washed once with 10 III of 50 % acetonitrile and 0.1 % TFA, then washed three times
with 10 III 0.1 % TFA. Ten III of peptide extract was bound to the column by drawing up and
expelling the solution 10 times. The bound peptides were washed three times with 10 III 0.1 %
TFA, then eluted and concentrated by drawing up 4 III of 50 % acetonitrile/O.l % TFA and
expelling the entire contents into a clean tube. Clean peptides were either stored at -80 DCuntil
used, or spotted directly onto a MALD! target plate (see section 2.20).
2.t8 MALDI target plate cleaning
The MALDI target plate (Waters, Elstree, UK) was submerged in 100 % methanol for 5 mins after
which it was scrubbed with Decon 90 detergent (Decon laboratories, Hove, UK) and rinsed with
distilled water. The plate was then re-submerged in methanol and sonicated in a water bath
sonicator for 15 mins. The plate was then rinsed with acetone and air-dried both after sonication
and again just before use.
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2.19 MALDI-TOF MS plating and analysis
For peptide mass fingerprinting (PMF), 0.75 III of clean peptides were spotted onto a stainless steel
MALDI target plate (Waters) then 0.75 III of matrix solution (10 III of 0.1 % TFA, 495 III
acetonitrile and 495 III ethanol containing 10 mg/ml of a-cyano-4-hydroxycinnamic acid (Sigma)
was added and mixed, then left to dry. In addition to peptide extracts, 1 pmol Renin (Sigma)
peptides was used as the lock mass to correct the mass accuracy with a tolerance of 0.5 Da and 1
pmol alcohol dehydrogenase (ADH - Sigma) digest was used as the calibrant to optimise the pulsed
voltage settings. The ADH peptides were obtained by dissolving 1 mg ADH in 300 III of 50 mM
AmBic, then dissolving 1 mg of porcine trypsin in 500 III of 50 mM AmBic. Five III of the trypsin
solution was added to the ADH solution and mixed, then incubated at 37 DCfor 90 min. Ten III of
this digest was mixed with 990 III of 0.1 % TFA to give c. 1 pmol ADH peptides per Ill. The plate
was loaded into a MALDI-TOF reflectron Mass Spectrometer (Waters, Hertfordshire, UK)
operated by the Masslynx software, equipped with a 337 nm nitrogen laser and set to positive ion
mode. The following voltages were applied; a source voltage of 15,000 V, a pulse voltage of 2700
V, a reflectron voltage of 2000 V and the detector (micro channel plate detector or MCP) had a
variable voltage in the region of 1800-2000 V. Spectra were collected 40 times from each sample
well and 20 times from each lock mass well at a rate of 2 wells per ms and a laser firing rate of 20
Hz. Ions were detected over a mass range of 800 to 4000 Da.
2.20 LC-MS/MS analysis of peptide samples (GeLQ
Peptides were analysed using online nano liquid chromatography and tandem mass spectrometry
(nano LC-MSfMS) on an Ultimate 3000 Dionex nano/capillary HPLC system (Dionex) coupled to
a LTQ Orbitrap mass spectrometer (Thermo Fisher, Hemel Hempstead, UK). The separations were
perfonned on a nano analytical Cl8 column (75.um id x 15 cm, 3.um) (Dionex) using a 45-min
linear gradient of 5 to 45 % solvent B (90 % acetonitrile/O.l % formic acid) versus solvent A (2 %
acetonitrile/O.1 % formic acid), then to 90 % B for an additional 5 min. MSIMS data was acquired
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in a 'data-dependent' mode to automatically switch between MS and MS/MS acquisition using
Thermo Finnigan Xcalibur software (version 2.0.6). The precursor ion scan MS spectra (m/z 440-
2000) were acquired in the Orbitrap, followed by MSIMS scans in which the six most abundant
peptide precursor ions detected in the preceding survey scan were dynamically selected and
sequentially isolated for further fragmentation in the linear ion trap using collision-induced
dissociation (CID) to generate MSIMS spectra.
2.21 Database searching
For protein identifications, generated MS/MS spectra were searched usmg MASCOT (Matrix
science, www.matrixscience.com) against a genus-specific database curated in-house containing all
non-redundant (nr) protein sequences of the target organism available on NCBI
(http://www.ncbi.n1m.nih.gov/). The following search parameters were applied in MASCOT: two
maximum missed trypsin cleavages; variable methionine oxidation; fixed cysteine
carbamidomethylation, a state charge of up to +2, a fragment ion mass tolerance of 0.1 Da and a
parent ion mass tolerance of 10 ppm. Large batch searches were carried out using Mascot Daemon
and the .DAT result files were collated and viewed in Scaffold (version 3.3.2; proteome software
inc., Portland, USA). Scaffold was used to validate MS/MS based peptide and protein
identifications and assign probability scores using the built-in Protein Prophet and Peptide Prophet
algorithms. Peptide identifications were accepted if they established minimum peptide probability
of 95 %. Protein identifications were accepted if they contained at least two identified peptides and
established minimum protein probability of 99 %. To further characterise hypothetical or
unmatched proteins, the BLASTp algorithm (http://blast.ncbi.nlm.nih.gov/) was used to search for
homologous proteins (NCBI default settings were used unless otherwise stated). The Uniprot
database (www.uniprot.org) was used for information regarding the function of proteins and the
web-based tools InterProScan and PSORTb (www.ebi.ac.uk!Tools/pfa/iprscan/ and
www.psort.org!psortb/) were also utilised respectively to detect conserved domains and predict
subcellular localisation of unknown proteins of interest.
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2.22 Peptide analvsis using Scaffold software
Scaffold (version 3.3.2) uses the Protein Prophet and Peptide Prophet algorithms which are run and
compared with the results from Mascot Daemon. A result which satisfies both algorithms generates
protein identifications with higher scores and lower false discovery rates (FDR). The FDR
describes the expected proportion of incorrectly-rejected null hypotheses (or false discoveries) with
regards to assigning protein identifications. Adding Scaffold into the proteomics workflow
therefore gives higher confidence in protein identifications which are more robust than either
program alone. Scaffold can also base a protein identification on the number of peptides detected
for that particular protein, this is another measure to give better confidence in the false discovery
rate e.g. identification of 20 peptides across a protein sequence suggests a greater likelihood for the
presence of that protein, than using 1 peptide across a sequence. Protein and peptide identifications
were accepted if they could be established at greater than 99.0% and 95.0% probability respectively
and contained at least 2 identified peptides. Proteins that did not meet these requirements were not
pursued for further analysis.
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3. Results
Multidrug resistance plasmids in Escherichia coli
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3.1 Introduction of isolates
The isolates used in this study included E. coli J53, a common strain used for transconjugation
experiments due to its F+ phenotype and azide resistance allowing for selection of transformants
(Yi et al. 2012). J53 was used to receive two plasmids: pEK204 and pEK499, to generate
transformants J204 and J499 respectively. The resistance genes harboured by these plasmids are
tabulated in methods section 2.2, Table 2.1.
To characterise the changes to the proteome of J53 caused by plasmid acquisition, the
isolates were compared by 20GE. Then their SOS-PAGE profiles were characterised by LC-
MSIMS analysis to determine the effect of plasmid acquisition on the proteome. The isolates were
also compared using a Phenotype Microarray (PM) system which evaluated their growth on c. 2000
substrates. The aim was to determine which compounds gave specific advantages or disadvantages
to the plasmid host, J53 i.e. whether the plasmid provided its host with the means to grow on a
substrate/metabolite, to which it had no resistance genes against.
This investigation aims to elucidate the effect of acquisition of a multi-resistance plasmid
on protein expression levels and cellular processes of the host cell. There is much speculation as to
why certain plasmids seem to give an advantage to their host compared with others and why those
that offer no obvious advantage are retained. Proteomics provides a good opportunity to better
investigate the changes in cell physiology resulting from plasmid acquisition. It is hoped
proteomics could aid in the identification of promoters or cellular cofactors associated with the
resistance plasm ids and may provide new targets to prevent their transfer, or with the specific
CTX-M enzymes, in this case CTX-MIS and CTX-M3. The worldwide spread of CTX-M is a
paradigm of antibiotic resistance dissemination and any insights on how to halt the spread could be
utilised against other resistance enzymes poised to flourish in a similar manner, such as the NOM
carbapenemases (Kumarasamy et al. 2010).
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3.2 2DGE separation of E. coli protein extracts
3.2.1 Separation over a pH 4-7 gradient
The E. coli transfonnants were the first isolates to have their whole-cell protein extracts separated
by 2DGE. Initially, the extracts were separated over pH 4-7 gradients, as many of the cytosolic
proteins are resolved in this pH range. The method of protein loading into the IPG strips was
optimised for efficient protein delivery into the strip and subsequent gel resolution.
There are two commonly used methods, cup-loading and in-gel rehydration. The gels
displayed below (Figs 3.1-3.3) were produced with cup-loading and gave better separation and
resolution compared to the rehydrated gels.
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4 pH 7
Figure 3.1 2DGE protein profile of E. coli J53 separated over a pH 4-7 gradient and on a 12%
polyacrylamide gel. Proteins were stained with SYPRO ruby (Invitrogen) and visualised with an
Ettan DALT imager (GE Healthcare).
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4 pH 7
Figure 3.2 2DGE protein profile of E. coli J204 separated over a pH 4-7 gradient and on a 12%
polyacrylamide gel. Proteins were stained with SYPRO ruby (Invitrogen) and visualised with an
Ettan DAL T imager (GE Healthcare).
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4 pH 7
Figure 3.3 2DGE protein profile of E. coli 1499 separated over a pH 4-7 gradient and on a 12%
polyacrylamide gel. Proteins were stained with SYPRO ruby (Invitrogen) and visualised with an
Ettan DALT imager (GE Healthcare).
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3.2.2 Separation over a gradient of pH 6-11
One of the original aims of this study was to visualise the CTX-M ESBLs via 2DGE, however, as
the pI of these proteins is around pH 8-9 and therefore would not separate on pH 4-7 gradients.
Therefore, to better visualise these proteins on the gels, the same extracts were separated by pH 6-
11 gradients and compared using Proteomweaver software (version 3.0).
While running two separate pH gradients (of pH 4-7 and 6-11) increases the time and
labour compared to running a pH 3-10 gradient, the resolution of proteins will be much greater.
This would yield a higher number of separated spots and allow a more thorough characterisation of
the proteomic response to plasmid acquisition.
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6 pH 11
Figure 3.4 2DOE protein profile of J53 separated over a pH 6-11 gradient and on a 12%
polyacrylamide gel. Proteins were stained with SYPRO ruby (Invitrogen) and visualised with an
Ettan DALT imager (OE Healthcare).
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6 pH 11
•
•
Figure 3.5 2DGE protein profile of J204 separated over a pH 6-11 gradient and on a 12%
polyacrylamide gel. Proteins were stained with SYPRO ruby (Invitrogen) and visualised with an
Ettan DALT imager (GE Healthcare).
91
6• •
pH 11
Figure 3.6 2DOE protein profile of J499 separated over a pH 6-1 1 gradient and on a 12%
polyacrylamide gel. Proteins were stained with SYPRO ruby (Invitrogen) and visualised with an
Ettan DALT imager (OE Healthcare).
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3.3 Identifications of proteins excised from E. coli gels using MALD[- TOF MS
A small number of proteins were highlighted as present only in transformants, first by manual
inspection and then confirmed with Proteomweaver software (version 3.0, Bio-Rad). These spots
were manually excised, digested to peptides and desalted with Ziptips and submitted for MALOI-
TOF analysis (refer to methods sections 2.16; 2.17; and 2.20). This was to see if 20GE had
achieved sufficient separation for protein identification and if any resistance enzymes could be
detected. The spots that were predicted to be present in only one isolate and were identified
through peptide mass fingerprints (PMFs) are displayed below in Figure 3.7 and described in Table
3.1.
Spot 1
pH 4-7
Spot 1
pH 4-7
Spot 1
pH 6-11
Spot 1
pH 6-11
Spot 2
pH 4-7
Figure 3.7 Protein spots thought to be expressed only in one isolate from transformant 20GE
protein profiles (circled in red).
The PMFs were searched against an in-house database consisting of all E. coli protein sequences
downloaded from CBI and the identifications returned are tabulated in Table 3.1.
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Organism Spot pH Protein Protein function MASCOTnumber gradient Identification Score
TEM is a ~-lactamase; it
Spot 1 4-7 TEM -1 precursor hydrolyses ~-lactam antibiotics 79/67
J204 such as Eenicillin
CTX-M hydrolyses extended-
Spot 1 6-11 CTX-MESBL spectrum p-Iactam antibiotics 70/67
such as cefotaxime
AAC( 6) acetylates
Spot 1 4-7 AAC(6) aminoglycoside antibiotics and 69/67
inactivates them
TEM is a p-Iactamase; it
J499 Spot2 4-7 TEM -1 precursor hydrolyses p-Iactam antibiotics 190/67
such as Eenicillin
CTX-M hydrolyses extended-
Spot 1 6-11 CTX-MESBL spectrum ~-lactam antibiotics 81/67
such as cefotaxime
Table 3.1 Identifications assigned to the protein spots that were present only in one of the
transformants and not the others. MASCOT scores display the assigned score of the identification
against the threshold value generated by MASCOT.
Although the CTX-M enzymes were successfully identified from the pH 6-11 profiles of the J53
transformants, presence or absence of plasmid-borne proteins can be assessed using other, more
established methods e.g. PCR. To further elucidate the effects of plasmid acquisition, the more
subtle changes in protein expression caused by acquisition of plasmids must be identified i.e. rather
than the appearance/disappearance of spots, the proteins expressed by each isolate must be
quantified. To achieve this, 2DGE was performed in triplicate and analysed by Proteomweaver and
later SameSpots software. However, even in triplicate, no consensus of statistically significant
changes could be reached due to variability between the gel profiles, highlighting a major
reproducibility issue in 2DGE. To avoid this reproducibility issue, the ID SDS-PAGE profiles of
the transformants were analysed using the GeLC workflow (described in methods section 2.21).
Prior to this, the phenotypes of the transformants were analysed to see if any differences could be
identified, which might allow a more targeted approach to the GeLC proteome analysis. For
instance, large differences in growth on glucose substrate could suggest protein differences in the
pathways of carbon metabolism, while differences in osmotic tolerance may mean changes to the
outer membrane protein complement.
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3.4 Phenotypic analvsis of CTX-M plasmid-bearing E. coli
As proteomic data describes but one aspect of resistance, additional approaches are required for a
more in-depth analysis. For instance, a protein may not be expressed, but genome analysis is
required to ascertain whether the gene is still present. Using a wider range of complementary
techniques allows for validation of results from one technique against the others e.g. a proteome
change that can be confirmed by a genome change allows for greater confidence in the
interpretation of results. For this reason, the phenotypic characteristics of the transformant isolates
compared with J53 were investigated. The phenotypic changes between the isolates could then be
compared with any observed proteomic changes to allow a more comprehensive analysis of the
effects of resistance plasmid procurement.
3.4.1 Compounds carried on PM plates
PM plates 1 and 2 contained substrates to investigate growth on organic metabolites and were thus
used to infer any deficiencies in carbon metabolic pathways. PM plates 3 contained substrates to
test for abnormalities in nitrogen metabolism, while plate 4 substrates investigated phosphorus and
sulphur metabolism. PM plate 5 contained a variety of nutrient supplements such as amino acids,
nucleic acids, vitamins metabolites and energy sources. PM plates 6, 7 and 8 all contained amino
acids, di- and tripeptides to probe amino acid metabolism. PM plates 9 and 10 tested growth on a
variety of osmotic challenges e.g. increasing NaCI concentrations, while the remaining PM plates
11 to 20 tested organism growth on a wide range of challenges, such as antibiotics, toxic
compounds and anti-metabolites (See appendix 1 for a complete list of all compounds). All PM
tests were carried out in duplicate.
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3.4.2Calculation of cut-off parameters
Numerical RA (respiration) values of growth were returned from the PM analysis and from this
data, cut-offs were calculated for significant growth (more than the negative control) and
stimulated growth (more growth than on the positive control) e.g. a metabolite has given the isolate
an advantage, as in Methods section 2.4.2. These cut-offs are displayed in Table 3.2 and were used
to calculate the cut-offs for significant differences in growth, given in Table 3.3.
Cut-offs for significant growth Isolates
J53 J204 J499
Negative ctrl well PMl Al 6668 6761 7679
Negative ctrl well PM2 Al 14348 10735 13901
Mean Average (avg) 10508 8748 10790
Standard Deviation (SO) 5430 2810 4399
Significant growth (avg + 1 SD) 15938 11558 15189
Parameter for significant growth (~) 16000 11500 15000
Positive ctrl well PMI Cl (D-glucose-6-phosphate) 30040 29296 27799
Positive ctrl well PMl 09 (D-Iactose) 31008 30275 26177
MeanAvg 30524 29785.5 26988
SD 684 692 1146
Avg+ 1 SO 31208 30477 28134
Parameter for stimulated growth ~) 31000 30500 28000
Table 3.2 Table describing how the PM cut-offs for significant (greater than the negative control
well) growth and stimulated (greater than the positive control well) growth were calculated. Cut-off
calculations were based on the method used by Morales et al. (Morales et al. 2005). Numbers
correspond to RA (respiration) values generated by the Omnilog instrument.
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Cut-offs for significant difference in growth Comparison
J53 vs. J204 J53 vs. J499
Negative ctrl well PMI Al -93 1011
Negative ctrl well PM2 Al 3613 1359
MeanAvg 1760 1185
SD 2620 246
Significant growth (avg + 1 SD) 4380 1431
Parameter for significant growth (?:) 4380 1430
Table 3.3 Table describing how the cut-offs for the significant difference in growth between either
J53 and J204 or J53 and J499. Cut-off calculations were based on the method used by Morales et
al. (Morales et al. 2005). Numbers correspond to RA (respiration) values generated by the Omnilog
instrument.
3.4.3 Results of P~1 analvsis
The E. coli isolates were grown on PM plates for 48 hours as described in Methods section 2.4,
time curves of their growth were recorded and are displayed in figures 3.8 and 3.9. J53 appeared to
grow better on the amino acids and the di- and tri-peptides (PM plates 3-8), as well as the osmotic
challenges (plates 9 and 10). While the transfonnants showed greater levels of respiration on many
of the antimetabolite and antibiotic sensitivity plates (plates 12-20), this was expected for many
substrates, given the resistance genes these plasmids encode. The carbon metabolism plates (PM 1
and 2) gave mixed results, with some substrates giving growth advantages to J53 and some to the
transformants (see Figs. 3.8 and 3.9).
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While there were many changes in growth between J53 and its transfonnant derivatives, the focus
will only be on the changes which were statistically significant (p < 0.05, using Students' T-test),
demonstrating greater than a 2-fold difference in growth and had no obvious resistance bias e.g. as
the transformants both contained ~-lactamases, all ~-lactam substrates were removed from
comparison with J53. These significant changes are displayed in Tables 3.4 and 3.5.
3.4.3.1 Similarities between plasmids
Both J204 and J499 showed a greater level of growth on the compounds: dichlofluanid, patulin and
chloroxylenol, compared to J53. Dichlofluanid is an antifungal agent with antibacterial activity,
often used as an anti-fouling agent to prevent attachment of organisms to a wetted surface, or
biofouling (Fernandez-Alba et al. 2002). The activity stems from the ability to block thiol-
containing enzymes involved in respiration (Leroux et al. 2010). The transfonnants had a particular
advantage in the presence of this compound, both J204 and J499 displayed an 8-fold greater
difference in RA values compared to J53.
Patulin is a mycotoxin produced by a variety of molds, most notably Aspergillus and
Penicillium. It has antibacterial activity and may act as a quorum sensing inhibitor in P. aeruginosa
(Liaqat & Thomas 2010), although its specific mechanism of action is unknown. J204 and J499
displayed differences in RA values of 5.4- and 4.8-fold greater than J53, respectively.
Chloroxylenol is an antibacterial drug with little toxicity to mammals and is present in
antibacterial soaps such as Dettol. Its bactericidal activity is due to its ability to disrupt bacterial
cell membrane potentials (Lear et al. 2002). J204 and J499 displayed differences in RA values of
3- and 2.7-fold greater than J53, respectively.
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Conversely, 2-phenylphenol and the polymyxin antibiotics (polymyxin B and colistin) both gave a
growth advantage to J53 over its transfonnant derivatives. The polymyxins act on the bacterial
membrane, binding lipopolysaccharide which then allows disruption of the membrane and cell
lysis. The susceptibility of the transfonnants to these agents suggests modification to the LPS/cell
wall of J204 and J499, as 2-phenylphenol acts on DNA and would need entry to the cell for
antimicrobial activity. J53 also displays increased growth during osmotic stress caused by 10%
NaCl (vs. J204) and 3% urea (vs. J499), which also suggest changes to the cell wall which may
affect cell permeability.
3.4.3.2 Effect of pEK204 on J53
The largest difference came when the isolates were grown on dequalinium, which gave J53 a 17-
fold greater difference in RA values compared with J204. Dequalinium is a topical medicine and
has been used in throat lozenges, mouthwashes and creams and ointments, although it is said to
have lower activity against E. coli than against S. aureus due to the Gram-negative outer membrane
(Tischer et al. 2012). Although many sites of action have been proposed for dequalinium, its exact
mechanism is still unknown.
3.4.3.3 Effect of pEK499 on J53
The greatest difference between J53 and J499 RA values was from growth on vanadate ions,
growth on metavanadate gave J499 a 13-fold greater difference in RA value compared to J53.
Similarly high differences on the orthovanadate substrates were observed, the action of vanadate
ions is thought to be through non-specific inhibition of ATPases. Growth in the presence of
vanadate ions causes P. aeruginosa to alter it s LPS composition (Damron et al. 2012) and as J499
displayed such a difference in growth compared to J53, it suggests that J499 may have alterations
to its cell envelope to cope with the vanadate stress.
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3.5 GeLC analysis of E. coli extracts
Three biological replicates of J53, J204 and J499 protein extracts were separated by SDS-PAGE,
the gel lanes cut into sections (Fig. 3.10.), digested to peptides and analysed with an orbitrap classic
LC-MSIMS (see methods section 2.20). The resulting data was searched using Mascot (version
2.2.2, Matrix science) against an E. coli database, curated using all E. coli protein sequences
downloaded from NCBI in August 2012. This identified all the peptides found in the digested gel
fractions, rather than separating out proteins of interest and identifying them individually. The
resulting Mascot .DAT files were analysed with Scaffold (version 3.3.2 Proteome Sciences) and in
total, 767 proteins were identified between the isolates with a false discovery rate (FDR) of 0 %.
Six hundred and ninety four of these proteins were identified in all three isolates, 16 were identified
in both transformants, nine were identified in both J53 and J204, and eight were identified in both
J53 and J499 (Fig. 3.10). The results also showed some proteins were identified in one isolate only:
one was identified in J53, seven in J204 and 32 in J499 (Fig. 3.11).
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Figure 3.10. SDS-PAGE profiles of whole-cell extracts of the transfonnants. Three biological
replicates of J53 (lanes I, 2 and 3), J204 (Janes 4, 5 and 6) and J499 (lanes 7, 8 and 9) were run.
Red ladder illustrates how protein profiles were divided and cut for GeLC analysis.
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J204 J499
J53
Figure 3.11 Venn diagram displaying the number of identified proteins shared between isolates or
detected only in one isolate; generated by Scaffold software. Red numbers correspond to the
number of plasmid-encoded proteins e.g. out of seven proteins identified only in J204, two were
encoded by pEK204.
3.5.1 Identification of resistance plasmid proteins
The proteins identified from the GeLC profiles included TEM j3-lactamaseprecursor and CTX-M-3
ESBL in both J204 and J499 (Table 3.8). It is understandable that the search algorithms used could
not differentiate between the two different CTX-M enzymes carried by the two plasmids as they
only differ by one amino acid (Poirel 2002) and the peptides with this difference may not have
been detected. These are the only two resistance enzymes carried by pEK204 and this approach
was able to identify them both. The resistance proteins: aminoglycoside N(6')-acetyltransferase
AAC(6'), OXA-1 precursor, macrolide 2'-phospho transferase I, DfrA 17, aminoglycoside resistance
protein and dihydropteroate synthase were identified as only expressed in J499. As well as the
TEM and CTX-M proteins, this approach identified six out of the eight remaining resistance
proteins on pEK499, a total of 8/10, leaving the tetracycline resistance protein (TetA) and
chloramphenicol resistance protein (CatB4) undetected.
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This left 10 plasmid encoded proteins identified in J499, which were primarily involved in
maintainance of pEK499 and included plasmid-partitioning protein SopA (Protein 1; Table 3.6),
plasmid-partitioning protein (Protein 2; Table 3.6) which returned as SopB via BLASTp analysis
(E = 0), conjugal transfer protein TraM (Protein 4; Table 3.6), conjugal transfer surface exclusion
protein TraT (Protein 5; Table 3.6), plasmid segregation protein ParM (Protein 6; Table 3.6), stable
plasmid inheritance protein PemK (Protein 7; Table 3.6), plasmid stable inheritance protein
(Protein 11; Table 3.6) which returned as StbB via BLASTp analysis (E = 2e-74), putative HTH-
type transcriptional regulator yfaX (Protein 14; Table 3.6), hypothetical protein pEK499 _p136
(Protein; Table 3.6) and toxin-antitoxin system, toxin component, PIN family (Protein 16; Table
3.6).
There were two proteins from J204 which were expressed from the plasmid but not
involved in resistance. These were plasmid segregation protein ParM (Protein 17; Table 3.6) and
hypothetical protein EcE24377A_D0059 (Protein 18; Table 3.6) which returned as plasmid
mobilisation protein MobC (E = 2e-71).
In total, this left five proteins identified in J204 and 16 proteins identified in J499 which
were not plasmid-encoded and where expression was likely to be induced only after plasmid
acquisition (as these proteins were not detected in J53).
3.5.2 Effects of plasmid acquisition on the host E. coli strain J53
3.5.2.1 Non-plasmid encoded proteins induced or repressed bv plasmid acquisition
The single protein identified only in J53 (Fig. 3.11) was periplasmic TolA-binding protein (Table
3.7) and returned as YbgF by BLASTp analysis (E = 0), a co-regulator of the Tol-Pal system
required for membrane integrity and which participates in the septation process during cell division
(Krachler et al. 2010). YbgF is not required for Tol-Pal functional activity and although YbgF is
known to bind ToIA, to date the exact function is unknown.
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There were seven proteins identified only in J204 including two proteins which were identified as
originating from the plasmid pEK204. The remaining five proteins (Table 3.7) included
Dihdropyrimidine dehydrogenase (Protein 17; Table 3.7) which is required for uracil catabolism.
Threonine dehydratase (Protein 18; Table 3.7) is involved in amino acid metabolism, while
Quinone oxidoreductase (Protein 19; Table 3.7) participates in electron transfer in respiration.
Cobyrinic acid a,c-diamide synthase (protein 20; Table 3.7) is involved in the synthesis of vitamin
B12, while protein 21 returned as ClpB by BLASTp analysis (E = 0), involved in disaggregation
and refolding of proteins rather than degradation (Zolkiewski 2006).
The 32 proteins identified only in J499 included 16 proteins which originated from the plasmid
pEK499. The remaining 16 proteins (Table 3.7) included Bifunctional diaminohydroxy-
phosphoribosylaminopyrimidine deaminase/5-amino-6-(5-phosphoribosylamino) uracil reductase
(Protein 1; Table 3.7), which returned as RibD via BLASTp analysis (E = 0) and is involved in the
biosynthesis of riboflavin. Thymidylate kinase or Tmk (Protein 2; Table 3.9) is an essential enzyme
catalysing the synthesis of Thymidine deoxynucleotide precursors. UDP-N-acetylglucosamine 1-
carboxyvinyltransferase or MurA (Protein 5; Table 3.7), this protein has been highlighted as a
potential resistance determinant for fosfomycin with a Iow fitness cost (Couce et al. 2012).
TldD (protein 6, Table 3.7) is known to be involved in the control of DNA Gyrase
regulation and may play a role in Ccd toxin addiction systems (Allali et al. 2002), which would
explain the presence of this protein in J499 (pEK499 encodes a Ccd addiction system).
Hypothetical protein ECP_3589 (Protein 7; Table 3.7) returned as YhiR via BLASTp
analysis (E = 0) and is involved in the methylation of rRNA.
Lysine decarboxylase, inducible (Protein 8; Table 3.7) is involved in protection against
acid stress and also the stringent response, though to regulate lysine metabolism under nutrient-
limiting conditions (Kanjee et al. 2011).
The ubiD gene product (Protein 10; Table 3.7) is involved in the synthesis of coenzyme Q,
required for the periplasmic oxidizing system in removing electrons via the electron transport
system (Gulmezian et al. 2008).
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tRNA-specific 2-thiouridylase MnmA (Protein 12; Table 3.7), the Mnm proteins are
involved in the modification oftRNA (Armengod et al. 2012).
Neither hypothetical proteins; hypothetical protein EcHS_A4153 (Protein 14; Table 3.7)
and Hypothetical protein APECOl_OlCoBM79 (Protein 15; Table 3.7) returned any definitive
matches by BLASTp analysis.
Hydrolase, alpha/beta fold family (Protein 16; Table 3.7) returned as X-Pro dipeptidyl-
peptidase via BLASTp analysis (E = 0), which cleaves any dipeptides containing proline. As there
was little further information on the functions and activities of the remaining proteins, their role in
this resistance mechanism is unknown.
3.5.3 Proteins found onlv in two isolates
3.5.3.1 Proteins shared by transform ants
There were sixteen proteins identified as present in both transformants and not in J53, these
included TEM-precursor and CTX-M-3 as mentioned in section 3.5.1, these and the remaining 14
are displayed in Table 3.8. Aside from the proteins 1 and 2 (Table 3.8), there were no additional
proteins identified as expressed from the plasmids pEK204 and pEK499. Other proteins identified
included: hypothetical protein ECP_2945 (Protein 3; Table 3.8) which returned as YggS by
BLASTp analysis (E = 1e"17<).
Translocation protein TolB (Protein 4; Table 3.9) is a major constituent of the Tol-Pal
system mentioned in section 3.5.2.1, TolB works with the other members of the Tol-Pal system to
preserve membrane integrity and organise the septation process of cell division. Deletion of any tol
genes results in non-functional membrane (leaking, reduced LPS) and sensitivity to large
antibiotics and detergents (Bonsor et al. 2009).
Peptidoglycan-associated outer membrane lipoprotein returned as the pal gene product by
BLASTp analysis (E = 5e·123), Pal is also part of the Tol-Pal system required for membrane
integrity and which participates in the septation process during cell division (Krachler et al. 2010).
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Protein Protein Name Ginumber No. uniquenumber pep tides
1 Beta-lactamase CTX-M-3 precursor gil256367540 9,11
2 Beta-lactamase TEM precursor gil16930300 1 6,8
3 Hypothetical protein ECP_2945 gilll0643100 2,2
4 Translocation protein TolB gill10640948 2,2
5 Peptidoglycan-associated outer membrane lipoprotein gill10640949 2,2
6 Nitric oxide dioxygenase gill10642714 2,2
7 23S rRNA methyltransferase gill10643419 2,2
8 ABC transporter ATP-binding protein gill10640346 2,2
9 6-phospho-beta-glucosidase gill10643050 2,2
10 3,4-dihydroxy-2-butanone 4-phosphate synthase gi1110643290 2,2
11 Ribonuclease III giI110642729 2,2
12 D-ribose transporter ATP-binding protein gi1110644090 2,2
13 obgE gene product gil386602734 2,2
14 N-methyltryptophan oxidase, FAD-binding gil16129022 2,2
15 RNA-binding protein YhbY gi1110643420 2,2
16 DNA-binding/iron metalloproteinlAP endonuclease gi1110643308 2,2
Table 3.8. Proteins identified in both transformants J204 & J499, but not in J53. Two values are
given for the unique peptides, corresponding to J204 and J499 respectively, as differing numbers of
peptides were found in each transformant.
Nitric oxide dioxygenase (protein 6; Table 3.8), which returned as HmpA or
flavoheamoprotein by BLASTp analysis (E = 0), it is involved in the tolerance of reactive nitrogen
intermediates (RNls) and is utilised by pathogenic bacteria, including ExPEC (Bateman & Seed
2012).
3,4-dihydroxy-2-butanone 4-phosphate synthase (Protein 10; Table 3.8) returned as RibB
via BLASTp analysis (E = 5e-lS7) and is involved in flavin biosynthesis.
Ribonuclease III (Protein 11; Table 3.8) is an endonuclease that produces functional RNAs
such as ribosomal RNA from cleaving its precursor (Macrae & Doudna, 2007).
ObgE (Protein 13; Table 3.8) or CgtA, is an essential GTPase in E. coli and has been
implicated in the control of the stringent response in response to amino acid starvation (Persky et
al.2009).
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DNA-binding/iron metalloproteiniAP endonuclease (Protein 16; Table 3.8) returned as
YgjD via BLASTp analysis (E = 0) and is involved in tRNA modifications but may also have
glycoprotease activity (Hashimoto et al. 2011).
Very little further information was obtained for the remaining proteins, therefore their
potential role in this resistance mechanism is currently unknown.
3.5.4 Proteins shared by J53 and one transform ant
Nine proteins were identified as expressed in J53 and J204 but not in J499, these included: FtsH
protease regulator HflC (Table 3.9) regulates the protease FstH (HflB), which re-folds misfolded
proteins. HflC also protects the bacteriophage protein CII from degradation, which promotes the
lysogenic cell cycle (Bandyopadhyay et al. 2010).
The mtlA gene product (Protein 2; Table 3.9) returned as the mannitol-specific EllA
subunit of the phosphotransferase system (PTS) (E = 0), which catalyses the transport and
concomitant phosphorylation of sugars, in this case, mannitol (Kumar et al. 2011).
Protein 3 (Table 3.9) returned as MppA by BLASTp analysis (E = 0), MppA is a peptide
permease which also has haem-binding activity and hence iron regulation. To utilise haem, E. coli
must express either DppA or MppA (Letoffe et al. 2006).
The wzzB gene product (Protein 4; Table 3.9) acts as a regulator of polysaccharide chain
length in the biosynthesis of lipopolysachaarides (LPS), which can affect the properties of LPS
(Woodward et al. 2010).
Protein 7 (Table 3.9) returned as yrbD gene product by BLASTp analysis (E = 3e·128), a
toluene transport protein which has been implicated as an immunogenic protein of Y. pestis
(Tanabe et al. 2006).
As in the previous section, little further information was obtained for the remaining
proteins, therefore their potential role in this resistance mechanism is currently unknown.
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There were also eight proteins identified as expressed in J53 and J499, but not in J204 and include:
S-formylglutathione hydrolase (Protein 10; Table 3.9), required for detoxification of formaldehyde.
Sigma (54) modulation protein (Protein 11; Table 3.9) returned as Yhbh by BLASTp analysis (E =
3e-62) which promotes and stabilises lOOS ribosome formation during the transition to stationary
phase growth (Veta et al. 2005). lOOSribosomes are 70S dimers and have no translational activity,
they are thought to protect against ribosomal degradation, resulting in a longer cellular lifespan.
Co-chaperone HscB (Protein 12; Table 3.9) is required for transfer of Fe-S clusters into
proteins (Ciesielski et al. 2012). Proteins 13, 14 and 15 (Table 3.9) were involved in metabolic
processes but the reasons for their presence in J53 and J499, but not in J204 are unknown.
Competence damage-inducible protein A or YgaD returned as similar to CinA by BLASTp
analysis (E = le_1l4), CinA is thought to be required for the process of transformation as expression
is required for competence (Luo &Morrison 2003).
Peroxide resistance protein returned as YaaA by BLASTp analysis (E = 0), it acts to reduce
hydrogen peroxide toxicity through suppression of unincorporated intracellular iron levels (Liu et
al. 2011).
3.6 Chapter Summary
This investigation into MOR plasmid acquisition (pEK204 and pEK499) in E. coli sought to
characterise the proteins changes caused by uptake of these plasmids. The aim was to use the PM
results to corroborate with the proteomics results to confirm any changes identified and try to
elucidate why these changes may have occurred. 20GE was used to separate the proteins from a
whole-cell extract and identify the digested proteins with MALDI-TOF MS. While useful in this
case to identify single proteins expressed from the transformants, 20GE is not an applicable
technique for a high-throughput reference laboratory, as it generally requires analysis of multiple
isolates and is a lengthy technique. Also, the approach only identifies single proteins, whereas the
GeLC approach is more suitable and has the potential to profile the expressed resistance proteins.
Although the GeLC method was not the optimal approach to identify all the proteins on the plasmid
(compared with e.g. sequencing), it was certainly an effective method to ascertain which proteins
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were actually expressed from the plasmid. Eight of the ten resistance proteins from pEK499 were
detected in the J499 protein extract and both the resistance proteins from pEK204 were detected.
The two remaining resistance proteins from pEK499 were tetracycline resistance protein Tet(A)
and chloramphenicol resistance protein CatB4, however, the reasons why these proteins were not
detected are unknown. This approach therefore has the potential to identify proteins in an extract,
as well as to profile the resistance proteome expressed by a resistant isolate. This is a technique that
would be more applicable to a reference laboratory, as it is high-throughput, sensitive and simple
sample preparation (however, an LC-MSIMS is still required). Due to its rapid timescale and global
coverage of so many phenotypes, the Biolog system could also be utilised in a reference laboratory,
but at a reduced scale. There are too many plates which give information that is not relevant when
investigating resistance phenotypes e.g. aside from MIC testing, very few phenotypic/biochemical
tests are ever utilised for investigation in resistance laboratories.
PM analysis demonstrated that pEK204 provided 1204 with an advantage on dequalinium, for
which resistance is usually conferred by efflux pumps (Turner et al. 1997; Korkhov & Tate 2008).
The acquisition of pEK204 may have caused the upregulation of one or more efflux proteins in J53.
PM analysis also showed that pEK499 provided J499 with high tolerance to vanadate ions (more
than a 10-fold difference in growth compared to J53). Vanadate ions inhibit ATPase activity
(Matsuo et al. 2008), so pEK499 may confer J53 with some way of overcoming this inhibition,
either through increased expression of the targets, or expression of an additional ATPase to quench
the vanadate ions. However, even after proteomic analysis, the precise reasons for these substrate
advantages are unknown.
Both the transformants could grow on higher levels of patulin, dichlofluanid and
chloroxylenol than their parent J53. Dichlofluanid, chloroxylenol and patulin to a lesser extent are
all present in the environment, Dettol (of which chloroxylenol is an active ingredient) is used in
hospitals and homes and dichlofluanid is used around watery areas e.g. rivers and ports. These
plasmids could provide the recipient with a slight survival advantage compared with bacteria
without these phenotypic changes which may allow ex vivo survival in human-populated areas e.g.
places of rest/work and the water system. This may contribute to the plasmids' dissemination and
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prolonged carriage and could help to explain why in the absence of antibiotic selection pressure,
these MDR plasmids are kept by the bacteria. This is a logical viewpoint as bacteria use the same
general mechanisms for biocide and antibiotic resistance (Sheldon 2005). Indeed, it is known that
exposure to biocides may select for antibiotic resistance (Gilbert & Mcbain 2003), but this result
suggests (but does not confirm) that the opposite may be true, that antibiotic resistance could also
select for reduced biocide susceptibility.
It was demonstrated that plasmid acquisition did confer some disadvantages on some of the
compounds tested, as PM analysis showed that J53 displayed more growth on polymyxin
antibiotics (polymyxins B and colistin), 2-phenylphenol and displayed greater osmotic tolerance
than both transformants (by growing better on both urea and sodium chloride). Combined with the
advantages the plasmids appear to give, the data suggests that the transformants undergo some
modulation of the cell envelope. For instance, the polymyxins act on the cell membrane and show
greater activity against transformants and 2-phenylphenol has an intracellular target, so it must be
more able to permeate the membrane.
The proteomics results support this general hypothesis, as proteins novel to J204 and J499 and to
J53 included membrane proteins. In particular, plasmid acquisition seemed to cause modulation of
the Tol-Pal system, required for membrane structural integrity (Krachler et al. 2010) e.g. a
modulator of TolA (FhgY) was identified only in J53, whereas TolB and Pal were identified in
only J204 and J499. This could explain the differences in the organisms' phenotype as deletion of
any tol genes can result in a non-functional membrane (leaking, reduced LPS) and sensitivity to
large antibiotics (such as peptide antibiotics) and detergents (Bonsor et al. 2009). Therefore, if
plasmid acquisition did affect FhgY levels, this may have compromised membrane functionality
and led to increased sensitivity to certain antibiotics e.g. polymyxins. It should be noted that
although a protein was identified in two isolates and not the other one, it may not necessarily
suggest that this protein was not expressed, rather it may have been at levels too low to detect.
Peptides could have been sampled but fragmented insufficiently or simply the stochastic manner of
data dependent acquisitions could have lead to the missing data.
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Additional proteins identified only in the transfonnants included HmpA, which protects
against RNI and is utilised by pathogenic bacteria in stress defence. Also identified was ObgE,
which modulates the stringent response to amino acid starvation and is involved in DNA repair
through stimulation of recA (Zielke et al. 2003). From the proteomic data, it appeared that these
proteins were not expressed in J53 and they could be advantageous to the transfonnants under
conditions of stress, such as antibiotic treatment. They could therefore be responsible for the
unexplained effects of plasmid acquisition e.g. increased tolerance to antiseptics, due to their stress
defence functions, although further work is required to confirm the role of these proteins. There
were also many differences between proteins expressed in J53 and J204 compared to J53 and J499.
The reasons for expression of these proteins in one transfonnant and not the other are as yet
unclear, as they do not correlate with the phenotypic differences.
Proteins have been identified which were expressed or repressed upon acquisition of MDR
plasmids, some of which may contribute to the altered susceptibilities of the transfonnants. It is
recognised that although plasmids may not encode enzymes directly responsible for resistance to
antibacterial agents, plasmid acquisition can change the resistance profile of an organism. For
instance, certain R plasmids were found to reduce the levels of expressed OmpF in E. coli, which
reduced susceptibilities to many other agents (Rossouw & Rowbury 1984). Russell also highlights
examples where plasmid acquisition has altered cell envelope composition (Russell 1997),
corroborating with the results in this study, that acquisition of MDR plasmids can alter the
proteome and phenotype of the host organism. Also, different MDR plasmids can produce subtly
different phenotypes and protein profiles, so further testing of a wide variety of plasmids on the
same organism (J53) is required.
The proteomic experiments undertaken in this chapter have identified many proteins and
subsequently highlighted areas which require further investigation. More experimentation needs to
be carried out on the proteins identified in this study to further characterise their precise role in
modulation of host cell proteome upon acquisition. For instance, mutants lacking these proteins
should be generated and tested again to see if susceptibilities have changed. Further work also
needs to be done on the susceptibilities of transfonnants to biocides and antiseptics, because,
118
although there are no specific resistance genes on the plasmids for tolerance to antiseptics, the
transformants clearly have an advantage in the presence of certain agents.
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4. Results
Carbapenem resistance in Klebsiella pneumonlae
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4.1 Background of Isolates
A well-described mechanism of resistance to carbapenems is through expression of a metallo-B»
lactamase or carbapenemase enzyme. These include KPC from Klebsiella sp. (Nordmann et al.
2009), OXA-type carbapenemases from e.g. A. baumannii (Woodford et al. 2006), IMP and VIM
enzymes from P. aeruginosa (Livermore & Woodford, 2006) and the notorious NDM-l from E.
coli and K. pneumoniae (Karthikeyan et al. 2010). However, other resistance mechanisms may
confer carbapenem resistance, such as reduced porin expression in combination with AmpC or
ESBL enzymes and upregulated efflux-pumps. Altered porin expression and the effects of outer
membrane protein rearrangement on the organism is of particular interest, as isolates displaying
altered porin expression have MICs similar to carbapenemase-producers but will return negative
PCR results for carbapenemases.
Due to the rapid inter-species dissemination of plasmid-mediated carbapenemases e.g.
KPC enzymes, originally from Klebsiella pneumoniae (Queenan & Bush, 2007), carbapenem-
resistant organisms are an increasing healthcare concern as this resistance eliminates the agents of
last resort for many Enterobacteriaceae. Hence, carbapenem-resistant K. pneumoniae are associated
with fewer treatment options, namely combination therapies using tigecycline with polymyxins and
increased mortality (40-50%) (Qureshi et al. 2012).
The organisms used in this study consist of a pre- and post therapy pair of K. pneumoniae
clinical isolates, lA and lB, respectively. lA was recovered from a patient receiving
piperacillinltazobactam and gentamicin and upon isolation, treatment was changed to meropenem.
Four weeks later a second carbapenem-resistant K. pneumoniae isolate, IB, was recovered and
while both isolates were PCR-negative for carbapenemases, they tested positive for a group 1
CTX-M ESBL. The deduced mechanism of resistance was porin reduction combined with ESBL
production.
The aims of this study are to characterise changes in K. pneumoniae proteome caused by
differential porin expression. For instance, it is worth investigating whether any other OMP
expression is affected by the potential reduction of two major porins. Or, if there is a potential
121
target to circumvent this mechanism of resistance and more importantly, whether there are potential
markers which may be used to speed up the detection of this resistance mechanism.
4.2 Membrane fractionation and lD gels of K. pneumoniae
Initially, to check the suspected differential porin expression, the OMPs from lA and lB were
analysed using SDS-PAGE. Proteins extraction methods were optimised using a variety of OMP
fractionation methods and the ROMP method proved fastest and gave good OMP separation (see
methods section 2.7.2). The OMP extracts were run on two different SDS-PAGE systems, one was
cast in-house and the other was the Nu-PAGE bis-tris gel system supplied by Invitrogen (Fig. 4.1).
It was determined that the in-house gels gave improved porin resolution compared with the Nu-
PAGE gels, so they were used for this preliminary experiment.
Figure 4.1. Comparison of two types of SDS-PAGE used to run OMP protein extracts, shown here
are the bands between 30 and 40 kDa: NuPAGE gels (A) were purchased from Invitrogen while
gels cast in-house (B) gave preferred separation of OMPs.
The OMP fractions of the paired isolates lA and IB were run alongside a pair of
carbapenem-susceptible K. pneumoniae, isolate K2, a control for porin loss lacking OmpK35 and
OmpK36 and the K. pneumoniae type strain ATCC 13883 (NCTC 9633) for a full OMP
complement (Fig. 4.2). From the OMP profiles of the gel, it was clear that while isolate lA had
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similar expression to the other carbapenem-susceptible isolates, 1B had lost two bands at roughly
38-40 kDa and reduced expression of the remaining bands at 36.5 kDa. This pattern is similar to
that of isolate K2, which lacked expression of two major porins OmpK35 and OmpK36 (Doumith
et al. 2009) and confirmed the suspected carbapenem-resistance mechanism mediated by porin loss
and ESBL-production (Webster et al. 2010).
Figure 4.2. In-house SDS-PAGE profiles of K. pneumoniae OMP fractions. Proteins were run on a
12% polyacrylamide gel with M) marker, 1) ATCC 138832/3) a pair of carbapenem-susceptible K.
pneumoniae isolates 4) isolate lA 5) isolate IB 6) K. pneumoniae isolate K2, which is lacking
OmpK35 and OmpK36 expression.
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4.3 GeLC analysis of K. pnell1noniae outer membrane proteins
As SDS-PAGE only provides information on the presence or absence of a band and no
identifications are assigned, the OMP fraction from K. pneumoniae isolates were subjected to
GeLC analysis. The protein profile from SDS-PAGE was cut into 12 pieces (Fig. 4.3), digested
with trypsin and submitted for LC-MSIMS analysis. The SDS-PAGE added a preliminary layer of
separation to the complex mixture of proteins prior to LC peptide separation and allowed greater
resolution of peptides for improved protein identification.
Figure 4.3. Invitrogen SDS-PAGE profiles of OMP extracts of the K. pneumoniae clinical pair.
Three biological replicates of isolate lA (lanes 1,2 and 3) and isolate 1B (lanes 4, 5 and 6) were
run. Red ladder illustrates how protein profiles were divided and cut for GeLC analysis.
124
The raw MS spectra output files were first subjected to peptide matching, against a protein
sequence database using Mascot (version 2.2.2, Matrixscience). The database used was curated in-
house using sequences of all Klebsiella sp. protein sequences obtainable from NCBInr (August
2012). The resulting .DAT files were analysed with Scaffold software (version 3.6, Proteome
sciences) as detailed in methods section 2.22. In total, 224 proteins were identified between the
isolates with a false discovery rate (FDR) of 0 %. However, many of these matches were cytosolic
proteins arising from 1-2 peptide matches, indicating that there had been some carry over of
cytosolic proteins into the OMP fraction. 164 of 224 identifications were shared between two
isolates, while 19 proteins were identified only in lA and 41 proteins identified only in lB (Fig
4.4).
1A 18
164
Figure 4.4. Venn diagram displaying number of protein identifications shared between isolates lA
and IB, or detected only in carbapenem-susceptible isolate lA, or carbapenern-resistant isolate IB;
generated by Scaffold software.
To make sure that the analysis was focused on outer membrane proteins, the lists of proteins
identified in just one isolate were submitted to PSORTb (http://www.psort.org/psortbD, to confirm
their subcellular localisation. Any proteins that were predicted to be cytosolic were excluded from
further analysis. Similarly, any protein that could not be localised to a specific area of the cell or
returned as hypothetical by BLASTp analysis, were also removed, to ensure that only the
expression of membrane proteins was compared between isolates lA and lB. This left 14 proteins
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identified in only lA and 12 proteins identified in only lB. While many cytosolic proteins were
identified in the OMP fraction, the fractionation was still successful in enriching for more
membrane proteins than in previous GeLC experiments. This resulted in more peptide
identifications associated with outer membrane proteins, giving increased confidence to the
identifications e.g. OmpK35 matched 16 peptides while TalB (cytosolic) only matched 2 peptides.
4.3.1 Proteins identified with roles in antibiotic resistance
There were five of the identified proteins thought to be involved in antibiotic resistance, including
two identified in isolate lA, including OmpK35 (protein 2; Table 4.1), one of the major porins of
K. pneumoniae. When expression of OmpK35 is reduced or repressed, the OM permeability is
lowered causing reduced accumulation of antibiotics (Martinez-Martinez, 2008). There was also an
outer membrane porin protein C identified, which was identified in both isolates and returned as
OmpK36 by BLASTp analysis (E = 0). However, it was only identified by 1 peptide in isolate 1B,
below the set cut-off of 2 unique peptides. It is likely that the peptide was an artefact from another
protein, as many more peptides (23) hit this protein in lA. OmpK36 is also involved in antibiotic
resistance, for the same reasons as OmpK35.
There were three proteins identified as present in isolate lB: oligogalacturonate-specific
porin protein KdgM (Protein 1; Table 4.2), which is likely to be a replacement porin for OmpK35
and OmpK36. KdgM is also known as OmpK26 and is thought to be essential for carbapenem-
resistant isolates lacking OmpK35/36 (Garcia-Sureda et al. 2011).
The emrA gene product (Protein 7; Table 4.2) is a periplasmic membrane-fusion protein
(MFP) of the multidrug efflux pump EmrAB-ToIC in E. coli. although its contribution to antibiotic
resistance is masked by AcrAB-TolC (Tikhonova et al. 2009).
Protein 11 (Table 4.2), putative APH(3") streptomycin phosphotransferase or StrA, is an
aminoglycoside phosphotransferase enzyme which confers resistance only against streptomycin
(Ramirez & Tolmasky, 2011). With the loss of porins OmpK35 and OmpK36, and with the
expression of these additional proteins, 1B seems the more resistant isolate based on the OMP
profile.
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4.3.2 Proteins involved in virulence/pathogenicity
As the OM proteome was being analysed, it was expected that many of the proteins identified
might have a role in pathogenicity or virulence. As these are the proteins most likely in contact
with both the natural and host environments and potentially with the immune system of the latter.
There were eight proteins identified in lA which were thought to be involved in virulence, these
included the conjugal transfer surface exclusion protein TraT (Protein 1; Table 4.1). TraT is an OM
lipoprotein that is usually encoded by conjugative plasmids and functions to prevent the transfer of
its plasmid to bacteria that already carry that plasmid, or a very similar plasmid, thereby promoting
the spread of its plasmid into diverse hosts (Sukupolvi & Connor, 1990). TraT also acts as a
virulence factor by increasing the survival rate of host cells in serum and acts as a transporter
across the outer membrane (Tomazella et al. 2011).
Four proteins coding for the assembly of fimbriae were identified only in lA, they included
an OMP for export and assembly of type 1 fimbriae (Protein 3; Table 4.1), which returned as FimD
via BLASTp analysis (E = 0). FimD is an usher protein, involved in the polymerisation and
translocation of the fimbrial proteins to the bacterial surface (Palomino et al. 2011). The
periplasmic chaperone (Protein 5; Table 4.1), which returned as the fimbrial chaperone FimC via
BLASTp analysis (E = 2e-16S), complexes with the structural subunits and initiates translocation via
FimD (Gossert et al. 2008). Type 1major fimbrial subunit precursor (Protein 7; Table 4.1) returned
as FimA by BLASTp analysis (E = 2e-122) and is the main structural subunit of the pilus (Puorger et
al. 2011). Lastly is the adaptor protein FimF (Protein 10; Table 4.1), which links the adhesive tip of
the pilus to the filamentous body and is also involved in the regulation of pilus biogenesis (Gossert
et al. 2008).
Two proteins involved in iron acquisition; ferrichrome outer membrane transporter (Protein
4; Table 4.1), which returned as Tonls-dependent siderophore receptor FhuA via BLASTp analysis
(E = 0) and involved in transporting iron bound to siderophores across the membrane. There was
also a dipeptide transport protein (Protein 14; Table 4_1), which returned as DppA (dipeptide
permease) by BLASTp analysis. It is involved in the transport of dipeptides across the membrane
and is also required for utilisation of haem as an iron source (Letoffe et al. 2006).
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Lipid hydroperoxide peroxidise (Protein 13; Table 4.1) returned as Tpx, a thiol peroxidise
required for oxidative defence and also shown to be important for biofilm production in shiga-toxin
producing E. coli (Kim et al. 2006).
There were two proteins identified in lB that could potentially be involved in virulence, including:
anaerobic dimethyl sulfoxide (DMSO) reductase subunit A (DmsA) (Protein 4; Table 4.2), which is
able to utilise alternative electron acceptors for anaerobic growth and is said to contribute to
virulence under anaerobic conditions inActinobacillus pleuropneumoniae (Baltes et al. 2003).
GTP-binding protein (Protein 12; Table 4.2) returned as TypAlBipA via BLASTp analysis
(E = 0), it is a translational GTPase which regulates virulence mechanisms in E. coli, possibly
through control of protein translation (Margus et al. 2007). Salmonella typhimurium TypA mutants
have shown reduced growth at lower temperatures, display reduced motility and have lower
survival rates in murine macrophages (Sabbagh et al. 2012).
4.3.3 Proteins identified with other functions
There were other proteins identified that were considered unlikely to be involved in either
antibiotic resistance or virulence, these included five proteins identified in lA; Klebicin B (Protein
6; Table 4.1) is a colicin-type peptide molecule. It functions as a nonspecific endonuclease and is
potentially used as a toxin against bacterial competitors (Riley et al. 2001).
Protein 8 (Table 4.1), putative enzyme returned as lipoprotein LppC by BLASTp analysis
(E = 0), which has been described as a potential secreted virulence factor in Actinobacillus
pleuropneumoniae (Zijnge et al. 2012), however, little is known about its function in K.
pneumoniae.
Maltose transporter subunit (Protein 9; Table 4.1) returned as MalE via BLASTp analysis
(E = 0), it seems likely that MalE is repressed by IB to further reduce its membrane permeability.
Hypothetical protein KPI_3289 (Protein 11; Table 4.1) returned as YidY by BLASTp
analysis (E = le·'63), an acid-inducible OMP (Stancik et al. 2002).
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Malate dehydrogenase (Protein 12; Table 4.1) is involved in the TCA cycle for carbon
utilisation.
There were also seven proteins identified with other functions in 1B, such as three proteins
identified as belonging to an oligosaccharide transport system. These include oligogalacturonate-
specific porin protein KdgM (Protein 1; Table 4.2). Protein 2 (Table 4.2), putative
oligogalacturonide ABC transport system periplasmic binding component, returned as TogB by
BLASTp analysis (E = 0). TogB is part of a multicomponent transporter which recognises the
oligosaccharide substrates and translocates them across the membrane (Abbott & Boraston, 2008).
Protein 3 (Table 4.2), putative oligogalacturonide ABC transport system ATP-binding component,
returned as TogA by BLASTp analysis (B = 0). TogA is the cytoplasmic domain that utilises ATP
for energy required for translocation (Abbott & Boraston, 2008). As OmpK26 has a potential role
in antibiotic resistance, this complex may also have as yet unknown roles in resistance.
The secA gene product (Protein 5; Tale 4.2) is an OMP which works with the SecYEG
translocase system to export partially folded proteins across the cytoplasmic membrane. SecA has
ATPase activity, thus providing energy for protein translocation (Plessis et al. 2011 and Sardis &
Economou 2010).
Protein 8 (Table 4.2), apolipoprotein N-acyltransferase, returned as Lnt via BLASTp
analysis (E = 0). It is an essential protein in E. coli and catalyses the last step of lipoprotein
modification before translocation to the outer membrane (Narita & Tokuda, 2011).
Protein 9 (Table 4.2), protease 4, returned as signal peptide peptidase SppA via BLASTp
analysis (B = 0). SppA is a serine protease which cleaves the signal peptide from lipoproteins,
allowing mature lipoproteins to insert into the membrane (Wang et al. 2009).
Protein 10, (Table 4.2), the fdoG gene product is the major subunit of formate
dehydrogenase-O, which works to reduce formate under aerobic conditions. There is a similar
complex which acts under anaerobic conditions and it is thought that having both complexes allows
rapid switching of metabolic pathways in response to changes in environmental oxygen (Benoit et
al. 1998).
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The nupC gene product (Protein 5; Table 4.2) transports pyrimidine nucleosides (but not
purines) across the membrane and into the cell (Patching et al. 2005).
4.4 Chapter summary
The aims of this study were to characterise changes in the K. pneumoniae OM proteome potentially
caused by differential porin expression and to investigate whether any other OMP expression was
affected, which could act as potential markers of this carbapenem resistance mechanism. The
technique of 1D SDS-PAGE to visualise the OMP composition of suspected non-carbapenemase-
mediated carbapenem-resistant isolates has been described previously (Doumith et al. 2009;
Martinez-Martinez. 2008) and here it was successful in confirming the suspected resistant
mechanism in this clinical pair of isolates (Webster et al. 2010). However, very little information
on the proteins themselves was available in the literature, therefore the OMP profiles of the isolates
were analysed by LC-MSIMS to obtain identifications for all the proteins present in the OMP
fraction. The bottom-up proteomics approach used here yielded a greater amount of information
about the isolates and the proteome changes as a result of carbapenem resistance, including many
changes in addition to the loss of OmpK35/36 porins.
Few studies have investigated the K. pneumoniae proteome, especially the OM proteome.
For example, Kurupati et al. analysed the immunogenicity of the proteins in an OMP fraction of K.
pneumoniae (Kurupati et al. 2006). While Cho et al. analysed the OMPs of imipenem-resistant K.
pneumoniae, they were measuring the effects of a green tea extract on the OM proteome rather than
changes caused by imipenem resistance (Cho et al. 2011). To our knowledge, no work has been
published investigating changes in the OM proteome with respect to investigating carbapenem
resistance in K. pneumoniae.
There were five proteins thought to have roles in antibiotic resistance identified in the OMP
analysis, such as the OmpK35/36 porins, which need to be repressed to give the carbapenem-
resistant phenotype and neither were expressed in IB. The little-known porin OmpK26 was also
expressed in lB, this porin is known to be expressed in carbapenem resistant isolates lacking
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OmpK35/36 expression (Garcia-Sureda et al. 2011). Although many more OMP profiles need to be
tested to confirm this observation, the presence of OmpK26 could be a marker protein for this
carbapenem-resistant phenotype.
The streptomycin resistance protein APH(3") and efflux protein EmrA were also
expressed only in isolate lB. It may be possible that APH(3") was from a plasmid acquired by IB,
however emrA is chromosomally located, indicating that this carbapenem-resistance mechanism
could be involved with the induced expression of drug efflux pumps. This finding suggests that
low-level efflux activity may be playing a role in carbapenem non-susceptibility in this isolate,
although this requires further confirmation by testing other isolates.
1B was found to express SecA, required for the Sec protein transport system, which
delivers (among other proteins) p-lactamases such as TEM, AmpC and CTX-M enzymes to the
periplasm (Pradel et al. 2009). Therefore, SecA may be important for resistance against p-lactam
antibiotics, particularly in combination with expression of EmrA and repression of ompK35/36. 1B
has reduced expression of OmpK35/36 and expression of a CTX-M ESBL and is also expressing
MDR effiux protein EmrA and OM transporter SecA. The collective activity of these proteins is
likely to confer higher resistance to carbapenems than just OmpK35/36 loss through reduction of
the periplasmic concentration ofCTX-M.
There were many virulence factors expressed in both lA and 1B respectively. Some seemingly
important proteins for virulence were missing from lB, including FhuA and DppA (iron acquisition
proteins). Isolate IB also lacks the machinery for the synthesis and assembly of fimbriae or pili,
which are one of the main virulence-associated properties of K. pneumoniae, required for
attachment to mammalian cells to initiate colonisation and infection. FimD is an usher protein,
essential for the polymerisation and translocation of the fimbrial proteins to the bacterial surface.
Fimbrial ushers are among the largest pores in the OM (Palomino et al. 2011), which could explain
why IB does not express any of the proteins due to the size of FimD porin being used for antibiotic
entry. Perhaps the lack of these proteins could contribute to reduced pathogenicity in an infection,
alternatively, isolate 1B may have lost the proteins as an immunoevasion strategy (to become
'invisible' to the immune system) and would be valuable to investigate further.
133
Klebicin B, a colicin-type protein was also absent form the IB OMP fraction. Assuming it
is plasmid encoded, 1B may not be expressing the plasmid, or may even have lost it. This could
also contribute to it being outcompeted by other bacteria. IB also lacked iron acquisition proteins
FhuA and DppA (required for haem uptake) and potential virulence factor TraT. With all these
proteins absent, it is possible that 1B may not be as able to colonise a host and initiate infection as
well as lA.
Overall, the results suggest that 1B lost or reduced the expression of many membrane
transport proteins, as reduced permeability is what confers carbapenem non-susceptibility.
Therefore, it is logical for 1B to restrict as many entrances to the cell as is feasible. This is why
OmpK35 and OmpK36 were not expressed (which was expected), but possibly TraT, MalE and
FimD as well. IB has also expressed other membrane transport proteins to replace those that were
repressed e.g. the Tog system, OmpK26 used by Tog system and the transporter NupC. There were
also many other proteins with other functions identified in both isolates but their relevance to the
resistance mechanism has yet to be determined.
As 1B shows such an altered virulence/resistance phenotype compared with lA, it may be possible
that some genetic reorganisation had taken place e.g. regions of gene deletions, insertions etc.
Therefore, to validate the results generated by this OMP GeLC technique, the genomes of the
isolates would ideally be sequenced to determine their genetic similarity. The proteomics
techniques used in this study have detected the suspected loss of OmpK35/36 as well as additional
changes to the OMP profiles between this clinical pair of isolates, which were potentially
associated with the acquisition of a carbapenem-resistant phenotype. The expression differences
detected by proteomics could be result of the loss/acquisition of genetic material. If this is
confirmed by DNA sequence analysis it could give an insight into the selection process bacteria
undergo while colonising the host and acquiring resistance. If the changes observed are purely
protein expression differences and not underlined by genetic changes, then they are indicative of
major changes in regulatory networks affecting porins, iron uptake and many other functions and
could not have been elucidated with traditional phenotypic and genetic amplification or sequencing
assays. This study also revealed changes in expressed proteins that could have implications on the
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antibiotic resistance and pathogenic capabilities of organisms which acquire a similar resistance
mechanism.
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5. Results
Tigecycline resistance in Acinetobacter baumannii
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5.1 Introduction of isolates
Tigecycline is an agent of last resort to tackle multidrug resistant bacteria. A. baumannii is known
for its pandrug resistance potential (Falagas & Bliziotis, 2007), including the ability to develop
efflux-mediated resistance to tigecycline; it is critical to investigate strategies for overcoming
efflux-mediated resistance. The protein expression profile of A. baumannii has been characterised
previously (Soares et al. 2010; Fernandez-Reyes et al. 2009 and Shin et al. 2009), as with the
mechanism of tigecycline resistance (Ruzin et al. 2007; Homsey et al. 2010a). However, the
potential of a proteomic approach to further investigate this resistance mechanism has not yet been
realised.
The isolates analysed in this study included: a clinical pair of A. baumannii, recovered
before (AB210; tigecycline MIC of 0.5 mg/L) and after (AB211; tigecycline MIC of 16 mg/L)
tigecycline therapy, a laboratory-mutant derived from AB210 (AB210-6; tigecycline MIC of 64
mg/L) and a knockout-mutant derived from AB211 (AB21 L~adeB; tigecycline MIC of 0.5 mg/L)
to give a group of extremely closely related isolates. Comparative genomics of this clinical pair
demonstrated a high sequence similarity between these organisms (Homsey et al. 2010a), making
these isolates a highly desirable candidate group for comparative proteomics. The fact that the
isolates are closely related should minimise protein expression differences related to strain
heterogeneity often observed in proteomic investigations. Thus allowing the detection of
expression differences directly linked to tigecycline resistance.
DIGE was chosen as the method for quantification of protein expressions as 2DGE
techniques had been optimised previously (see methods section 2.12) and the isolates were all
highly similar. As there were unlikely to be major differences in the proteome content, the aim was
to use DIGE to highlight the subtle changes in protein expression/abundance to reveal new insights
into efflux-mediated resistance mechanisms.
The aim of this study was to identify expression changes in proteins potentially associated
with the efflux-mediated tigecycline resistance mechanism, thereby characterising which proteins
may be required for upregulation of the efflux pump. These proteins could potentially provide
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novel drug targets to inhibit this resistance mechanism and restore susceptibility to a range of
antimicrobial agents.
5.2 Protein profiling of the extracts by 2-D gel electrophoresis
5.2.1 Separation on gradient of pH 4-7
The protein extracts from A. baumannii were obtained using protocols previously optimised on E.
coli (see methods sections 2.5.1 and 2.5.2). The crude protein extracts from each replicate of every
isolate were separated on 2-D gels prior to CyDye labelling (Figures 5.1-5.4). These initial
separations were to demonstrate that (i) the extracts were free from any charged or insoluble
contaminants that could cause streaking and (ii) the proteins would separate with good resolution
using the specified pH gradient (see Figures 5.1-5.4). The gels shown here yielded the highest
number of resolved spots and were subsequently used as picking gels to supply the material needed
for protein identification. As the spot-picking robot could not image CyDye-labelled proteins,
SYPRO-stained gels were used for spot picking and subsequent protein identification.
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4 pH 7
Figure 5.1 2DGE profile of tigecycline-susceptible clinical isolate AB210. Total cell extract was
separated over a gradient of pH 4-7 and a 12% polyacrylamide gel. The proteins were stained with
SYPRO Ruby and visualised using an Ettan Dalt imager (GE Healthcare).
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4 pH 7
Figure 5.2 2DGE profile of tigecycline-resistant laboratory mutant AB21 0-6. Total cell extract was
separated over a gradient of pH 4-7 and through a 12% polyacrylamide gel. The proteins were
stained with SYPRO Ruby and visualised using an Ettan Dalt imager (GE Healthcare).
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4 pH 7
Figure 5.3 2DGE profile of tigecycline-resistant clinical isolate AB211. Total cell extract was
separated over a gradient of pH 4-7 and a 12% polyacrylamide gel. The proteins were stained with
SYPRO Ruby and visualised using an Ettan Dalt imager (GE Healthcare).
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4 pH 7
•
...
Figure 5.4 2DGE profile of tigecycline-susceptible knockout mutant AB211!:"adeB. Total cell
extract was separated over a gradient of pH 4-7 and a 12% polyacrylamide gel. The proteins were
stained with SYPRO Ruby and visualised using an Ettan Dalt imager (GE Healthcare),
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Once all extracts had been optimised, a DIGE experiment was designed to label all three replicates
of each extract with alternating dyes (see methods section 2.10) as in table 5.1 below.
Gel no. Labelled with Cy3 Labelled with Cy5
2
3
4
5
6
AB210 (1)
AB210-6 (3)
AB210 (3)
AB211 (2)
AB211 Sadeb (2)
AB210-6 (2)
AB211 (3)
AB210 (2)
AB211D.adeB (1)
AB210-6 (1)
AB211 (1)
AB211D.adeB (3)
Table 5.1 DIGE experimental setup for A. baumannii protein extracts with the biological replicate
number in brackets. An internal standard was also included in each gel, this was composed of an
equal amount of each sample and labelled with Cy2 for more accurate spot analysis.
5.3 Separation ofDIGE labelled proteins over a gradient of pH 3-10
The DIGE procedure (see methods section 2.10) was first attempted on IPG gradients of pH 3-10
(Fig. 5.5), with the aim of resolving efflux pump proteins as well as cytosolic proteins (as the
AdeAB proteins have high pl values c. pH 9). However, the gradient of pH 3-10 proved to be
unsuitable as the majority of spots were poorly resolved. As a result many proteins may not have
been visualised due to masking by proteins of greatest abundance, so a pH 4-7 gradient was
investigated, although using this narrower gradient would mean the AdeAB proteins would not be
seen on the gels, it was determined that the increased number of resolved spots would provide more
information regarding tigecyc1ine resistance.
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pH 10
pH 10
Figure 5.5 Examples of A. baumannii protein extracts separated on 2-D DIGE gels using gradients
of pH 3-10 and a 12% polyacrylamide gel. The separated proteins were labelled with CyDye
minimal dyes and visualised using an Ettan Dalt imager (GE Healthcare).
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The DIGE experiment was repeated on pH 4-7 gradients, yielding good resolution and separation
with changes in expression that were statistically significant. When performing DIGE, all the
protein extracts were labelled and separated together in one large experiment, whereby three
replicates of four extracts were run, at two samples per gel, requiring six gels. The SameSpots
software (version 3.3.2) was able to separate each image into its respective dyes, providing three
images of each gel taken at different wavelengths. SameSpots then allowed the user to select which
images to use for comparison. From the example experiment outlined in table 5.1, it was
determined that the most applicable comparisons would be: i) the clinical pair AB2l 0 vs. AB2 I 1 ii)
the tigecycline-susceptible AB2 I0 vs. tigecycline-resistant lab mutant AB210-6 iii) both
tigecycline-resistant isolates AB2 I I and AB210-6 and iv) AB211 vs. the tigecycline-susceptible
knockout mutant AB211t:.adeB.
5.4 DIGE comparison of the pre-therapv (AB2 10) and post-therapv (AB21 1) clinical isolates
Homsey et al. (20 I0) showed that expression of the adeAB operon was up-regulated in tigecycline-
resistant isolate AB211 versus AB210 (Homsey et al. 2010a). However, components of the
AdeABC efflux pump were predicted in silica not to separate sufficiently on pH 4-7 gels, therefore,
the protein extracts were also separated and analysed on pH 6-11 gels. However, no differential
protein expression was observed in this pH region for Ade proteins. The limitations of the 20
electrophoresis system could explain this, as high pI and membrane proteins are poorly represented
on polyacrylamide gels and should be analysed using a gel-free system where possible.
Nonetheless, gel-based OIGE was chosen to explore broad-scale protein expression differences of
the isolates and not merely the membrane proteins.
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4 pH 7
Figure 5.6 2-D separation of DfGfi-labelled proteins using extracts from AB210 (green) and
AB211 (red) separated over a pH gradient of 4-7 and through a 12% polyacrylamide gel. Numbers
correspond to the proteins in tables 5.3 and 5.4.
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In total c. 650 protein spots were detected by SameSpots software (version 3.3) over a pH
range of 4-7, eight protein spots were detected only in the tigecycline-susceptible isolate AB2l0
and five only in the tigecycline-resistant isolate AB211 (Table 5.2). A further 35 proteins were
identified in both isolates but displayed differential expression (Figure 5.6); 24 proteins showed
increased expression Q:2-fold) in AB210 (Table 5.3) and 11 proteins showed increased expression
in AB211 (Table 5.4). Several of these differences may be associated with bacterial virulence and
were clustered into the following functional groups: (i) antibiotic resistance-related proteins; (ii)
attachmentlbiofilm formation-related proteins; and (iii) iron acquisition-related proteins.
5.4.1 Proteins detected onlv in one isolate
The proteins detected by DIGE in one isolate included a putative lactam utilisation protein (spot 1;
Table 5.2, Fig. 5.7), which was detected only in the tigecycline-susceptible isolate AB210. A
BLASTp search showed high similarity with proteins belonging to the LamBN scF superfamily (E
value = 8e-97), which includes the LamB carbohydrate porin, a specific maltose transporter. Spot 9
(Table 5.2, Fig. 5.8) was detected only in tigecycline-resistant isolate AB211 and was identified as
Porin B, a carbohydrate-selective porin belonging to the OprB family. The appearance of this
protein in AB211 suggests expression of an alternative transporter in response to the absence of the
lactam-utilising LamB family protein.
The other proteins unique to AB210 were poorly characterised proteins lacking clearly
defined cellular functions. These included a putative polysaccharide biosynthesis protein (spot 6;
Table 5.2, Fig. 5.7), highly similar to N-acylneuraminate cytidylyltransferases, which synthesise N-
acetylneuraminic acid polymers. This is an important virulence factor in pathogenic bacteria such
as Escherichia coli, Neisseria meningitidis, Haemophilus ducreyi and group B streptococci
(Mizanur & Pohl, 2008). There were four hypothetical proteins unique to AB2l0 (Table 5.2); spot
3 showed high similarity to phosphopantothenoylcysteine synthetase I carboxylase (E = 0) which is
involved in the synthesis of coenzyme A; spot 4 was highly similar to ferridoxin; spot 7 was
potentially a member of a Bacterial OB-fold (BOF) superfamily, which consists of sub-families
with diverse functions including an enterotoxin family and DNA-binding domain family (Ginalski
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et al. 2004) and spot 8 showed high similarity to a GcvT-like aminomethyltransferase (E = 6e·172).
GcvT is a glycine cleavage system-protein, working to convert glycine to serine when cellular
concentrations are high. There was a single hypothetical protein that was unique to AB211 (spot
11; Table 5.2) but no conserved domains could be identified (as searched in InterProScan) and only
matched to hypothetical proteins from the Acinetobacter genus by BLASTp analysis.
Spot 1
Spot 2
Spot 3
Spot4
Spot 5
Spot 6
Spot 7
Spot 8
Figure 5.7 Proteins spots which were detected in AB210 and not in AB211 (see Table 5.2). Red
circles highlight spots that were incorrectly missed by SameSpots software and manually corrected.
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Spot 9
Spot 10
Spot 11
Spot 12
Spot 13
Figure 5.8 Protein spots which were detected in AB211 but not in AB210 (see Table 5.2)
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5.4.2 Changes in antibiotic resistance profile
Two of the eight proteins detected only in AB21 0 were associated with resistance to antibiotics or
other compounds. These included the aminoglycoside-modifying enzyme, aminoglycoside 6' N-
acetyl transferase type 1b or AAC(6')-Ib (spot 2; Table 5.2). This finding is consistent with the
eight-fold reductions in aminoglycoside MICs for AB211 versus AB210 (see methods 2.2 for A.
baumannii MrCs) (Homsey et al. 2010a).
The other resistance-associated protein, spot 5 (Table 5.2), was identified as a putative
NADPH quinone reductase (modulator of drug activity B or MdaB). This protein has previously
been described in Escherichia coli and grants protection to the cell from quinoid compounds. These
occur naturally as electron carriers in the electron transport chain, but can cause toxicity through
increased production of intracellular reactive oxygen species (Adams & Jia, 2006).
5.4.3 Iron acquisition proteins
Spot 13 (Table 5.2) was identified as 3-dehydroquinate dehydratase and appeared unique to AB211
by DIGE. This protein is associated with iron acquisition and is known as QuiB or AroD in the
Enterobacteriaceae (Elsemore & Ornston, 1995), where it is part of the biosynthetic pathway of
shikimate, a precursor for aromatic amino acid and also catechol-based siderophore production,
implying that AroD could have an indirect role in iron acquisition.
Consistent with this, an outer membrane receptor for monomeric catechols, which can be
used to sequester iron, showed an increase in expression of3.1-fold in isolate AB21 I (spot 4; Table
5.3). Using BLASTp analysis, this protein showed a high degree of similarity to TonB-dependent
iron receptor protein BfrD (E value = 0).
Expression of a ferrichrome iron receptor protein (spot 9; Table 5.3) was also increased
2.l-fold in AB2It. The increased expression of this protein and the BfrD catechol receptor protein,
combined with the presence of AroD suggests that AB211 may be better equipped to sequester iron
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from its environment than AB21 0 and consequently, may be more virulent in vivo (Zimbler et al.
2009).
5.4.4 Changes in protein expression related to pilus production, attachment and biofilm
formation
It has been reported that A. baumannii grown under iron-limited conditions demonstrated increased
biofilm formation when compared with the same isolate in iron-rich conditions, suggesting that
proteins involved in biofilm formation and iron acquisition may share common
promoters/regulators (Tomaras et al. 2003 and Shin et al. 2009). Consistent with this, other proteins
showing increased expression in AB211 were predicted to mediate attachment and biofilm
formation, including the outer membrane usher protein PapC (spot 3; Table 5.3), which recruits
pilus subunits, catalyses their assembly and translocates them across the outer membrane (Huang et
al. 2009). PapC expression was increased 3.2-fold in isolate AB211 and was consistent with the
presence of the CsuNB subunit (spot 10; Table 5.2). This was detected only in AB211 and is a
secreted pilus subunit required for motility and biofilm formation (Vashist et al. 2010 and Siroy et
al. 2006). It was shown by Tomaras et al. that correct pilus assembly was essential for biofilm
formation in A. baumannii (Tomaras et al. 2003)
PldA or phospholipase Al (spot 12; Table 5.2) was also identified as unique to isolate
AB211. It is involved in biogenesis and modification of the cell envelope and is a virulence factor
known to promote colonisation of Yersinia enterocolitica (Istivan & Coloe, 2006).
The expression of outer membrane protein assembly complex YaeT was also increased 2.2-
fold in isolate AB211 and is required for the insertion of proteins into the outer membrane, as well
as for autotransporter secretion in certain organisms (Jain & Goldberg, 2007). The increase of
YaeT (spot 8, Table 5.3) in isolate AB211 could be a consequence of the increased traffic of outer
membrane proteins (Porin B, phospholipase A and the majority of proteins with increased
expression in AB211), which require chaperoning to be correctly inserted into the membrane to
function correctly.
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Organic solvent tolerance protein OstA (spot 7, Table 5.3) showed increased expression in
AB211 by 2.3-fold, it is also known as lipopolysaccharide (LPS) assembly protein or LptD. This
protein is required for LPS biogenesis, specifically the transport of LPS across the outer membrane
and assembly at the cell surface (Chng et al. 2010).
The RstA protein of the two-component regulatory system response regulator RstAIB (spot
31; Table 5.4), showed a 2.2-fold increase in expression in AB210 when compared with AB211.
This protein is also known as BfmR and is required to repress transcription of a number of genes
implicated in iron uptake, responding to stress conditions and attachment and biofilm formation
mediated by the Csu pili chaperone-usher assembly system (Jeon et al. ,2008 and Tomaras et al.
2008). Hence, reduced expression of RstA may explain the increased levels of iron-, attachment-
and biofilm-related proteins observed in AB211.
The expression of spot 30 (Table 5.4) increased 2.2-fold in AB210 and was identified as
PhoU, part of the pst- (phosphate transporter) operon involved in phosphate transport across the
membrane. PhoU acts as a transcriptional regulator that negatively regulates the pho regulon. PhoU
and the pst system have previously been implicated as virulence factors for Proteus mirabilis
urinary tract infections (Jacobsen et al. 2008), due to the association of the pst system and the
regulation ofbiofilm formation under phosphate limited conditions.
The expression of Spot 15 (Table 5.4) increased 3.1-fold in AB210 and identified as CsuD,
part of the chaperon-usher pilus-assembly system (Tomaras et al. 2008) and is required for pilus-
mediated motility (Siroy et al. 2006). The reason for its increased expression in AB210 when
related proteins CsuAIB and PapC were identified as increased in AB211 is unknown. As little is
known about the functions of the individual Csu subunits, CsuD may have other roles aside from
pilus formation.
Overall, the number of differentially-expressed proteins clustered in this functional group,
combined with their specific functions, suggests that AB211 may be more adept at cell attachment
and/or biofilm formation than AB21O.
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5.4.5 Other proteins with expression increases in isolate AB21 1
Two proteins showed expression increases of 4.9-fold and 3.9-fold in AB211 (spots 1 and 2
respectively, Table 5.3); spot 1 was identified as a putative outer membrane protein by BLASTp.
Whereas spot 2 returned as a possible capsule assembly protein and a signal peptide (both E values
= 0 by BLASTp). Capsule assembly proteins transport capsular polysaccharides across the outer
membrane, playing an important role in virulence in A. baumannii (Russo et al. 2010).
Expression of two isoforms of the ATP-dependant protease HsplOO were increased 3-fold
and 2-fold in AB211 (spots 5 and 11 respectively, Table 5.3), indicating an increased response to
stress. By BLASTp analysis these proteins were identified as variants of ClpB, which is involved
less in protein degradation but more in disaggregation and reactivation of misfolded protein
aggregates (Zolkiewski, 2006) caused by stressful conditions e.g. extreme pH, osmolarity or
temperature. Differential expression of ClpB in isolate AB211 could have been caused by the
increased expression of proteins which localise to the outer membrane.
Other protein expression increases in AB2II include elongation factor G, which was
increased 2-fold (spot 10; Table 5.3); this protein catalyses the translocation of the tRNA-mRNA
complex across the ribosome, allowing polypeptide chain elongation to occur. Methionine synthase
(cobalamin-binding subunit MetH) was increased 2.S-fold (spot 6; Table 5.3); it synthesises
methionine from homocysteine via a vitamin B12-dependant pathway. The triggers for the increase
in these particular enzymes and their biological significance are unclear.
5.4.6 Other proteins with expression increases in isolate AB210
The LysM domainIBON superfamily protein (spot 12; Table 5.4) showed a S.4-fold expression
increase in isolate AB210. The LysM or lysin domain contains a peptidoglycan-binding motif,
present in many proteins capable of cell wall degradation. The BON superfamily consists of
proteins containing the BON (Bacterial OsmY and nodulation) domain, as found in e.g. OsmY, an
osmotic-shock-resistance protein. The BON domain is thought to interact with phospholipid
membranes (Yeats & Bateman, 2003).
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MinD (spot 14, Table 5.4) is involved in the inhibition of FtsZ cell division proteins (the Z
ring); it activates the inhibitor, MinC and directs the site of septum formation for cell division,
ensuring it initiates at mid-cell (Lutkenhaus, 2007). Expression of MinD was increased 4.4-fold in
AB210, which indicates that AB211 may divide at a slower rate than AB21O.
The higher levels of these metabolic proteins in AB210 could mean a higher level of
energy generation, which could increase the production of free-radicals as respiration by-products
relative to AB211. Consistent with this are the observed increases in expression of antioxidant
proteins glutathione S transferase (spot 16, Table 5.4; 3.1-fold increase), alkyl hydroperoxide
reductase subunit C (spot 17, Table 5.4; also a 3.1-fold increase) and superoxide dismutase (SOD;
spot 18, Table 5.4; 2.9-fold increase) in AB210 as a possible countermeasure to greater levels of
respiration. The remaining proteins (n = 16, Table 3) that were all down-regulated in AB211 all had
roles in carbohydrate and amino acid metabolism. Further work is needed to determine the
significance of these proteins.
5.5 DIGE comparison of the post-therapy isolate (AB211) v.~.the laboratory mutant (AB210-
After initially comparing the pair of clinical isolates, the post-tigecycline therapy clinical isolate
AB211 was compared with the laboratory mutant AB210-6, created by subculturing AB210 in
increasing concentrations of tigecycline (Homsey et al. 2010a). The two isolates used acquired
their resistance in different manners (in vivo and in vitro) and were selected for comparison in order
to demonstrate which proteins were required by or affected by tigecycline resistance. The aim was
to identify a 'core' set of proteins common to the Ade efflux-mediated resistances, which may be
essential for this particular mechanism. Also, as AB210-6 has a greater tigecycline MIC than
AB211 (64 mgIL vs. 16 mgIL), there was a possibility that proteins expressed at a higher level in
AB210-6 could be used as indicators of the level of resistance.
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4 pH 7
Figure 5.9. 2-D separation of DIGE-labelled proteins, using extracts from AB211 (green) and
AB210-6 (red) separated over a pH gradient of 4-7 and through a 12% polyacrylamide gel.
Numbers correspond to the identifications in table 5.5.
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SameSpots analysis of the AB2ll vs. AB2l0-6 DIGE gels identified 29 proteins as having
differential expression between the two isolates (Fig. 5.9). Twenty of these proteins were
successfully identified by LC-MSIMS, 14 of which showed increased expression in isolate AB210-
6, while six showed increased expression in isolate AB211.
5.5.1 Proteins identified as increased in AB211 vs. AB210-6
The expression of polysaccharide biosynthesis protein (Spot 1; Table 5.5) increased 2.S-fold in
AB211. A similar protein was highlighted previously in the comparison between AB210 and
AB211 as present in AB210 but absent in AB211 (section 5.4.1 table 5.2). Its appearance suggests
that expression of the polysaccharide synthesis protein in AB21 0 and not AB2ll was not a unique
event and highlights the difficulties of making inferences on the basis of spot presence/absence.
The acyl-CoA dehydrogenase protein (Spot 3; Table 5.5) also showed a 2.2-fold increase
in expression in AB2ll. It was identified as an AcdB-like protein, which utilises long-chain fatty
acids for energy metabolism. Acinetobacter is known to produce a waxy ester as an energy storage
molecule, synthesised from an alcohol and an acyl-CoA. It is possible that an increase in this
protein could mean that AB211 is more adapted to energy storage than AB21 0-6 (Tani et al. 2002)
The DegTlDnrJlEryClIStrS aminotransferase family protein (Spot 4; Table 5.5) displayed
an expression increase of 2.1-fold, the products of this family are involved in the biosynthesis of
sugar portions of cell-surface polysaccharides (Shoji et al. 2002). The increased expression of this
protein plus the increased expression of the polysaccharide biosynthesis protein (Spot 1; Table 5.5)
shows that AB211 may better equipped to form biofilms than AB210-6 as well as AB2l0.
DNA-directed RNA polymerase subunit alpha (Spot 5; Table 5.5) increased 2.1-fold in
expression, this protein is a key element in gene transcription, mediating the interactions between
RNA polymerase, transcription factors and DNA. Subunit alpha associates with such regulators as
MarA and SoxS to activate a wide variety of genes (Dangi et al. 2004).
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The 3-oxoacyl-acyl-carrier-protein reductase (Spot 6; Table 5.5) showed a 2-fold increase
in expression and is an essential protein involved in fatty acid biosynthesis. The protein is coded
for by the fabG gene and as part of the fatty acid synthase multi enzyme complex, it catalyses an
essential step in fatty acid elongation. FabG has been speculated as a potential antimicrobial target
due to the specificity of the reaction and the conserved sequence and Ubiquity of the enzyme
(Kristan et al. 2009).
5.5.2 Proteins identified as increased in AB210-6 v.\'. AB211
5.5.2.1 Proteins involved in lipid metabolism
The following proteins all displayed increased expression in AB210-6 and seemed to participate in
lipid metabolism. For instance, the alpha subunit of the multifunctional fatty acid oxidation
(MFAO) complex (Spot 9; Table 5.5) displayed a 2.6-fold increase in expression and returned as
FadB gene product by BLASTp (E value = 0). Enoyl-CoA hydratase (Spot 7; Table 5.5) displayed
an expression increase of 3-fold and returned as PaaB by BLASTp analysis (E value = 0). 3-
hydroxylacyl-CoA dehydrogenase (Spot 13; Table 5.5) showed a 2.2-fold increase in expression, it
also had high similarity to the paaC gene product by BLASTp analysis (E value = 0). These latter
two proteins are known to be associated with the MFAO complex (Yangs & Elzinga, 1993).
Also included in this group are acetyl/propionyl-CoA carboxylase subunit alpha (Spot 8;
Table 5.5) which showed an expression increase of 2.7-fold in AB210-6 (returned as biotin
carboxylase accA gene by BLASTp; E value = 0). NAD-dependant aldehyde dehydrogenase (Spot
20; Table 5.5) showed an expression increase of 2-fold and showed high similarity to
phenylacetaldehyde dehydrogenase (PAD) by BLASTp analysis (E value = 0). Some of the
proteins in this group displayed high similarity to the paa (phenylacetic acid degradation) genes of
E. coli which degrade aromatic compounds by converting them into phenylacetyl-CoA which can
be catabolised into TCA intermediates. The Paa degradation pathway is also a common pathway
for metabolism, implying that AB210-6 may be better at utilising phenylalanine for energy. It is
also required for full pathogenicity for Burkholderia cenocepacia in a Caenorhabditis elegans
infection model (Law et al. 2008), these same organisms showed a reduction in virulence when
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these genes were knocked-out. However, the relevance of these changes to laboratory-acquired
tigecycline resistance is unknown.
5.5.2.2 Increased expression of stress defence proteins in AB210-6
There were three proteins displaying increased expression which functioned as stress defence
proteins. Expression of a putative antioxidant protein (Spot 10 ; Table 5.5) increased 2.6-fold in
AB210-6 and returned as a oxidoreductase enzyme of the AhpC family by BLASTp analysis (E
value = 4e·107).
Expression of glutathione S-transferase (Spot 16; Table 5.5) increased 2.l-fold in AB210-
6. It catalyses addition of glutathione (GSH) group onto potentially harmful electrophilic
compounds, 'quenching' their reactive groups and protecting cell from e.g. DNA damage. It has
been highlighted as an important gene required for the intrinsic resistance of A. baylyi to multiple
antibiotics, as inactivation of the glutathione gene gshA confers hypersusceptible phenotypes
(Gomez & Neyfakh, 2006).
Expression of chaperonin GroEL (Spot 18; Table 5.5) increased 2-fold in AB210-6. This
protein re-folds denatured or mis-folded proteins and has been shown to playa role in resistance to
antibiotics and heat stress in A. baumannii (Cardoso et al. 2010).
5.5.2.3 Other proteins with increased expression in AB210-6
The LysMIBON superfamily protein (Spot 12; Table 5.5) showed a 2.S-fold expression increase in
AB210-6. There have been reports that the LysM protein domain is required for binding the
peptidoglycan layer to the membrane in Gram-positive (Frankel et al. 2012) and Gram-negative
bacteria (Poggio, 2010). This has also been demonstrated to be true also for Acinetobacter sp.
(Cabral et al. 2011). Proteins containing this domain were identified in all comparisons with
AB211 where it is consistently reduced in expression.
Aconitase A or AcnA (Spot 14; Table 5.5) expression increased 2.2-fold in AB210-6,
AcnA catalyses the interconversion of citrate and isocitrate in the TCA cycle, it may have
162
importance in iron regulation, growth, superoxide/radical sensitivity due to key function and its
essential 4Fe-4S cluster (Varghese et al. 2003). AcnA is generally induced under stress conditions
by SoxRS and regulated by Fur, it also has the ability to bind mRNA (Tang et al. 2005). AcnA is
also reported to have post-transcriptional regulatory activity on flagellum synthesis in Salmonella
enterica (Tang et al. 2004).
The cell division inhibitor (Spot 15; Table 5.5) expression increased by 2.1-fold in AB2l0-
6, it is also known as septum site-determining protein MinD, part of the MinCDE operon which
regulates cell division (Lutkenhaus, 2007). This protein has been highlighted before in the
comparison of AB21 0/AB21l.
Outer membrane protein A (Spot 19; Table 5.5) showed a 2-fold increase in expression. It
is an important multifunctional protein and among its roles; OmpA is thought to anchor the outer
membrane to the peptidoglycan layer (Park et al. 2012), mediate attachment to biotic surfaces/cells
(Choi et al. 2008) and is essential for biofilm formation (Cabral et al. 2011).
5.6 DIGE comparison oflaboratory mutant (AB210-6) with pre-therapy isolate (AB210)
The next comparison involved the pre-tigecycline therapy clinical isolate AB210 and its laboratory-
generated mutant AB210-6. Because the two isolates are so similar, it was hoped that proteins
required for tigecycline resistance could be highlighted and identified with less 'noise' i.e. fewer
changes unrelated to the resistance mechanism. For instance, when comparing AB210 and AB211,
there were many changes in protein expression which were not caused by the acquisition of
resistance but by unrelated genetic mutations (Homsey et al. 2011). In this comparison, it was
thought that the only factor differing between the two isolates is the resistance mechanism, so any
differentially-expressed proteins were more likely to be an effect of tigecycline resistance.
SameSpots highlighted 23 protein spots as displaying differential expression between
AB2l0-6 and AB210 (Fig. 5.10). However, on this occasion, only 7 identifications were returned
by LC-MSIMS; three proteins displayed increased expression in AB210 and four showed increased
expression in AB210-6. It is unclear why such a small proportion of proteins returned
identifications by Le-MS, although as the excised gel spots were stored at -80°C for extended
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periods and subjected to some degree of freezing and thawing, it is possible that some protein
degradation occurred.
4 pH 7
Figure 5.10 2-D separation of DIGE-Iabelled proteins using extracts from AB210-6 (green) and
AB210 (red) separated over a pH gradient of 4-7 and through a 12% polyacrylamide gel. Numbers
correspond to the proteins in table 5.6.
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5.6.1 Proteins identified as increased in AB210-6
Most of the proteins highlighted in this comparison as differentially regulated have been seen in
earlier comparisons of these isolates. While this suggests similar mechanisms are producing
upregulated AdeAB both in vitro and in vivo, too few proteins were identified in this comparison to
make reliable mechanistic inferences.
The ATP-dependent protease, Hsp 100 (spot 1; Table 5.6) increased in expression 2.8-fold
in AB210-6 and was identified as a variant of ClpB by BLASTp analysis (E value = 0). ClpB is
involved less in protein degradation, but more in disaggregation and reactivation of misfolded
protein aggregates (Zolkiewski, 2006). This protein has been identified previously as increased in
AB211 (see section 5.4.4), possibly due to the increased expression and trafficking of other
proteins such as BfrD and YaeT to the outer membrane.
The Holliday junction DNA helicase RuvB (spot 2; Table 5.6) showed an expression
increase of 2.5-fold in AB210-6. RuvB is part of the ruv operon, encoding homologous
recombination proteins that make up the resolvase complex, which processes holliday junctions
formed during genetic recombination (Zhang et al. 2010). These Ruv proteins also participate in
mutation repair due to the similar enzyme activities required and may provide AB210-6 with
greater protection against DNA damage than AB211.
The expression of malate synthase G (spot 3; Table 5.6) increased 2.2-fold in AB210-6 and
catalyses the formation of malate and coenzyme A (CoA) from acetyl-CoA and glyoxylate. This
allows the bypass of the TCA cycle by permitting growth on acetyl-CoA sources (e.g. lipids). It is
thought that this glyoxylate bypass facilitated by malate synthase G is of high importance to
pathogenesis in e.g. Mycobacteruium tuberculosis and Pseudomonas aeruginosa by allowing
growth on host-derived lipids to increases chances of survival (Roucourt et al. 2009).
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Alanyl-tRNA synthetase (spot 4; Table 5.6) expression increased 2.1-fold in AB2l 0-6 and
catalyses the attachment of alanine to its corresponding tRNA for delivery to the ribosome. tRNA
synthetases can have alternative functions such as modification of cell peptidoglycan (Villet et al.
2007), although the significance of alanyl-tRNA synthetase differential regulation here is unknown.
5.6.2 Proteins identified as increased in AB210
The proteins displaying increased expression in AB210 compared to AB2l0-6 include a signal
peptide (spot 5; Table 5.6) which increased in expression 2.3-fold and was confirmed a signal
peptide by Signalp 4.0 (http://www.cbs.dtu.dk/services/SignalP/).This protein also has an OB-fold
(or Bacterial OB-fold/BOF), found via BLASTp, which is known to be common in nucleic-acid
binding domains (Ginalski et al. 2004). Interestingly, in the comparison between AB2l0 and
AB211, an OB-fold-containing protein was detected as unique to AB2l0. These independent
comparisons show that the upregulation of the AdeAB efflux pump can result in lower levels of
periplasmic BOF proteins, however the exact function of these proteins is unknown.
Nucleoside diphosphate kinase or NDK (spot 6; Table 5.6) showed a 2.2-fold increase in
expression in AB21 0 compared with AB2l 0-6. Strains of E. coli lacking this protein have shown
elevated mismatch mutation rates and in NDKlMutS double mutants this rate is increased further,
NDK deficiency is thought to stimulate replication errors by DNA polymerase (Miller et al. 2002).
Homsey et al. (Homsey et al. 2011) showed via whole-genome sequencing that AB211 had a
mutation in the mutS gene which could have led to the high number of mutations found in this
strain. The results from the earlier AB21 01AB2I1 comparison show that NDK is also higher in
AB210 than AB211. It is unknown whether the differential regulation of NDK or the mutS
mutation occurred first i.e. whether one change causes the other.
Elongation factor Ts or EF-Ts (spot 7; Table 5.6) expression increased in AB210 2.1-fold,
EF-Ts is involved in polypeptide synthesis and functions by stimulating the binding of aminoacyl-
tRNA to the ribosome. EF-Ts has a role as a stress-induced protein in E. coli, acting as a chaperone
to enhance protein folding (Han et al. 2007).
167
5.7 Comparison of AB211 vs. AB211!J.adeB
The aim of this comparison was to try and determine which proteins/processes were affected by the
regulation of AdeAB and which could be attributed to natural differences in the isolates (e.g. If a
protein increased expression in AB211 vs. AB210 and then displayed reduced expression in
AB211!J.adeB, its differential expression was likely an effect of AdeABC regulation). Multiple
changes in protein expression were expected here due to the number of processes affected by the
knockout of a key protein. But, if an expression pattern was found which is similar to any of the
other comparisons e.g. protein expression increased in tigecyc1ine-resistant isolates and reduced in
-susceptible isolates, proteins/processes directly affected by pump upregulation may be elucidated.
There were originally 64 spots highlighted as differentially expressed between the two
isolates, however, after digestion and LC-MSIMS analysis, only 39 were successfully identified
(Fig. 5.11, Tables 5.7 and 5.8); 14 displayed increased expression in AB211 and 25 showed
increased expression in AB211!J.adeB. As discussed earlier, there could be many reasons for this
including; a degree of protein degradation due to storage of the excised gel spots, the stringency of
the small Acinetobacter sp. database, or insufficient levels of peptide were eluted from the gel plug
for LC-MSIMS identification.
168
4 pH 7
Figure 5.11. 2-D separation of DIGE-labelled proteins using extracts from AB2l1!J.adeB (green)
and AB211 (red) separated over a pH gradient of 4-7 and through a 12% polyacrylamide gel.
Numbers correspond to the proteins in tables 5.7 and 5.8.
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5.7.1 Proteins increased in AB211
Multifunctional fatty acid complex subunit alpha (Spots 1 and 2; Table 5.7) expression was
increased 4.4- and 3.6-fold respectively in AB21l. Also known as FadB, this protein was discussed
earlier in section 5.5.
B12 dependent methionine synthase or MetH (Spot 3; Table 5.7) expression increased 3-
fold in AB21l. This protein also increased expression in AB211 relative to AB210 (Table 5.3).
Hondorp et al. showed that B12 independent methionine synthase is inactivated by oxidative stress
(Hondorp & Matthews, 2004). As AB211 has lower levels of stress defence proteins compared to
AB211t:.adeB, it may be possible that MetH expression increased to counteract the reduction in
MetE to continue providing the cell with methionine. Also, RNAP alpha subunit is a known
transcriptional activator of MetH and its increased expression may explain that of MetH (Fritsch et
al.2000).
ATP-dependent protease Hsp100 (Spot 4; Table 5.7) was previously identified as the
chaperone ClpB and here expression was increased 3-fold. This protein has been previously
identified as increased in AB211 and in AB21O-6 (both tigecycline resistant isolates), suggesting its
expression is increased in response to efflux upregulation.
Ferrichrome-iron receptor protein or FhuA (Spot 5; Table 5.7) expression increased 2.6-
fold in AB21l. FhuA expression also increased in AB211 compared to AB210 and its reduced
expression in AB211t:.adeB implies that its increase is caused by AdeABC upregulation.
Succinate dehydrogenase flavoprotein subunit (Spot 6; Table 5.7) expression increased 2.4-
fold in AB211. Succinate dehydrogenase expression is known to increase in biofilms (Gaupp et al.
2010) and Sdh is the main linker enzyme between the TCA and the electron transport (respiration)
chain, it is possible that Sdh expression is increased as a consequence of the energy requirement of
upregulated AdeABC.
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Two elongation factors were identified as displaying increased expression in AB211:
elongation factor G (Spots 8 and 9; Table S.7) expression increased 2.1-fold for both spots while
elongation factor Tu (Spot 14; Table 5.7) expression increased 2-fold. These elongation factors
have additional chaperone activities similar to EF-Ts (see section 5.6.1); EF-Tu in particular
possesses a wide range of functions from DNA repair to RNA processing (Caldas et al. 1998). EF-
G and EF-Tu may act as chaperones to replace oxidative stress defence proteins, many of which
were reduced in AB211 compared with AB21111.adeB.
UDP-N-acetylenolpyruvoylglucosamine reductase or MurB (Spot 11; Table 5.7)
expression increased 2.1-fold in AB211. MurB is involved in peptidoglycan turnover in the
synthesis of the bacterial cell wall. Mur proteins are highly conserved and essential, the murB gene
was found to be upregulated in biofilm-growing cells of Leptospiri/la spp. (Moreno-paz et al.
2010).
DNA-directed RNA polymerase subunit alpha (Spot 12; Table S.7) expression increased 2-
fold in AB211. Interestingly, in every comparison featuring AB211, the RNAP alpha subunit
consistently displayed increased expression in AB211, suggesting that it is a trait of the isolates
rather than a consequence of upregulated AdeABC (expression was greater in AB211 than in
AB210-6, even though tigecycline MIC is higher in AB2I 0-6).
tRNA uridine 5-carboxymethylaminomethyl modification enzyme or GidA (Spot 13; Table
5.7) expression increased 2-fold in AB211. GidA was identified by Shin et al. as upregulated in A.
baumannii biofilm cells (Shin et al. 2009) and functions by modifying tRNAs to prevent errors in
gene expression, but also has activity as a global regulator and could aid in biofilm persistence,
although its exact role in biofilms is unknown.
5.7.2 Proteins increased in AB21ltladeB
5.7.2.1 Stress defence proteins
There were many more proteins with increased expression in AB21111.adeB and this selection
includes a variety of proteins involved in oxidative/stress defence. These included alkyl
hydroperoxide reductase C22 subunit or AphC (Spots 17 and 20; Table 5.8), expression of which
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increased 4.1- and 3.4-fold respectively in AB211fladeB and superoxide dismutase (Spot 19; Table
5.8) expression of which increased 3.6-fold in AB211fladeB. Both of these proteins were
previously reduced in AB211 in comparison with AB210 (Table 5.4). The putative antioxidant
protein (Spot 18; Table 5.8) expression increased 3.6-fold in AB211fladeB, this protein returned as
peroxiredoxin by BLASTp analysis (E value = 2e-1l5) which is part of the AhpC family (listed
above), this exact same protein was increased in AB210-6 compared with AB211.
Flavohaemoprotein (Spot 35; Table 5.8) expression increased 2-fold in AB211fladeB
Flavohaemoproteins are thought to play a role in oxidative stress defence as they have been
reported to protect Pseudomonas aeruginosa against reactive oxygen species or ROS
[Koskenkorva-frank & Kalmo, 2003).
5.7.2.2 Proteins involved in metabolism
There were some enzymes with expression increases from the TCA cycle; aconitase A (Spot 34;
Table 5.8) expression increased 2.2-fold fold in AB211AadeB. Three spots were identified as
malate dehydrogenase (Spots 24, 27 and 28; Table 5.8) which increased 2.9-, 2.5- and 2.4-fold
respectively in AB211AadeB. This protein consistently displayed reduced expression in all
comparisons of AB211, even its knock out derivative, suggesting that this expression change is
isolate specific rather than a consequence of efflux upregulation. Three spots were identified as
succinyl-CoA synthetase, two as the alpha subunit (Spots 32 and 38; Table 5.8) which increased
expression 2.3- and 2-fold respectively and one as the beta chain (Spot 37; Table 5.8) which
showed a 2-fold expression increase. Succinyl CoA synthetase was not identified in any of the
other comparisons, which suggested that its increased expression here may be purely due to the
absence of active AcrABC. Succinate metabolism appears to be a significant factor in AdeABC
upregulation, as succinate dehydrogenase was increased in AB211 and succinate CoA synthase was
increased in its knockout mutant.
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Transaldolase B or TalB (Spot 33; Table 5.8) expression increased 2.3-fold in
AB2llf>.adeB, while the other proteins in this group belong to the TCA cycle, TalB is part of the
pentose phosphate pathway (PPP). Due to the reactions it catalyses, TalB is an important link
between the PPP and glycolysis. Expression of both aconitase and TalB proteins also increased in
AB2l0-6 in comparison with AB2ll, suggesting that expression of TCA cycle enzymes in AB2ll
is reduced.
5.7.2.3 Other proteins displaving expression increases
Enoyl-CoA hydratase/carnithine racemase (Spots 16 and 36; Table 5.8) expression increased 4.5-
and 2-fold respectively in AB2llf>.adeB, this protein is also known as PaaB, a phenylacetic acid
degradation protein, which also showed increased expression in AB2l 0-6 vs. AB2ll.
Hypothetical protein ACICU_03l25 (Spot 22; Table 5.8) was returned as
ATP:cob(I)alamin adenosyltransferase by BLASTp analysis (E value = 2e-137) and its expression
increased 3.2-fold in AB211f>.adeB. This protein synthesises coenzyme B12 (adenosy1cobalamin)
from regular vitamin B12 (cobalamin) (Mera & Escalante-Semerena, 2011). It is interesting that
AB2ll displayed increased expression of MetH, yet here upon removal of the AdeABC efflux
pump AB2ll f>.adeBappears to be utilising cobalamin. There could be a potential role of cobalamin
in the upregulation of AdeABC efflux pump.
Nucleoside diphosphate kinase (Spot 23, Table 5.8) displayed a 2.9-fold expression
increase in AB21lfladeB and has been highlighted previously in section 5.6.2 as increased in
AB2l0 compared with AB2l0-6. It also increased expression in AB2l0 compared with AB2ll
(Table 5.4), showing that it is lower in the resistant isolates compared with susceptible isolates.
5.8 Chapter Summary
In this study the expression patterns offour isolates of A. baumannii were compared using DIGE in
order to detect changes related to resistance/susceptibility to tigecycline. When comparing AB2l0
and AB2ll, eight proteins were detected only in AB2l0 and five only in AB2l1. However, due to
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the limited dynamic range of 2DGE it is not possible to provide a proof of absence for a particular
protein and confirmation is required by other means e.g. genomics. The observed differences could
be explained by large variations in abundance or posttranslational modifications. The genome
sequences of AB210 and AB2ll are available (Homsey et al. 2011) which allowed corroboration
of the proteomics findings with the genomics data. Two proteins confirmed as unique to AB2l0
were identified as AAC(6')-Ib, and MdaB and were absent from the genome of AB211. The AAC
protein is an aminoglycoside resistance enzyme which acetylates the antibiotic and renders it
ineffective and its absence in AB2ll is consistent with the reduction in aminoglycoside MICs.
There were multiple proteins identified that could potentially confer an increased ability to
sequester iron from the environment in AB2l1. These included the identification of AroD unique
to AB211, whose catechol products can be used in iron acquisition. AB211 also displayed increases
in BfrD (a catechol receptor) and a ferrichrome iron receptor protein, these three proteins taken
together strongly suggest that AB2ll would be better at scavenging iron than AB210 and may have
a competition advantage in vivo. This potential in vivo advantage of AB2l1 is given further weight
by the increased expression of proteins involved in pilus- and biofilm-formation and also capsule
assembly. Ferrichrome iron receptor was also identified as displaying reduced expression in
AB211 f:.acrB compared with AB211, suggesting that AdeABC efflux pump regulation has a direct
effect on the expression of ferrichrome iron receptor.
Overall, the majority of proteins with increased expression in AB211 were outer membrane
proteins, while many of the proteins increased in AB21 0 were cytosolic and seemed to function in
metabolism and oxidative stress defence (three antioxidant proteins all increased in AB210). These
may be required due to lower levels of efflux than AB211, or because of an apparent increase in
metabolic enzyme expression. From the protein profiles generated by this comparison, AB211
appeared potentially more virulent and may have a competitive advantage over AB210 under
certain conditions e.g. low iron concentrations.
The additional comparisons of the clinical pair with the mutants provided extra insight into how
differential regulation of the AdeABC pump affects the A. baumannii proteome. By comparing
AB211 with a lab-mutant and an adeB knockout, expression of biofilm-forming proteins was
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increased again in AB211. The polysaccharide biosynthesis protein combined with the presence of
sugar-modifying enzyme for biofilm carbohydrate moieties provides more evidence that
upregulated efflux causes expression increases in proteins that facilitate biofilm formation e.g. the
DegTlDnrJlEryCl/StrS aminotransferase family protein is involved in the biosynthesis of sugar
portions of cell-surface polysaccharides (Shoji et al. 2002). There are other proteins increased in
AB211 which support this same conclusion: that the tigecycline-resistant isolates with upregulated
efflux are more adept at forming biofilms.
Although AB210 and AB210-6 were compared, not enough protein identifications were
returned to make reliable inferences about the significance of proteins displaying differential
expression. However, there were some proteins identified that have been seen in other
comparisons: such as ClpB, NDK and malate synthase G.
The comparison of AB211 and AB21 0-6 revealed, amongst other changes, differences in
the isolates' metabolism of lipids. AB211 displayed increased expression of proteins which
together suggest an increase in the biosynthesis of fatty acids, possibly for energy storage. Whereas
the proteins in AB210-6 suggest this isolate is more likely to utilise lipids for energy generation.
This lipid catabolism could possibly be due to increased demand from TCA cycle for acetyl CoA
(lipid metabolism would supply Acyl-CoA) which was suggested by Fernandez-Reyes et al.
(Fernandez-Reyes et al. 2009). Alternatively, avoiding lipid catabolism could help control the
cellular pH (generation of fatty acids would lower the pH). Malate synthase G, which increased in
AB210-6 compared to AB210, provides further evidence for AB210-6 utilising lipids for energy.
The tigecycline-susceptible isolates display more metabolic proteins with increased expression,
AB211 particularly has consistently reduced expression of TCA cycle enzymes, suggesting it relies
on alternative energy sources. This may explain the reduced expression of lipid-metabolising
proteins which were found to be increased in AB210-6, to generate acetyl-CoA to feed the TCA
cycle.
As fatty acids and other cellular metabolites are substrates of the AdeABC efflux pump,
the expression of these proteins may increase to make up for the fatty acids being lost to increased
efflux activity. Alternatively, in E. coli FadB is known to be consistently increased when grown in
biofilms (Beloin et al. 2004) and as efflux pumps are known to significantly contribute to biofilm
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formation (Matsumura et al. 2011) this increase in expression of this protein may be caused
directly by upregulated AdeABC.
This needs further work utilising more clinical pairs of isolates to rigorously test these
inferences and pin down whether any are in fact specific to the resistance mechanism or just
isolate-specific changes unrelated to resistance. It is important to map these proteins onto their
biological pathways to try and elucidate the subtle effects that differential efflux regulation has on a
bacterial cell.
It was also observed that AB210-6 displayed higher expression of stress-defence proteins
than AB211, which may contribute to AB210-6 being able to withstand higher tigecycline
concentrations (64 mgIL vs. 16 mgIL in AB211). When comparing AB211 and its derivative
knockout, the latter had more stress defence proteins with increased expression than AB211'
emphasising how upregulated efflux protects the cell from stresses. ClpB was repeatedly identified
in these DIGE comparisons; for instance it increased in AB211 in every comparison, as ClpB
functions to re-fold misfolded proteins the upregulation of AdeABC may have detrimental effects
on protein folding in AB211.
As mentioned earlier, NDK deficiency can stimulate replication errors in E. coli. A
reduction in NDK expression may be advantageous to the resistant isolates by causing elevated
rates of mutation under selection pressure. Strains of E. coli lacking this protein have shown
elevated mismatch mutation rates and in NDKlMutS double mutants this rate is increased further,
NDK deficiency is thought to stimulate replication errors by DNA polymerase (Miller et al. 2002).
Homsey et al. (Homsey et al. 2011) showed via whole-genome sequencing that AB211 had a
mutation in the mutS gene which could have led to the high number of mutations found in this
strain. The results from the earlier AB2101AB211 comparison show that NDK was also higher in
AB210 than AB211. It is unknown whether the differential regulation of NDK or the mutS
mutation occurred first i.e. whether one change causes the other.
Due to the reduced production of metabolic proteins, proteins for lipid storage rather than
utilisation, reduced stress defence proteins and increases in biofilm forming- and iron scavenging-
related proteins, it appears that overall, AB211 seems set up for persistence. Many of the proteins
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with expression increases in AB211 could confer a survival advantage under antibiotic therapy and
potentially allow AB211 to outcompete its tigecycline-susceptible counterpart, AB21o.
This work has contributed to the proteomic characterisation of A. baumannii by elucidating some
of the effects of AdeABC differential regulation on the A. baumannii proteome e.g. NDK was
consistently reduced in tigecycline-resistant isolates and increased in -susceptible isolates, ClpB
was always increased in AB211 as was RNA polymerase subunit alpha, while Min cell division
proteins, metabolic proteins and stress defence proteins were increased in tigecycline-susceptible
isolates. While the original aim was to use proteomics to investigate the mechanism of resistance
acquisition, the results were not able to answer this question. Instead this work shed light on the
diverse changes in organism physiology and metabolism caused by the differential regulation of the
AdeABC pump, including changes which may affect the virulence, persistence and recalcitrance of
these isolates. By comparing the pre- and post-therapy A. baumannii clinical pair alongside
derivative isolates, we can see patterns of protein expression begin to emerge. However, while
DIGE has provided vast amounts of information about the test organisms, the techniques are not set
up for high-throughput workflows as they are time consuming and require elaborate data analysis.
A greater number of isolates need to be tested to confirm the reproducibility of the results, as
confirmation of these observed differences in other A. baumannii pairs would allow us to draw
more solid conclusions about the proteins involved in resistance. Nonetheless the DIGE technique
is suitable for smaller scale analysis, revealing many changes in the tested clinical pair and its
derivatives which would otherwise remain unobserved. This fact alone should warrant the use of
proteomics in the analysis ofunusuallcomplex resistance mechanisms/pathogens.
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6. Results
Tigecycline resistance in Enterobacter cloacae
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6. t Background of isolates
To date, much work investigating E. cloacae and its antimicrobial resistances has been
undertaken (Sanders & Sanders, 1997; Perez et al. 2007; Homsey et al. 2010b). However, while it
is understood that upregulation of the AcrABC efflux pump confers resistance to tigecycline in E.
cloacae (Keeney et al. 2007 and Homsey et al. 20 1Ob); the consequences of this upregulation on
the bacterial cell or whether there are any regulators/cofactors of the pump, are unknown. Here,
the DIGE experimental approach (see methods section 2.10) was applied to investigate tigecycline
resistance in E. cloacae. The lack of any previously published comparative proteomics studies on
this clinically-relevant species makes this work all the more pertinent.
The clinical pair of isolates TGC-S and TOC-R were obtained from a patient before (TOC-
S) and after (TGC-R) ciprofloxacin therapy. These isolates were selected to investigate the
potential effects of differential levels of expression of the AcrABC efflux pump on the rest of the
E. cloacae proteome. The antibiotic susceptibilities of the isolates were evaluated in AMRHAI at
the HPA, where TOC-R was found to be resistant to both ciprofloxacin and tigecycline (both with
an MIC of 4 mg/L) while TGC-S was susceptible to both compounds (with MICs of 0.5 mgIL
each). TGC-R had been used to create an acrB gene knockout mutant, TGC-MacrB. in which the
gene was inactivated by the insertion of a gentamicin resistance cassette (Homsey et al. 2010b),
leaving TGC-MacrB susceptible to tigecycline (MIC of 0.125 mgIL). As the level of efflux is
increased in TOC-R compared to TGC-S and TOC-MacrB, (Homsey et al. 20tOb) we hoped to
identify proteins whose expression was affected by both the increase and decrease in efflux
activity.
The aim was to identify proteins that may be involved in the efflux-mediated tigecycline
resistance mechanism, with the additional objective of characterising the E. cloacae proteome. It is
hoped that increased knowledge of the efflux resistance mechanism, its regulation and the effects
of its differential regulation on E. cloacae cell physiology could contribute to the development of
novel inhibitors/antagonists potentially capable of disabling efflux activity thus overcoming a
broad and troublesome resistance mechanism.
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6.1.1 2-Dimensional gel electrophoresis of Enterobacter extracts
All E. cloacae isolates were grown to late log phase in LB broth, cells were collected via
centrifugation and lysed (as described in Methods section2.5.2). The extracted proteins were
quantified and separated by 20GE using Immobilised pH gradients of 4-7 (see methods section
2.12.1). Each biological replicate (four in total) for each extract was optimised using 20GE before
any labelling with CyOyes due to availability of the dyes. These initial 20GE separations were to
demonstrate that; (i) the extracts were free from any charged or insoluble contaminants that could
cause streaking and (ii) the proteins would separate with good resolution using the specified pH
range. (see Fig. 6.1 Fig. 6.2 and Fig. 6.3). The gels displayed here yielded the highest number of
resolved protein spots and hence, were used as 'picking gels' to supply the material needed for
protein identification. The ProPic II scanner/picking robot used for this task could not visualise
CyOye-labelled proteins, therefore SYPRO-stained gels were used for picking instead of the
labelled originals. Although some gels displayed 'warping' caused by uneven acrylamide
polymerisation, there was sufficient protein separation to use for spot-picking.
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4 pH 7
Figure 6.1 2DGE profile ofTGC-S isolate. Total cell extract was separated using pH gradient of 4-
7, and 12% polyacrylamide gel. The separated proteins were stained with SYPRO Ruby
(Invitrogen) and visualised using an Ettan Dalt imager (GE Healthcare).
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4 pH 7
Figure 6.2 2DGE profile of TGC-R isolate. Total cell extract was separated using pH gradient of 4-
7, and 12% polyacrylamide gel. The separated proteins were stained with SYPRO Ruby and
visualised using an Ettan Dalt imager (GE Healthcare).
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4 pH 7
Figure 6.3 2DGE profile of TGC-~acrB isolate. Total cell extract was separated using pH
gradient of 4-7, and 12% polyacrylamide gel. The separated proteins were stained with SYFRO
Ruby and visualised using an Ettan Dalt imager (GE Healthcare).
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6.2 Comparison of TGC-S, TGC-R and TGC-R AacrB protein profiles using DIGE
2D DIGE gels were setup as described in Table 6.1 and gel images were analysed using the
SameSpots software package (see methods section 2.14) from which c. 550 individual protein spots
over the range of pH 4-7 were detected. Comparison of isolates TGC-S and TGC-R revealed 24
spots that were differentially expressed (Fig. 6.4). Of these, 21.were identified using LC-MSIMS (3
proteins did not return an identification), yielding 17 different proteins. Relative expression was
greater for 6 spots and lower for 15 spots in tigecycline-resistant isolate TGC-R (Table 6.2). When
isolate TGC-R was compared with mutant, TGC-R~acrB (Fig. 6.5) 26 differentially-expressed
spots were highlighted: 23 of these spots returned identifications to give 21 different proteins, four
spots showed greater relative expression in TGC-R and 17 had reduced expression in this isolate
(Table 6.3). Most of the differentially-expressed proteins could be placed into the following two
groups; (i) proteins which correlated directly with efflux expression i.e. increased with efflux pump
up-regulation and decreased with efflux knockout and (ii) changes in protein expression with the
potential to alter virulence. Further work needs to be done to characterise the remaining identified
proteins.
Gel no. Labelled with Cy3 Labelled with Cy5
1 TGC-S (4) TGC-R(2)
2 TGC-MacrB (3) TGC-S (2)
3 TGC-R(l) TGC-MacrB (2)
4 TGC-S (3) TGC-MacrB (1)
5 TGC-MacrB (4) TGC-R(3)
6 TGC-R(4) TGC-S (1)
Table 6.1 DIGE experimental setup for E. cloacae protein extracts with the biological replicate
number in brackets
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4 pH 7
Figure 6.4 2-D DIGE image of TGC-R (Cy5 - red) vs. TGC-S (Cy3 - green). Green spots
correspond to proteins from TGC-S, red spots correspond to proteins from TGC-R and yellow
spots indicate that the protein is present in both isolates. Numbered, circled spots correspond to the
identified proteins of interest in Table 6.2.
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4 pH 7
Figure 6.5 2-D DIGE image of TGC-R (Cy5 - red) vs. TGC-R.0.acrB (Cy3 - green). Green spots
correspond to proteins from TGC-R.0.acrB, red spots correspond to proteins from TGC-R and
yellow spots indicate that the protein is present in both isolates. Numbered, circled spots
correspond to the identified proteins of interest in Table 6.3.
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6.3 Changes in protein expression that appear to associate with acrB upregulation
The eight proteins in this group were found to have expression patterns which mimicked that of the
AcrB protein, some were positively associated Le. when the efflux pump was upregulated, these
proteins increased in expression, and some were negatively associated i.e. when the pump was
upregulated, the expression of these proteins was reduced. The following two proteins displayed a
positive association with AcrB, while six others displayed negative associations. All proteins in this
associated group are listed in Table 6.4.
6.3.1 Proteins displa~;ng a positive association
The outer membrane protein (spot 21; Table 6.2 and spot 1; Table 6.3) was identified as OmpD (or
NmpC) by BLASTp (E = 0). Expression of OmpD was increased in TGC-R 2-fold and reduced by
3.4-fold in TGC-MacrB. It is differentially regulated in both comparisons of the E. cloacae
isolates and is the first of two proteins which show an increase in expression that correlates with
the increased expression of the AcrB efflux pump protein. When comparing TGC-R/ TGC-
MaerB, OmpD expression drops 3.4-fold when AcrB is not expressed (in tigecycline-susceptible
TGC-MacrB).
Expression of SdhA (succinate dehydrogenase/ SDH) flavoprotein subunit; spot 17; Table
6.2 and spot 2; Table 6.3) was similarly increased in TGC-R vs. TGC-S by 2.3-fold and reduced by
2.1-fold in TGC-Rl~acrB.
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Protein Identification
Positive OmpDlNmpC
association Succinate dehydrogenase flavoprotein subunit (SdhA)
Enolase
Glycyl radical cofactor (GreA)
Negative Isocitrate dehydrogenase
association Pyruvate dehydrogenase
Ribosomal subunit interface protein (RaiA)
DNA protection during starvation protein (Dps)
Table 6.4 Proteins displaying expression patterns which were associated positively or negatively
with efflux activity.
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Figure 6.6. Positive and negative associations that many of the identified proteins had with AcrB
observed in the three isolates tested.
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6.3.2 Proteins displaving a negative association with acrB upregu)ation
The following proteins showed expression patterns that associated with the inverse of
AcrABC pump expression (designated as negative association). Spots 12, 15 (Table 6.2) and spot
21 (Table 6.3) were all identified as enolase, spots 12 and 15 showed reduced expression in TGC-R
by 2.1- and 2-fold respectively, while spot 21 displayed increasing expression in TGC-Rl~acrB by
2-fold. Enolase converts 2-phosphoglycerate into phosphoenolpyruvate, an essential step in
glycolysis and is also a component of the RNA degradosome complex which processes and decays
mRNA, although its exact role in the complex remains to be determined (Carpousis 2007).
The acid-induced glycyl radical enzyme, represented by three spots of interest (spots 1, 4
and 6; Table 6.2) showing reduced expression in TGC-R by 4.6-, 2.9- and 2.5-fold respectively.
This same protein displays increased expression in TGC-Rl~acrB by 2.1-fold (spot 18; Table 6.3).
Following BLASTp analysis, the protein showed high similarity with glycyl radical cofactor
(GrcA, E value = 2e,S7).GrcA is a homologue of YfiD of E. coli and functions to reconstitute the
glycyl radical domain of pyruvate-formate lyase, which requires a glycyl radical active site under
oxidative stress conditions (Wagner et al. 2001). This serves as a stress defence protein against
oxidative environments and is essential for anaerobic growth.
Isocitrate dehydrogenase (spot 11; Table 6.2 and spot 16; Table 6.3) displayed reduced
expression of 2.2-fold in TGC-R and an increase of 2.2-fold in TGC-Rl~acrB. Isocitrate
dehydrogenase catalyses the oxidative decarboxylation of isocitrate, producing a-ketoglutarate
and CO2 while converting NAD+ to NADH. Pyruvate dehydrogenase (spot 9; Table 6.2 and spot 7;
Table 6.3) showed a reduction in expression of 2.3-fold in TGC-R and an increase of 3-fold in
TGC-Rl~acrB._Pyruvate dehydrogenase catalyzes oxidative decarboxylation of pyruvate to form
acetyl-CoA, both pyruvate and isocitrate dehydrogenases are vital enzymes in the TCA cycle and
energy generation.
Spot 10 (Table 6.2) and spot 12 (Table 6.3) were identified as ribosomal subunit interface
protein or RaiA, the expression of which was reduced 2.3-fold in TGC-R and increased 2.5-fold in
TGC-Rl~acrB. RaiA responds to stress by binding to the ribosome and inhibiting translation,
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although its main activity is to reduce translation errors in protein biosynthesis (Agafonov &
Spirin, 2004).
DNA-binding ferritin-like protein (spots 2 and 3; Table 6.2 and spot 8; Table 6.3) showed
reduced expression in TGC-R of 4.4- and 2.9-fold respectively and increased expression of 2.9-fold
in TGC-Rl~acrB. They were later identified as DNA protection during starvation protein (Dps) by
BLASTp (E value = 2e-92). Dps binds DNA non-specifically and condenses it to offer protection
from a variety of damaging agents (radiation, thermal shock and pH stress) and as part of this
protection, it can sequester and recycle Fe2+ ions to prevent them forming reactive oxygen species
(Calhoun & Kwon, 2011).
6.4 Changes in expression with potential implications for virulence
Some of the differentially expressed proteins identified between the two comparisons (TGC-S vs.
TGC-R and TGC-R vs. TGC-MacrB) had the potential to alter the virulence of E. cloacae isolates.
These include spots 5 and 6 (Table 6.3), which were both returned as OmpA protein by BLASTp
analysis (E value = 7e-136) and showed an increased in expression of 4.5- and 4.l-fold respectively.
The LuxS protein (spot 15; Table 6.3) expression increased 2.3-fold in TGC-MacrB and is
part of the synthetic pathway that produces autoinducer-2 (AI-2), a molecule used for Quorum
Sensing (QS) in many species of pathogenic bacteria (Rezzonico & Duffy, 2008).
The outer membrane protein (porin) was identified as OmpD by BLASTp and was
increased 2-fold in TGC-R (spot 21; Table 6.2). OmpD serves a variety of functions but is
frequently associated with protection, from heat and oxidative stresses for example.
6.5 Other observed protein differences
6.5.1 Differences arising between TGC-S and TGC-R
In the comparison ofTGC-S vs. TGC-R, the expression of 11 proteins was increased in TGC-S and
six of these were found to have an association with AcrB. The remaining five include: superoxide
dismutase (SOD) (Spot 5; Table 6.2), which showed a 2.8-fold expression increase in TGC-S and is
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involved in oxidative stress defence. Septum site-determining protein MinD (spot 7; Table 6.2)
showed a 2A-fold expression increase and is involved in regulation of MinC which inhibits septum
formation at the cell poles during division (Lutkenhaus, 2007). The aldolketo reductase (spot 8;
Table 6.3) also showed a 2A-fold expression increase and returned as the dkgA gene product via
BLASTp analysis (E = 0) which is involved in fermentation in E. coli (Miller et al. 2009). The
hypothetical protein ENTCAN_05473 (spot 13; Table 6.2) showed a 2.l-fold increase in
expression and returned as pyruvate formate lyase via BLASTp analysis (E = 0) which catalyses
the cleavage of pyruvate to formate under anaerobiosis (Buckel & Golding, 2006). The predicted
periplasmic/secreted lipoprotein (spot 14; Table 6.2) also showed a 2.1-fold increase in expression
and returned as OsmY via BLASTp analysis (E = 4e-137) which is involved in protection from
hyperosmotic environments.
In this same comparison, six proteins were increased in TGC-R and two of these were associated
with AcrB. The remaining four include: Pyruvate ferredoxin/flavodoxin oxidoreductase (spot 16;
Table 6.2) showed a 2A-fold expression increase and catalyses the conversion of pyruvate to
acetyl-coA and CO2, while L-proline dehydrogenase (spot 18; Table 6.2), which participates in
proline and arginine metabolism showed an expression increase of 2.2-fold. The unnamed protein
product (spot 19; Table 6.2) showed an increase in expression of2.I-fold and returned as Succinate
dehydrogenase subunit B via BLASTp analysis (E = 3e-176). RNA polymerase subunit alpha (spot
21; Table 6.2) expression also increased 2.1-fold and has many functions as part of the RNA
polymerase complex, including recognition of transcription initiation sites and ensuring complex
stability (Rippa et al. 2010).
6.5.2 Differences arising between TGC-R and TGC-RAacrB
In the comparison ofTGC-R vs. TGC-MacrB, the expression of 4 proteins was increased in TGC-
R, two of which were found to have an association with AcrB. The remaining two were: L-seryl-
tRNA selenium transferase (Spot 3; Table 6.3), required for the synthesis of selenoproteins and
ribosomal protein L12 (spot 4; Table 6.3), which both showed a 2-fold expression increase.
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In this same comparison, 17 proteins were increased in TGC-MacrB and six of these were
associated with AcrB and two (OmpA influxes) were mentioned previously in section 604. The
remaining nine include: MinE (spot 9; Table 6.3), which showed a 2.8-fold expression increase and
is a regulator of MinC and MinD activity in the inhibition of septum formation during cell division
(Lutkenhaus 2007). Pyrroline-S-carboxylate reductase (spot 10; Table 6.3) showed a 2.7-fold
increase in expression and is involved in L-proline biosynthesis and ribosomal protein L5 (spot 11;
Table 6.3) showed a 2.6-fold increase in expression. Hypothetical protein TIGR00255 (spot l3;
Table 6.3) expression increased 2A-fold and returned as a potassium-transporting ATPase via
BLASTp analysis (E = 0). SCP-2 sterol transfer protein (spot 14; Table 6.3) expression also
increased 2A-fold and returned as Yhbt via BLASTp analysis (E = 7e-1l8). Phosphopentomutase
(spot 17; Table 6.3) is involved in nucleic acid metabolism and its expression increased 2.1-fold.
Dihydropicolinate synthase (spot 19; Table 6.3) expression increased 2.1-fold and is involved in
the biosynthesis of lysine. Maltooligosaccharide-binding protein (spot 20; Table 6.3) expression
increased 2-fold and functions to transport maltose across the membrane. Both spots representing
ribose-phosphate pyrophosphokinase (spots 22 and 23; Table 6.3) showed a 2-fold increase in
expression, also known as Prs, it is involved in the purine biosynthetic pathway.
6.6 Chapter Summary
This study has highlighted the impact that altered efflux pump expression can have on a diverse
range of cellular processes in E. cloacae, including: changes in stress-defence proteins, changes in
the levels of metabolic proteins and changes in cellular division proteins. Some of the proteins
identified display a repeated pattern of expression which may be associated (either positively or
negatively) with the expression of the AcrB efflux pump protein (and therefore the active pump
AcrABC). These include OmpD, a porin implicated in stress resistance and SdhA or succinate
dehydrogenase subunit A. Nouwen et al. (Nouwen et al. 2001) showed that a decrease in succinate
dehydrogenase caused a decrease in the proton motive force (PMF) in inner membrane vesicles and
as AcrABC efflux activity is driven by energy from the PMF (Martins et al. 2009), succinate
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dehydrogenase could be (at least indirectly), supplying the energy for efflux activity. This would
explain the increased expression of SdhA as a way to keep up with increased energy demand
caused by increased efflux activity.
Proteins displaying a 'negative' association with AdeB include the reduced expression of
enolase, which is essential in the RNA degradation complex and could suggest a decrease in
mRNA processing. Although, enolase has also been implicated in cell adherence and attachment,
through its fibrinogen-binding activity in pathogenic streptococci (Pancholi & Fischetti 1998) and
Gram-negative species (Sha et al. 2009). The RNA degradosome is known to bind the cell division
inhibitor protein MinD (Taghbalout & Rothfield, 2007). The precise relationship between MinD
and the degradosome is unclear, but this association could explain the increased expression by both
enolase and Min proteins (MinE is a regulator of MinD) in both tigecycline-susceptible isolates.
It was expected that SodB, Dps and other protection proteins demonstrated greater
expression in TGC-R (the resistant isolate) rather than TGC-S. However, TGC-S still has
resistances to multiple antibiotics and hence, the need for this protection. These proteins are still
present in TGC-R, although their expression levels may have been affected by the increase in
AcrABC activity. The increase in efflux activity in TGC-R could also contribute, as there is
evidence which strongly suggests that efflux pumps participate in oxidative stress defence (Jeon et
al. 2011). As fewer chemical challenges, toxins or antibiotics can accumulate to cause cellular
damage, the need for cell defence proteins would likely decrease. The changes observed in stress
defence protein expression between isolates would suggest that efflux pumps may playa larger part
in stress defence than was previously thought. A reduction in the requirement for stress defence
proteins and additional defence provided by increased AcrABC activity would lead to a slightly
reduced need for energy, which may explain the reduced expression of TCA cycle enzymes
pyruvate and isocitrate dehydrogenases. Similar findings were reported by dos Santos (2010) in an
investigation into efflux-mediated resistance to the antibiotic combination piperacillinltazobactam
in Escherichia coli (Dos Santos et al. 2010). Many proteins involved in stress defence and energy
metabolism demonstrated reduced in expression in the antibiotic-resistant isolate, while proteins
involved in anaerobiosis demonstarted increased expression.
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Other highlighted proteins have the potential to exacerbate the pathogenesis of this
organism e.g. OmpA, OmpD and LuxS. OmpA has been shown to be an important virulence factor
for closely-related Enterobacter sakazakii, required for bacterial attachment and invasiveness,
causing persistent infection and survival in blood (Mittal et al. 2009). OmpA is known to be
involved in bacterial attachment to host cells (Smith et al. 2007), as is the AcrABC efflux pump
(Blair et al. 2009). Therefore, an increase in the expression of OmpA may have been a response to
the reduced attachment capability ofTGC-MacrB caused by a lack of AcrABC.
Expression of LuxS was increased in TGC-MacrB, possibly due to the absence of AcrB
efflux pump protein. AI-2 may be a substrate for AcrABC, as this pump is known to extrude
quorum sensing (QS) signal molecules from the cell (Yang et al. 2006). With no AcrABC activity,
there will be less QS signal molecule released into the surroundings, which would mean a lack of
QS-mediated control on cell growth. Increased expression of LuxS seen in TGC-MacrB could be
a response to try and increase extracellular levels of the QS signal molecule.
It has been previously reported that MDR Enterobacter spp. with increased efflux activity
reduces porin expression (Masi et al. 2006). Here the opposite was observed; that OmpD
expression was increased in TGC-R while efflux activity was increased compared with TGC-S.
OmpD has been previously implicated in providing heat resistance to E. coli, (Ruan et al. 2011)
antibiotic resistance e.g. to antimicrobial peptides in Salmonella (Pilonieta et al. 2009) and
permeability-mediated resistance to carbapenems (Szabo et al. 2006). As the MICs of these
compounds did not change significantly between the isolates studied in this chapter, it is likely that
OmpD plays an alternative, unknown role that does not appear to participate in this mechanism of
resistance.
Consequently, changes in the expression of these proteins could potentially make E.
cloacae i) more resistant to stresses e.g. antibiotic-mediated killing, through increased OmpD
levels, ii) improved OmpA-mediated attachment and invasion of host cells, and iii) persistence of
infection via increased biofilm formation. Although changes in these specific proteins were not
detected between the clinical pair of isolates (TGC-S and TGC-R), there is potential for increased
virulence that could be conferred by proteins affected by expression levels of AcrABC. However,
additional work is required to confirm the relationship between these proteins and the AcrABC
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efflux pump, such as the generation and comparison of an OmpD knockout mutant (e.g. derived
from TGC-R) with TGC-R.
This work is the first DIGE proteomic analysis of E. cloacae and has helped to characterise the E.
cloacae proteome while highlighting some of the changes in protein expression associated with
acquisition of efflux-mediated tigecycline resistance. The subtle changes between the isolates,
detected here by DIGE, demonstrated the power of proteomics to detect previously unseen
differences associated with antibiotic resistance, particularly between pairs of isolates, with the
potential to identify markers of the resistance or cofactors involved in the mechanism itself.
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7. Results
Tigecycline resistance in Serratia marcescens
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7.1 Introduction of isolates
Serratia marcescens is an important nosocomial pathogen capable of causing infections in a broad
range of sites and is also frequently associated with outbreaks, where it is a problematic and
increasingly reported organism (Voelz et al. 2010). Treating S. marcescens infections can be
problematic due to the inherent resistance to many antibiotics, and as with previous isolates
described in this thesis, the remaining therapeutic options include only tigecycline and
carbapenems. The broad substrate ranges of many efflux pumps can complicate treatment regimes
and in an intrinsically drug-resistant species such as this, efflux-mediated resistance to multiple
antibiotics could make it an extremely difficult organism to treat.
In this study a S. marcescens clinical isolate SM346 was used, with resistance to
tigecyc1ine (MIC = 16 mg/L) that was later attributed to up-regulation of the SdeXY-HasF tripartite
efflux pump (Homsey et al. 2010c). As this was a single clinical isolate with no comparator
available, protein extracts of the S. marcescens type strain NCTC 10211 were used as a tigecycline-
susceptible counterpart. The additional derivative mutants; tigecycline-resistant 10211-10, an
efflux knockout 10211-10asdeY and a second knockout mutant 10211-10~hasF (Homsey et al.
2010c), were also compared with the aim of characterising the proteins associated with this efflux-
mediated resistance mechanism.
Following the successful use of DIGE as described in chapters 5 and 6, the technique was
applied to these isolates to see if any inferences into the effects of the resistance mechanism could
be gleaned despite their differences. To date, there have been no proteomics studies carried out on
S. marcescens with regards to antibiotic resistance and any information of the effects of efflux
pumps on its protein complement would be valuable to further understanding this efflux-mediated
resistance in this species.
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7.2 Separation of protein extracts on gradients of pH 4-7
As previously in sections 5.2 and 6.2, the extracts of all isolates used in the DIGE proteomics
experiment were tested for quality on gradient pH 4-7 gels before being labelled with the CyDyes.
Based on the results of the 3-10 and 6-11 pH gradients used previously, the protein extracts were
only separated on 4-7 gels.
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4 pH 7
Figure 7.1 2DGE profile of proteins from isolate NCTC 10211. Total cell extract was separated
using a pH gradient of 4-7, and 12% polyacrylamide gel. The separated proteins were stained with
SYPRO Ruby (Invitrogen) and visualised using an Ettan Dalt imager (GE Healthcare).
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4 pH 7
Figure 7.2 2DGE profile of proteins from isolate SM346. Total cell extract was separated using a
pH gradient of 4-7, and 12% polyacrylamide gel. The separated proteins were stained with SYPRO
Ruby (Invitrogen) and visualised using an Ettan Dalt imager (GE Healthcare).
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4 pH 7
Figure 7.3 2DGE profile of proteins from laboratory mutant, isolate 10211-10. Total cell extract
was separated using a pH gradient of 4-7, and 12% polyacrylamide gel. The separated proteins
were stained with SYPRO Ruby (Invitrogen) and visualised using an Ettan Dalt imager (GE
Healthcare).
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4 pH 7
Figure 7.4 2DGE profile of proteins from knockout mutant, isolate 10211-1Of1sdeY. Total cell
extract was separated using a pH gradient of 4-7, and 12% polyacrylamide gel. The separated
proteins were stained with SYPRO Ruby (Invitrogen) and visualised using an Ettan Dalt imager
(GE Healthcare).
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4 pH 7
Figure 7.5 2DGE profile of proteins from knockout mutant, isolate 10211-IOt..hasF. Total cell
extract was separated using a pH gradient of 4-7, and 12% polyacrylamide gel. The separated
proteins were stained with 8YPRO Ruby (Invitrogen) and visualised using an Ettan Dalt imager
(GE Healthcare).
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7.3 DIGE-lahelled protein separations
. Approximately 720 spots were detected on the DIGE gels using the SameSpots software
(Progenesis v3.03 Nonlinear Dynamics, Newcastle, UK). The isolates were labelled and grouped
into gels as described in Table 7.1.
Gel no. Cy3 Cy5
1 NCTC 10211 (1) SM346 (2)
2 10211-10 (2) ~SdeX (1)
3 ~HasF (1) NCTC 10211 (2)
4 SM346 (1) ~HasF (2)
5 ~SdeX (3) 10211-10 (1)
6 NCTC 10211 (3) 10211-10 (3)
7 SM346 (3) zsaex (2)
8 ~HasF (3)
Table 7.1 DIGE experimental setup for the S. marcescens isolates, numbers in brackets refer to the
biological replicate of the sample
From the comparisons performed in this experimental setup, three were chosen for further analysis.
Comparisons with the knockout derivatives yielded very low numbers of proteins, less than five,
with differential expression. These results would have been statistically weak with such a low
number of proteins and any inferences made would be purely speculative with so few
identifications, therefore these few spots highlighted by SameSpots were not submitted for LC-
MSIMS analysis. The three comparisons that were chosen for further analysis were as follows: (i)
tigecycline-resistant clinical isolate SM346 and NCTC 10211 (ii) clinical isolate SM346 and
derivative tigecycline-resistant mutant 10211-10 and (iii) resistant lab mutant 10211-10 and NCTC
10211.
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7.4 Comparison of NCTC 1021 1 type strain with SM346 clinical isolate
7.4.1 DICE-labelled separation of protein extracts
While these two isolates are not genetically similar as compared with the organisms in chapters 5
and 6, they were compared to test the limitations of this DIGE system, as identical pairs of bacteria
are not always available when investigating unusual resistance mechanisms. The genetic
dissimilarity was expected to produce many individual proteins that appeared 'unique' to either one
isolate or the other. However, due to the potential problems with confirming the 'uniqueness' of
proteins (see section 5.4.1), 'unique' proteins were not selected for further analysis and only the
differentially expressed proteins were selected for identification.
There were 28 proteins that displayed differential regulation between NCTC 10211 and
SM346, 17 of these showed increased expression in 10211 and 11 proteins showed increased
expression in SM346 (Fig 7.6).
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4 pH 7
Fig. 7.6 2-D separation of DIGE-labelled proteins over a pH gradient of 4-7 and a 12%
polyacrylamide gel, using extracts from SM346 (red) and NCTC 10211 (green). Numbers
correspond to the proteins in tables 7.2 and 7.3.
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7.4.2 Proteins displaving increased expression in SM346
Many of the 11 proteins that demonstrated increased expression in SM346 as determined by
SameSpots analysis, could be placed into one of three functional categories: (i) Membrane
transport (section 7.4.2.1); (ii) Stress defence proteins (section 7.4.2.2) and (iii) Proteins involved
in metabolism (section 7.4.2.3).
7.4.2.1 Membrane transport
The expression of preprotein translocase (spot 1; Table 7.2) increased 9.8-fold and returned as
SecA by BLASTp (E = 0). SecA works with the SecYEG translocase system to export partially
folded proteins across the cytoplasmic membrane. SecA has ATPase activity, thus providing
energy for protein translocation (Plessis et al. 2011 and Sardis & Economou 2010). The Sec
transport system is also required for delivering beta lactamases, such as TEM, AmpC and CTX-M
enzymes, to the periplasm (Pradel et al. 2009) and may be important for resistance to ~-lactams.
Ycel family protein (spot 3; Table 7.2) expression increased by 3.9-fold, this protein is
similar to Yeel of Escherichia coli, a periplasmic protein which is induced by high pH and can bind
lipids. It is thought that when Ycel is activated under basic conditions, it transports molecules that
will lower the pH across the membrane, such as acid-generating lipids (Stancik et al. 2002).
The Transporter protein (spot 10; Table 7.2) was later classified as a carbohydrate, sugar or
ribose-uptake ABC transporter periplasmic-binding protein by BLASTp (E = 0) and its expression
was increased 2.1-fold.
7.4.2.2 Stress Defence
Some of the proteins identified play a role in stress defence and include glycine
hydroxymethyltransferase or GlyA (spot 2; Table 7.2), which displayed a 4.3-fold expression
increase in SM346. This protein catalyses the interconversion of serine and glycine, hence it can
also be referred to as serine hydroxymethyltransferase. GlyA is an important enzyme in one-carbon
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metabolism and catalyses the conversion of tetrahydrofolate to 5, IO-methylenetetrahydrofolate, an
important step in both tetrahydrofolate and one-carbon metabolic pathways (Shirazi-Beechey &
Knowles, 1984).
Expression of single-stranded DNA-binding protein or SSB (spot 4; Table 7.2) increased
by 3.2-fold, this protein plays important roles in DNA replication, repair and recombination, which
are essential for survival. During these processes, SSB binds to and protects single-stranded DNA
from digestion and secondary-structure formation (Huang et al. 2011 and Reyes-Iamothe et al.
2010). SSB could also confer protection against many other stresses e.g. osmotic stress (Weber et
al.2006)
Expression of an unnamed protein (spot 5; Table 7.2) was increased by 3.l-fold and was
later identified as GroEL via BLASTp (E = 0). GroEL is a chaperone essential for cellular growth,
which quarantines newly synthesised polypeptide chains from the cytosol. It then folds/re-folds
them in the absence of similarly aggregative polypeptides, this ensures correct protein folding and
prevents the formation of protein aggregates (Chaudhuri et al. 2009). Mutations in this gene in E.
coli have demonstrated increased susceptibility to tluoroquinolones (Yamaguchi et al. 2003),
therefore it may play important role in the stress response against antimicrobials in S. marcescens.
7.4.2.3 Metabolic processes
There were two hypothetical proteins which both returned as formate acetyltransferase or pyruvate
formate lyase (Ptl) by BLASTp (E = 0) and displayed expression increases of 2.8-fold (spot 6;
Table 7.2) and 2.l-fold (spot 9; Table 7.2). This protein is required for the reversible conversion of
pyruvate and CoA into formate and acetyl-CoA under anaerobic respiration, as its glycyl radical is
highly sensitive to oxygen attack.
Pyruvate dehydrogenase El component (spot 7; Table 7.2) was increased 2.4-fold,
pyruvate dehydrogenase decarboxylates pyruvate to acetyl-CoA and links the pathways of
glycolysis and the citric acid cycle. This protein was identified in section 6.3.2 as increased in
tigecyc1ine-susceptible isolates and reduced in -resistant isolates.
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The expression of aconitate hydratase 2 (spot 8; Table 7.2) also known as aconitase B or
AcnB, was increased 2.I-fold in SM346. Aconitase B catalyses the interconversion of citrate and
isocitrate in the TCA cycle, it may have importance in iron regulation, growth and
superoxide/radical sensitivity due to its key function and essential4Fe-4S cluster, which would be
very sensitive to changes in the level of available iron in the environment (Varghese et al. 2003).
Other functions stem from its ability to bind mRNA and sensitivity to ironlsuperoxide, which allow
it to switch between central metabolism and regulatory functions (Tang et al. 2005). AcnA was
identified in section 5.5.2 as increased in tigecycline-resistant AB210-6 vs. AB211.
7.4.2.4 Other proteins increased in SM346
Finally, the cell division inhibitor protein MinE (spot 11; Table 7.2) was increased by 2-fold. MinE
is a regulator of the MinCO proteins, together, MinCDE acts to inhibit formation of the FtsZ (Z-
ring) complex, which primes the cell for division. The Min system ensures that this division occurs
at mid-cell rather than at the poles (Lutkenhaus, 2007).
7.4.3 Proteins displaving increased expression in NCTC 10211
SameSpots analysis demonstrated an increase in the expression of 17 proteins in NCTC 10211
compared with SM346. The identified proteins were placed into the following functional
categories: i) Metabolic processes (section 7.4.3.1), ii) Stress defence (section 7.4.3.2) and iii) Cell
division (section 7.4.3.3).
7.4.3.1 Metabolic processes
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (DapD) (spot 12; Table 7.3)
expression increased 4.3-fold and dihydrodipicolinate synthetase (DapA) (Spot 23; Table 7.3)
expression also increased, 2.2-fold in NCTC 1021. These two proteins are involved in the essential
diaminopimelic acid (OAP) biosynthetic pathway of lysine and its precursor, meso-
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diaminopimelate, a component of the cell wall peptidoglycan and have been suggested as
promising therapeutic targets (Schnell et al. 2012).
Pyruvate dehydrogenase El component (Spot 19; Table 7.3) expression was increased 2.7-
fold as was uracil phosphoribosyltransferase (Upp) (Spot 21; Table 7.3), expression of which was
increased 2A-fold in NCfC 10211. Upp reversibly converts uracil and ribose triphosphate into
uridine monophosphate and diphosphate as part of nucleic acid metabolism.
Hypothetical protein SOD_hOl030 (Spot 24; Table 7.3) expression increased 2.2-fold and
returned as the pkcA gene product, phosphoenolpyruvate carboxykinase via BLASTp analysis (E =
0) which generates pyruvate in glycolysis.
Aspartyl-tRNA synthetase or AspS (Spot 28; Table 7.3) expression increased 2-fold, and
catalyses the attachment of aspartate to its corresponding tRNA for delivery to the ribosome. tRNA
synthetases can have alternative functions such as modification of cell peptidoglycan (Villet et al.
2007).
7.4.3.2 Stress defence
The conserved hypothetical protein (spot 14; Table 7.3) was identified as the cold-shock-like
protein CspC and demonstrated increased expression of 3.l-fold. CspC also possesses nucleic acid-
binding sites involved in regulation, it has been suggested that CspC stabilises rpoS transcripts,
which encode the alternative sigma factor RpoS and is a major regulator of the general stress
response (Cohen-or et al. 2010).
The expression of the ATP-dependent Clp protease subunit; ATP-binding subunit ClpX
(spot 15; Table 7.3) was increased 2.7-fold in the NCTC strain. ClpX is the chaperone unit of a
two-component protease, recognising and unfolding proteins for proteolysis by ClpP, a serine
protease. Recently ClpX was proposed to possess diverse functions, including modulation of cell
division via FtsZ degradation (Camberg et al. 2011).
The heat shock protein (spot 16; Table 7.3) was identified as IbpB by BLASTp (E = Se-~
and showed a 2.7-fold increase in expression. IbpB has been demonstrated to increase in isolates of
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E. coli displaying increased propensity for biofilm formation, although its exact role in biofilm
growth is unknown (Kuczynska-Wisnik et al. 2010).
7.4.3.3 Cell division
Phosphoserine aminotransferase (spot 17; Table 7.3) showed an increase in expression of 2.7-fold.
An alternative role for SerC has been proposed by Mouslim et al., suggesting that SerC is a cell
division antagonist, a property independent of its phosphoserine catalytic activities (Mouslim et al.
2000).
The Mafprotein (spot 18; Table 7.3) increased in expression by 2.7-fold in NCTC 10211.
The major role of Maf is in controlling the cellular division process through inhibition of the
division septum, Maf also has nucleic acid-binding activity (Hamoen, 2011)
Septum site-determining protein MinD (Spot 25; Table 7.3) expression increased 2.1-fold.
Together, MinCDE acts to inhibit formation of the FtsZ (Z-ring) complex, which primes the cell
for division. The Min system ensures that this division occurs at mid-cell rather than at the poles
(Lutkenhaus, 2007). This expression difference in MinD was expected, as MinE (negative regulator
of MinD) was increased in SM346.
7.4.3.4 Other proteins increased in NCTC 10211
Extracellular solute-binding protein family 5 (spot 13; Table 7.3) was identified by BLASTp as
belonging to the OppA family (oligopeptide permease) (E value = 0). It has been demonstrated that
OppA is important for cytoadhesion in Mycoplasma hominis (Hopfe et al. 2011), OppA is located
in the periplasm and binds oligopeptides for transport across the membrane. Peptidyl-dipeptidase
(Dcp) (Spot 22; Table 2) also increased expression 2.2-fold, it is an exopeptidase which removes
dipeptides from the C-terminal of its substrates and displays structural and functional similarities to
OppA (Conlin et al. 1995).
Lastly, there were two ribosomal protein identified in 10211, 50S ribosomal protein L24
(Spot 20; Table 7.3) and 50S ribosomal protein Lt (Spot 27; Table 7.3) which showed expression
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increases of 2.5- and 2-fold, respectively. The anaerobic ribonucleoside-triphosphate reductase
large subunit (Spot 28; Table 7.3) showed an increase in expression of 2.1-fold, although it
returned as transcription anti-termination factor NusG via BLASTp (E = 1e·I2s). This protein
modulates transcription elongation and termination (Saxena & Gowrishankar, 2011).
7.5 Comparison ofSM346 and laboratorY mutant 10211-10
These two tigecycline-resistant isolates were compared as they possessed the same resistance
mechanism, but acquired it under different circumstances e.g. in vivo and in vitro acquisition. The
aim of this comparison was to compare the results with those from sections 7.4 and 7.6 to try and
determine which changes are associated with upregulated efflux and which are likely to be
unrelated differences between the clinical isolate and the 10211 isolates. For example, any
consistent changes between the resistant isolates (SM346 and 10211-10) and susceptible NCTC
10211 may be associated with efflux upregulation. While similar changes from the comparisons of
SM346 and 10211 isolates (SM346 vs. 10211-10 and SM346 vs. NCTC 10211) may be put down
to genetic dissimilarity between SM346 and the 10211 isolates.
There were 13 proteins that displayed differential regulation between 10211-10 and SM346
(Fig. 7.7), six of these showed increased expression in 10211 and seven showed increased
expression in SM346.
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4 pH 7
Fig. 7.7 2-D separation of DIGE-labelled proteins over a pH gradient of 4-7 and a 12%
polyacrylamide gel, using extracts from SM346 (red) and 10211-10 (green). Numbers correspond
to the proteins in table 7.4.
219
=0 ~';; ... Q
'" ~ -~I. .... I ~ le .... C'\ QC le II')= - II') r- ... .... ....c. ~ ... ~ N N N N N N v:; ,..; N N N N~ - N I I I I I I~ ~ Q".:l ~ - 0'0 -e Nr.. N
-~ e ... ... ~ ., ., ... ., ... .., ... 'T~ ., .., ci.:> '~ '~ ~ ~ ~ '~ ~ '~ '~ '~ ~ '~
=0 Q Q Q Q Q Q Q Q Q Q Q Q Q -QC Q ... Q Q r- Q Q Q Q tf') Q Q I~Z N ~ ,..; v:; Q'i N iii v:; N r..: r..: r..: v:;c::o..< N- 0
~ "0= (::0" '" ='= ~ \0::! "1"= - tf') ~ r- tf') C'\ ~ II') N ~ N QC N Q M... Cl. ... ... :E
° ~e c. (/)til
Z V....="0
...: = = = = = = = = = ('j ('j ('j ('j ,~~ 0 0 0 0 0 9 9 9 9 0 0 :3 0 (::- .".: ~ ...:.: ...:.: .".: ~ ~ ~ v0 00 ~ ~ M t- OO M - 00 M V') - 0 V:; M M \0 M M "1" 0'1 N ~ N - V') :::....v
.0
~ 0 \0 0 t- N \0 00 - V') 00 N s::.. t- O' M 0'1 - ~ M N ~ V') 0 M 0~ 0' N V') t- \0 N 00 0' \0 N N 00 'Vi.c V) N t- t- OO N N 0 0 0 0 M N til
5 \0 t- O' N \0 t- t- t- t- ~ t- \0 0' V
N M M 0' M M M M M V') M N M
....
= 0.C 0 t- M M t- t- t- t- t- O t- O M ><:t- V) 0'1 M V') V') V') V') V') N V) t- O' V- N !:::!... ~ M N N~ '8J '8J '8J '8J '50 '50 '8J '@) 'en '@) '50 '8J '@) (;3'';:::s::
V
00
....
~\0 <.;....;
Vi :a..,
.§ ell(::
,........, ;:: ';;"
00 <:,)
,........, =
\0 '::l ,........,
00 0..§ \0V) s::: V) til.., Cl :.0
s::: N <u t;
..,... .§ til,........, ~ Cl ~ ('jM (/) ,........, ~ ,........,- g ,........, < 00 00 ;:: V><: N \0 \0 ...: g ....
c:G 00 ci
V') ,~ V') Vi =~ § V) ~ ... !::: :::~ til ,........, ~
..,
'::l ¢::
~
00 ,........, s::: '::l ,........,<u :E ,~ ~ \0 ..!:! ,~ <u 0- 00 N~ Cl - Vi ~ \0 .... .... ,........, 00 til(/) ~ t; ;:: ,~ Cl~ 0 .., ........ V) g .... M V) til.... .... '::l s::: .., .t:) ~ - ~ (5.g ,~ '::l ~ !::: ..:a V s::: !::: § ><: c..til ,~ c:G :E
Cl ... .... '::l ;:: = ..!:! '::l E;' (/)'::l ~ ........ <u <:,) .... .... ~ (/) V= ~ ~ ~,~ !::: V .... '::l .... ,~ '::l 0 ,....... til Cl Cl (::= ... <u .g = .... !::: "0 .... .... =,~ '::l >. .... .... ~ ~ ~~ .... ~ '::l !::: ~ ~ (/)- !::: ........ Cl ~ ,~ <u ..c:= ~ V til .... V '::l ,~ .... ~ >.,~ Cl "0 <u ~ c.. .g .0c.; til s:: .... .... -S ........ = ... ('j ~ .... Cl '::l 0 .... "0s:: .... '::l .... .... ~~ ~ !::: ..c: Cl .g V- ~ !::: .... ~ '::l ('j = c.. ,~ ....= 'cu >. 0,:: .~ ~ Cl ~~ til ~ '::l f-- ... ........ s:: >. ........ 0 ,~".:l 0 '::l u '_ ........ I '::l= .... ....- .... ... ........ "0 V .... 0 '::l s:: t.o.. ~ !::: .... ::a0. .... 'C til .... til !::: >.!.l ~= 0 V = <u ,_ 'cu = ~'~ C (:: til = .... ~- ~ .... .... ell ~ :.c('j = ........>. 0 0 ........- 0 '6 (:: V ..c: <;9 ........ .... .... ~ ~ ~0 .... V Cii 0. 0. u ........I. = = 01l ..c: til .0 V V ~ ;; = 0 V~ "3 0 0 E ~ til ~ W01l "0 .... 0. ..c: = s:: s:: 0 :::'0 "0 til 0... ~ .... '6 ,SQ) 0 0. U 0 (:: ~.... = >. ..c: til V N = ~ '';::: .... 'cu V..c: :0 "0 0. til ..c:(;j 0 V 0. til V = 'C .... ('j ....C "0 I I = til ~ til 01l 0 V tils:: - \O~ "0 0. s:: u ....0 '6 V I '';::: S 0 0 til c.. (5 s::'';::: Cii Q) - 0. = N 0 ~ c .... 'cu0. = til I V .... < ('j 0.. ....s:: 0 V "0 ,5 .... 0'C s:: U til 0... >. s:: .... ....u '~ u = 0 .... 'ca ell c..til U .... ..c: 'C s::
(:: ..c: = "@) u .... ..c: ~u = V V u :.0= (/) I Cii r..:I 0.. <.l:: t.t....... "0 s:: s::Eo- f-- ....Q) '2 'ijj :0 QJ..c: ~ 0 .... I :cu 0 -<:(:: u .... == = 0.. Z Eo-<.... ca 0~ (::
,S
1:1s::
<2
i5
-o • tf') ~ II') le r-- QC C'\ Q .... N tf')c.0 .... N .... .... .... ....(/)c
7.5.1 Proteins displaving increased expression in SM346
7.5.1.1 Proteins involved in metabolic processes
The majority of the proteins (5/7) increased in SM346 vs. 10211-10 were involved in metabolism,
these include branched-chain amino acid aminotransferase (Spot 2; Table 7.4) which returned as
lIvE by BLASTp analysis (E = 0) and displayed a 2.7-fold increase in expression. lIvE is involved
in branched-chain amino acid degradation, branched-chain fatty acid production and has shown to
be important in acid tolerance in Streptococcus mutans (Santiago et al. 2012).
Succinate dehydrogenase or Sdh (Spot 3; Table 7.4) expression increased 2.4-fold and
returned as SdhA, the flavoprotein subunit, via BLASTp analysis (E = 0). SdhA was described
previously in Chapter 6 and has been shown to be associated with AcrAB expression in E. cloacae.
UTP-glucose-l-phosphate uridylyltransferase (Spot 4; Table 7.4) expression increased 2.1-
fold and is the product of the galU gene.
Fructose-l,6-bisphosphatase or Fbp (Spot 5; Table 7.4) expression also increased 2.1-fold,
fbp is involved in the pentose phosphate pathway.
Bifunctional aconitate hydratase 2, also Aconitate hydratase B or AcnB (Spot 7; Table 7.4),
expression increased 2-fold in SM346 and was identified in section 7.4.2 as increased in SM346 vs.
NCTC 10211. The protein AcnA was indentified in section 5.5.2 as increased in AB210-6 vs.
AB211.
7.5.1.2 Other proteins increased in S'-'I346
The remaining two proteins demonstrating increased expression in SM346 were the transcriptional
regulatory protein (Spot 1; Table 7.4) which showed an expression increase of 4.5-fold in SM346,
this protein returned as cytidine repressor protein (CytR) by BLASTp analysis (E = 0) and
regulates genes the transport and catabolism of nucleosides. It is from this monitoring of nucleoside
levels that CytR is said to have inhibitory activity on exopolysaccharide and biofilm formation,
Haugo suggests CytR is a mechanism to time biofilm formation with a plentiful supply of
nucleosides (Haugo &Watnick 2002).
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The second protein demonstrating increased expression was Peptidase PmbA (TldD) (Spot
6; Table 7.4) which increased expression 2.l-fold. TldD is part of the TldDE proteolytic complex
and modulator of DNA gyrase B (Allali et al. 2002).
7.5.2 Proteins displaving increased expression in 10211-10
Azoreductase (Spot 8; Table 7.4) expression increased 6.6-fold, azoreductase (AzoR in E. coli)
cleaves azo compounds into their corresponding aromatic amines and is involved in resistance to
thiol-specific stress (Liu et al. 2009).
Ferritin Dps family protein (Spot 9; Table 7.4) expression increased 3.l-fold, it binds and
condenses DNA to protect it from a variety of stresses.
Protein chain elongation factor EF-Tu (Spot 10; Table 7.4) expression increased 2.9-fold.
EF-Tu was previously described in section 5.7.1 and works to elongate polypeptide chains in
protein synthesis but has a variety of other activities, including chaperoning and DNA repair.
Transcriptional regulator PhoP (Spot 11; Table 7.4) expression increased 2.8-fold in
10211-10, PhoP is part of a two-component response regulator PhoPlPhoQ, which controls
magnesium homeostasis and governs the expression of critical virulence phenotypes in pathogenic
bacteria.
Protein ElaB (Spot 12; Table 7.4) expression increased 2.6-fold and also known as YqjD in
E. coli. This protein is poorly characterised, although it has an E. coli paralogue YqjD, which is
bound to the inner membrane and can also bind to ribosomes. Overexpression of YqjD has been
suggested to inhibit cell growth, possibly through inactivation of ribosomes (Yoshida et al. 2012).
Protease DO (Spot 13; Table 7.4) expression increased 2.5-fold and returned as a
periplasmic serine protease, product of the htrNdegP gene by BLASTp (E = 0), serine proteases
are known virulence factors for a variety of Gram negative pathogens.
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7.6 Comparison of NCTC 10211 and tigecvcline-resistant derivative 10211-10
The two isolates NCTC 10211 and the laboratory mutant 10211-10, were compared to investigate
whether any increases in protein expression found in resistant 10211-10 were also found in SM346
vs. NCTC 10211 and therefore more likely to be associated with upregulation of SdeXYF, rather
than an unrelated difference in expression between the reference and clinical isolates.
There were 18 spots highlighted by SameSpots as displaying differential expression, 15 of
which showed increased expression in 10211-10 and three showed increased expression in NCTC
10211.
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4 pH 7
Fig. 7.8 2-D separation of DIGE-labelled proteins over a pH gradient of 4-7 and a 12%
polyacrylamide gel, using extracts from NCTC 10211 (green) and 10211-10 (red). Numbers
correspond to the proteins in table 7.5.
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7.6.1 Proteins displaving expression increases in isolate 10211-10
The 15 proteins which demonstrated expression increases in 10211-10 were placed into three
functional categories; i) Stress defence (section 7.6.1.1), ii) Metabolic processes (section 7.6.1.2)
and iii) Potential virulence determinants (section 7.6.1.3).
7.6.1.1 Proteins involved in stress defence
GroEL, large subunit of GroESL (Spot 1; Table 7.5) expression increased 13.4-fold in 10211-10,
this protein was identified and described in section 7.4.2 as increased in SM346.
Superoxide dismutase (SOD) (Spot 3; Table 7.5) expression increased 3.7-fold, SOD is an
antioxidant stress defence protein, which catalyses the dismutation of superoxide, which can cause
irreversible damage to nucleic acids, protein and lipids, to hydrogen peroxide.
Hypothetical protein SOD_i00600 (Spot 8; Table 7.5) expression increased 2.9-fold and
returned as spermidine Nl-acetyltransferase (E = 6e-132). This protein functions to acetylate
polyamines to prevent polyamine accumulation, which can be toxic, and is increased under
conditions of cold shock or stress (Limsuwun & Jones 2000).
Ferritin Dps family protein (Spot 10; Table 7.5) expression increased 2.6-fold, this protein
was previously identified in section 7.5 as increased in 10211-10 vs. SM346.
Cold-shock DNA-binding domain-containing protein or Csp (Spot 15; Table 7.5)
expression increased 2-fold, Csp proteins are RNA chaperones activated by low temperatures
«15·C) which destabilise the unwanted secondary structures formed by RNA molecules (Phadtare
& Severinov 2009).
7.6.1.2 Proteins involved in metabolic processes
YceI family protein (Spot 6; Table 7.5) expression increased 3.1-fold, this periplasmic protein is
induced by high pH and can bind lipids. It was identified as increased in SM346 vs. NCTC 10211
(section 7.4.2).
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Short-chain dehydrogenase/reductase SDR (Spot 7; Table 7.5) expression increased 2.9-
fold and returned as 3-oxoacyl acyl carrier protein (ACP) reductase, product of the FabG gene by
BLASTp analysis (E = 4e-178). As part of the fatty acid synthase multi enzyme complex, FabG
catalyses an essential step in fatty acid elongation, this protein was also identified in section 5.5.1
as increased in AB211 vs. AB210-6.
Carboxymethylenebutenolidase (Spot 9; Table 7.5) expression increased 2.8-fold, this
protein has dienelactone hydrolase activity which is involved in the degradation of chlorocatechols,
intermediates in the catabolism of chlorinated aromatic compounds.
Carbamoyl-phosphate synthase small chain or CarA (Spot 11; Table 7.5) expression
increased 2.5-fold, it is an essential enzyme in arginine and pyrimidine metabolism and may have a
role in nitrosative stress defence in Coxiella bumetii (Park et al. 2010).
Hypothetical protein SOD_a04090 (Spot 12; Table 7.5) expression increased 2.3-fold and
returned as formate acetyl transferase by BLASTp analysis (E = 0). Also known as pyruvate
formate lyase, this protein was identified in section 7.4.2 as increased in SM346 vs. NCTC 10211.
7.6.1.3 Potential virulence determinants
There were three proteins identified with the potential to increase the virulence of S_ marcescens,
based on the current literature. The first is phosphoheptose isomerase, the gmhA gene product (Spot
2; Table 7.5) showed a 5.8-fold expression increase and is essential for native LPS biosynthesis in
E. coli (Kneidinger et al. 2002).
Hypothetical protein SOD_c05700 (Spot 5; Table 7.5) expression increased 3.2-fold and
returned as the fepA gene product, a TonB-dependant outer membrane siderophore receptor by
BLASTp analysis (E = 0). FepA or ferric enterobactin protein, binds enterobactin carrying iron and
transports it across the outer membrane, where it is taken across the inner membrane by FepB
(Newton et al. 2010).
DNA-binding transcriptional regulator PhoP (Spot 13; Table 7.5) expression increased 2.1-
fold. PhoP is part of a two-component response regulator PhoPlPhoQ, which controls magnesium
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homeostasis and virulence phenotypes. This protein was previously identified in section 7.5.2 in
10211-10.
7.6.1.4 Other proteins increased in 10211-10
Cell division inhibitor MinD (Spot 4; Table 7.5) expression increased 3.5-fold, MinD functions to
activate MinC which inhibits cell septum formation at the poles, leading to division at the correct
midpoint of the cell.
7.6.2 Proteins displaving expression increases in isolate NCTC 10211
There were only three proteins in this comparison that were identified as displaying increased
expression inNCTC 10211, these included the outer membrane protein TolC (Spot 16; Table 7.5)
which showed an expression increase of 2.6-fold in NCTC 10211. TolC and HasF are both outer
OMPs and components of tripartite efflux systems. As the SdeXY pump (and therefore HasF)
expression is increased in 10211-10, a concomitant reduction in TolC was expected, as it seems
logical to reduce overall energy costs and make less of the OMP not needed for drug efflux. This
seems a reasonable theory as TolC can be substituted for HasF in the SdeXY efflux pump (Chen et
al.2003).
Aromatic amino acid aminotransferase (Spot 17; Table 7.5) showed an expression increase
of 2.3-fold and returned as the tyrB gene product by BLASTp analysis (E = 0). TyrB is involved in
the biosynthesis of aromatic amino acids and was also identified in section 5.4 as increased in
AB210 vs. AB211.
Pyruvate dehydrogenase (Spot 18; Table 7.5) showed an expression increase of 2.2-fold
and has been previously identified in section 7.4.2 as increased in both SM346 and NCTC 10211.
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7.7 Chapter Summarv
The aim of this investigation was to characterise the differentially expressed proteins upon
upregulation of the S. marcescens effiux pump SdeXY. However, unlike in previous chapters, a
pair of isolates was not used as the tigecycline-resistant clinical isolate SM346 did not have a
tigecycline-susceptible counterpart. This was a major caveat in this investigation, as it was difficult
to interpret the protein results given the isolates' dissimilarity. This led to differentially expressed
proteins being identified that were unrelated to the resistance mechanism.
However, using the tigecycline-susceptible type strain NCTC 10211 and its -resistant
derivative 10211-10, the results from the DIGE comparisons demonstrate a diverse range of
proteins affected. As these isolates were closely related, it allowed the changes more likely
associated with resistance to be highlighted. Efflux upregulation in 10211-10 may be associated
with an increase in proteins that have the potential to increase virulence (PhoP) and iron acquisition
(FepA). PhoP can also confer increased survival under low magnesium, low pH and the presence of
polymyxin B (Barchiesi et al. 2012). PhoP mutants are also defective for survival in epithelial cells,
which may be associated with control of these virulence phenotypes. Iron acquisition has shown to
be a crucial process for S. marcescens infection in a Caenorhabditis elegans model (Kurz et al.
2003).
Expression increases in 10211-10 were observed for proteins involved in cell adhesion
(DegP) and biofilm formation (GmhA) vs. SM346. DegP is an essential virulence factor for many
pathogens, for instance it is required for enteropathogenic E. coli (EPEC) pathogenesis, as it
chaperones and assembles the fimbrial adhesins which confer bacterial attachment (Humphries et
al. 2011), DegP is also required for full virulence in S. pyogenes and reduces susceptibility to ROS
(Jones et al. 2001). GmhA is required for biofilm formation in Yersinia pestis (Darby et al. 2005)
and also for biosynthesis of the LPS inner core in E. coli.
Another protein with a potential role in LPS biosynthesis, GalU, was identified in section
7.5 in SM346 vs. 10211-10. Klein et al. showed that GalU mutants of Y. pestis attenuated survival
in murine macrophages and caused the formation of truncated lipooligosaccharides, suggesting its
importance in LPS formation (Klein et al. 2012). Nesper et al showed GalU is required for LPS
229
biosynthesis and biofilm formation in Vibrio cholerae (Nesper et al. 2001). The increase of these
proteins in both of the tigecycline-resistant isolates SM346 and 10211-10 suggests that LPS
biosynthesis may be associated with upregulated efflux in S. marcescens.
In previous comparisons, many tigecycline-resistant clinical isolates showed reductions in
metabolic proteins compared with their susceptible counterparts. However, SM346 was shown to
have higher expression of many metabolic proteins compared with NCTC 10211, possibly because
as a clinical isolate, SM346 may have adapted its metabolism to cope with decreased nutrient
availability (in the host environment). These differences were reflected in the comparison with
10211-10, where SM346 again showed relative increases in many metabolic proteins.
Stress defence proteins in 10211-10 demonstrate large increases in protein expression,
while fewer proteins increased expression in the clinical isolate. This suggests that SM346 has
alternative mechanisms for dealing with stress or that it has adapted to the protein expression
changes caused by upregulation of the SdeXY efflux pump. For instance, GroEL showed large
increases in both tigecycline-resistant isolates and could be utilised in stress defence in S.
marcescens. As the clinical isolate SM346 demonstrated increased levels of metabolic proteins,
possibly due to differences in its environment and nutrients, this may explain the concomitant
increase in stress defence proteins.
Other changes in S. marcescens included the Min proteins, which may have potential to be a novel
target for the treatment of MDR Gram-negative pathogens and needs further work to confirm
whether it has an active role in efflux-mediated resistance in S. marcescens. The increased
expression of CytR in SM346 confirms the increased biofilm-fonning capabilities of 10211-10.
CytR is known to repress biofilm formation in Vibrio cholerae (Haugo & Watnick 2002) and was
increased in SM346 vs. 10211-10 i.e. a lower level of CytR in 102l1-to may actually provide a
relative increase in biofilm formation, SM346 displays expression changes in proteins involved in
membrane transport e.g. the Sec transport system, lipid transporter and an ABC carbohydrate
transporter, involving rearrangement of the outer membrane proteome.
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Many changes have been identified in 10211-10, some of which may be attributed to the
upregulation of SdeXY, such as increased expression of proteins involved in biofilm formation,
iron acquisition and LPS biosynthesis. These are changes that could potentially make this organism
more virulent and could further complicate treatment. However, the changes identified in SM346
were more difficult to explain without an isogenic comparator and because of this, few changes
could confidently be attributed to efflux upregulation due to the genetic dissimilarity between
SM346 and the 10211 isolates. An example of these difficulties included the potential presence of
protein isoforms e.g. pyruvate dehydrogenase, which showed increased expression in both SM346
and NCTC 10211 in the same comparison. Differences in the respective complements of stress
response and metabolic proteins, confirms the anticipated difficulties of comparing genetically
unrelated isolates. Due to these difficulties, the results were more difficult to interpret than those
for Enterobacter and Acinetobacter.
This is the first work to investigate the proteomic changes associated with upregulated
efflux in S. marcescens and a number of proteins from different functional groups have been
identified. This chapter has highlighted the potential difficulties when using DIGE on unrelated
organisms and ideally, in future only isogenic pairs of isolates or different conditions applied to the
same isolate should be tested.
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8. General Discussion
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The overall aim of this study was to characterise the proteins involved in the selected antibiotic
resistance mechanisms, using proteomics approaches such as 2DGE, quantitative labelling and
mass spectrometry. While the modes of action of these drugs have been elucidated, there was also
an underlying objective, to ascertain whether proteomics could be used in tandem with current
molecular techniques to probe the broader implications on bacterial cell physiology.
Three key antimicrobial resistances of public health importance were investigated:
1) Plasmid-mediated multidrug-resistance in E. coli
2) Non-carbapenemase-mediated carbapenem resistance in K. pneumoniae
3) Efflux-mediated tigecycline resistance in A. baumannii, E. cloacae and S. marcescens.
This investigation identified a plethora of proteins with functions that relate to antibiotic resistance,
virulence and many other functional classes involved in general bacterial cell physiology. Some of
these could not have been defined without the use of modern MS-based proteomics e.g. the
analysis of the OMPs of K. pneumoniae or the quantification of differential protein expression
using DIGE. The differentially expressed proteins were assigned explanations for why they were
differentially expressed, present or absent in an attempt to assess their role in, or their relevance to,
the mechanism of resistance. The results obtained from each resistance-organism combination
reveal many further avenues for investigation and are detailed later in this chapter.
There are many proteomic methods available and a selection was used in these
investigations. Below is a short review of the techniques used and whether they may find future
applications in clinical laboratories.
2DGE was used to separate the proteins from whole-cell extracts and identify the digested
peptides, initially with MALDI-TOF MS. 2DGE is useful for obtaining protein identifications as
the excised spots are likely to release sufficient peptides upon digestion for MS analysis and
protein identification. Due to its large-scale coverage of the proteome, 2DGE is an effective
technique for detecting differences in the spot profile of expressed proteins and is still in use today
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(Marzoa et al. 2012). Because of its ease in visualising differences between profiles, it is often
applied at the preliminary stages of comparative differential expression profiling of
microorganisms. Additional advantages of DIGE include pooling the labelled samples and running
them in one gel along with internal standardisation, which removes the problems associated with
gel-to-gel variation which plague analysis of conventional 2DGE gels. Some of the disadvantages
of DIGE are that although a lot of information can be gleaned from one experiment, there is no
guarantee that the proteins of interest will be expressed (and detected) at a high enough level for
downstream analysis. Also, many proteins which appear as 'unique' to one isolate may not be
expressed, rather than demonstrating the loass of a protein, making interpretation of the expression
profiles more difficult. For example, in the comparison of A. baumannii isolates AB2l 0-6/AB2ll,
a protein highlighted as 'unique' to one isolate was later identified as differentially expressed
between both isolates. Although this could be a software error or a novel form of the same protein,
such as a post-translationally modified isoform of the protein.
DIGE also requires closely-related isolates to compare with the resistant isolate, otherwise
any potential changes are much harder to elucidate from the data. For instance, the differences in
expression identified in Serratia isolate SM346 were difficult to explain without an isogenic
comparator. Because of this, few changes could confidently be attributed to efflux upregulation due
to the dissimilarity between SM346 and the 10211 isolates. Due to these differences, the S.
marcescens DIGE results were more difficult to interpret then those for Enterobacter and
Acinetobacter.
To attempt to characterise the proteins in these antibiotic resistant isolates in the first instance, a
discovery proteomics approach was used which generates a vast amount of data and highlights
changes that are not necessarily attributed to the condition being studied. Therefore, a significant
amount of effort and time is dedicated to analysis in order to extract the relevant features from the
data. For this reason it is necessary to apply targeted approaches to further confirm that the
proteins of interest are truly associated with resistance. This would eliminate a lot of uncertainty
and increase confidence in the results, making the techniques more amenable to a reference
laboratory.
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When 20GE is combined with MALDI-TOF, in the absence of other higher resolution
techniques, the major proteins visualised on a gel may be rapidly identified in minutes. At the
commencement of this study, this was the only accessible technique. However, with the
subsequent arrival of an LC-MSIMS system, it became possible to run SOS-PAGE gels, excise
multiple bands and subject them to MSIMS analysis (designated GeLC-MSIMS) to extend the
range of proteins identified. Here 20GE was useful for identifying single proteins expressed from
the transformants, at the early stages of this study. The technique has limitations in that it is very
labour intensive, requires considerable technical skills and proteins that are not visualised in the
gels may missed. Also, as 20GE only identifies single proteins, the GeLC-MSIMS approach is
more suitable and has the potential to profile the expressed proteins which are affected by the
development of antimicrobial resistance.
Due to the low sensitivity of MALOI-TOF Also, as the approach only identifies single
proteins, the GeLC-MSIMS approach is much more suitable and has the potential to profile the
expressed resistance proteins. While more expensive and more technically demanding to operate,
the nano LC-LTQ Orbitrap considerably higher resolution than MALDI-TOF. In general, the
former provides large dynamic range, high mass accuracy and is able to process complex samples
(Graham et al. 2011). LC-MSIMS proved a powerful technique in the GeLC analysis, returning
hundreds of identifications from the gel profiles of whole-cell extracts. GeLC-MSIMS is also
useful in detecting lower abundance proteins that 20GEIDIGE may have missed.
The GeLC approach proved useful to map the exact changes in K. pneumoniae OMP
composition between a clinical pair of isolates and also to probe differences between J53 and
derivative transformants. The potential of this technique is reinforced by its application in profiling
organisms for their expressed resistance profile e.g. CTX-M-15 was detected in both the Klebsiella
isolates and CTX-M-3 was detected in both the E. coli transformants.
The Biolog System, which provides global coverage of the phenotype of an unknown
microorganism, was utilised here to facilitate broader coverage of changes upon plasmid
acquisition. Furthermore, the inclusion of antimicrobial agents against an appropriate control for
each test substrate enables a vast number of antimicrobial agents to be tested simultaneously. The
elucidation of phenotypes by this method provided considerable data and was useful in interpreting
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and validating the proteomic data. However, the full run of 20 phenotype microarray plates was
excessive, as there were few plates of relevance to the study of resistance mechanisms. The plates
that were available contained many old or dated compounds e.g. some of the biocides used had
very little information available, while for others the mechanisms of inhibition are poorly
characterised. However, the method has some advantages for probing phenotypic differences
between isolates/pairs. As well as for elucidating changes in organisms after gene knockout and
could be recommended for studies of this nature, particularly in combination with metabolomic
approaches. In the future, a more flexible system in which well characterised antimicrobial
mechanisms could be selected and tested in parallel with transcriptomics and proteomics may
prove useful as a novel approach to elucidating complex mechanisms of resistance in
microorganisms.
These approaches generated a lot of data on the presence/absence of proteins and expressed protein
profiles. However, quantitative proteomics was able to further probe the more subtle protein
changes in both antibiotic-susceptible and -resistant organisms. The large amount of data
generated in these chapters also raised many possibilities of further study on the resistances of
these organisms. These are described in detail, after a summary of the results of this PhD in each
of the organisms investigated.
Escherichia coli
It is known that the acquisition of a plasmid can affect the protein composition of a cell, such as
alteration of porin levels (Russell, 1997). Two transformants were subjected to whole-cell
proteome analysis to identify any changes in the expressed proteome. While more subtle changes in
expression could not be detected, the presence or absence of proteins were detected and compared
with J53, the host of the two resistance plasmids. The technique was able to identify proteins
present only in J53 and proteins only present in J204 and J499, some of which were expressed by
the plasmid and some were chromosomally located. The combined proteomics and phenomics
approaches allowed the identification of proteins involved in membrane integrity (the Tol-Pal
system), changes in which may be responsible for the altered phenotypes identified by PM analysis
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e.g. increased biocide resistance and increased polymyxin susceptibility. The results from the
GeLe-MSIMS experiments also opens the possibility of plasmid profiling by proteomics, to
ascertain the percentage of proteins expressed from a plasmid; and subsequent resistance profiling,
to identify as many resistant proteins expressed as possible.
Klebsiella pneumoniae
The use of SDS-PAGE to separate and visualise the OMP profiles of K. pneumoniae isolates lA
and IB, successfully confirmed the predicted resistance mechanism of reduced porin expression (of
Ompk35 and OmpK36) combined with ESBL-production in 1B (Webster et al. 2010). Further
analysis by Le-MSIMS yielded a unique perspective on OMP changes in carbapenem-resistant K.
pneumoniae. In particular, changes were observed which suggested the resistant isolate may fare
less well in an infection model, as it lacked proteins required for colonisation of a host (e.g. SuhA,
FimA, -C, -D, -F and TraT). 1B also lacked the colicin-type Klebicin B, which may allow it to be
outcompeted by other isolates. Interestingly, isolate 1B expressed OmpK26 which identified as
KdgM, a porin potentially used by the Tog oligosaccharide transport system. OmpK26 has
previously been identified as expressed in carbapenem-resistant Enterobacteriaceae with repressed
OmpK35/36 porins (Garcia-Sureda et al. 2011) and was confmned in this study in carbapenem-
resistant isolate 1B. There were also some additional antibiotic resistance proteins expressed only
in 1B, including; EmrA, periplasmic component part of a MDR efflux pump and APH(3"),
involved in streptomycin resistance. These results pose many questions regarding the effects of
these protein changes and require additional studies.
As with many of the isolates described in this thesis, (with the exceptional of the A.
baumannii clinical pair) it would have been very helpful to have had their genomes sequenced, to
confirm whether any of the observed presence/absence of proteins or increase/decrease in
expression are due to changes in the genome or whether they are purely just protein expression
differences.
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Acinetobacter baumannii
Based upon the initial analyses of the clinical pair, AB2IO and AB2II, there were some proteins
which were identified in one of the isolates and not the other. These proteins included AAC(6')-lb,
identified only in AB210 and was confirmed with genome sequencing data (Homsey et al. 2011)
and the reduction in AB2II aminoglycoside MICs (see methods section 2.2; Table 2.2). There
were other proteins identified in just one isolate, however, they could not be confirmed by genome
sequencing. This highlights a major caveat in 2DGEIDIGE as from the presence/absence of one
spot, there is no way to tell if there are isoforms of the protein in both isolates or the protein was
not abundant enough in one isolate. It also highlights the value of having a genome sequence to
confirm the changes reported by proteomics.
The DIGE approach highlighted many differences between the pair of isolates (Tables 5.2
and 5.3; section 5.4) including proteins which could potentially give AB211 an advantage over
AB210 in an infection. These included proteins such as ferrichrome iron receptor protein and PldA,
involved in cell envelope biogenesis and colonisation (Istivan & Coloe, 2006). NDK was also
found to be reduced in AB211 compared with AB21 0, which can cause elevated rates of mutation
when suppressed (Miller et al. 2002). In AB211, this protein was found to have a mutation by
whole genome sequencing which could have increased this isolate's mutation rate (Homsey et al.
2011). Similar results were found in the other comparisons with mutant derivatives of the pair, for
instance proteins increased in AB210-6 (a tigecycline resistant mutant) included a polysaccharide
biosynthesis protein and ferrichrome iron receptor (the same as identified in AB211). These results
also highlighted how the two different acquisitions of resistance in these two resistant mutants had
different effects on their protein profiles.
However, while many results were obtained from the DIGE technique, it wasn't always
successful. Although AB210 and AB210-6 were compared, not enough protein identifications were
returned to make reliable inferences about the significance of proteins displaying differential
expression. Even with high quality gels with good separation applied to pairs of isolates, DIGE
does not guarantee detection of all differentially expressed proteins.
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Enterobacter cloacae
This study aimed to characterise the changes in the protein profile of the E. cloacae isolates upon
upregulation of AcrAB-ToIC efflux pump conferring resistance to tigecycline. Some of the
proteins identified as differentially expressed between the isolates displayed positive associations
with AcrAB activity. The expression of these proteins increased when acrAB was upregulated, and
some displayed negative associations; expression of these proteins were reduced when acrAB was
upregulated. Those that demonstrated a positive association were OmpD, a porin implicated in
stress resistance and SdhA or succinate dehydrogenase subunit A (section 6.3.1). While the latter
was likely involved in supplying energy to the efflux pump, the contribution of OmpD is less well
understood, although other studies suggest it is involved in resistance to heat (Ruan et al. 2011)
and antibiotics (Szabo et al. 2006; Pilonieta et al. 2009)
However, there were also some proteins which, upon modulation of expression, may play
a role in the virulence of these isolates such as OmpA and LuxS. These proteins did not show any
association of expression with AcrAB but their expression was changed upon acrB knockout,
regulation of AcrB can affect the virulence of this organism. Alternatively, these proteins may
have differences in expression due to a key membrane component being lost and needs to be
investigated further.
Serratia marcescens
Few results from the comparisons with SM346 could be interpreted or discussed further as there
were no genetically similar isolates to compare against. The 10211 type strain and its derivatives
were all highly dissimilar to SM346, therefore any observed differences in protein expression may
not have been caused by the upregulation of SdeXY, but may arise from pre-existing genetic
differences between isolates. However, the comparison of NCTC 10211 and its tigecycline-
resistant laboratory derivative 10211-10 did reveal changes in protein expression. Changes in
proteins such as PhoP, GmhA and FepA were identified, which code for virulence phenotypes, LPS
biosynthesis and iron acquisition respectively (Barchiesi et al. 2012; Kneidinger et al. 2002;
Newton et al. 2010). In future studies, lone resistant organisms should not be analysed with
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proteomics, as an isogenic comparator is required to reduce the background 'noise' of unrelated
protein changes.
Some proteins were consistently identified in the DIGE experiments as differentially expressed
across all the species tested. The Min proteins may be important for efflux upregulation as changes
in the MineDE proteins were observed in almost every comparison of isolates from chapters 5, 6
and 7. Min proteins show differential regulation in almost every comparison in; Acinetobacter,
Enterobacter and Serratia DIGE chapters, with Mine and MinD most commonly identified. Mine
is the inhibitor of septum formation and MinD its regulator. This suggests that the upregulation of
major efflux pump genes has an effect on the cellular division processes, or may be regulated by
the same system, that may be conserved across bacterial genera. Although, given its essential
function in the regulation of cell division, Min may not have any role in the upregulation of efflux.
In either case, the role of these proteins is worth further investigation in the context of efflux
upregulation.
8.t Future work
There is a vast potential for further work arising from this investigation. Due to the number of
different organisms, the breadth of antibiotic resistance mechanisms and the range of techniques
used, which even individually, generated large amounts of data.
To validate any conclusions drawn from the proteins highlighted by the Gel.C experiment from the
J53/transformant comparison, further work needs to be done on these proteins to ascertain their
precise role in modulation of the host cell proteome upon plasmid acquisition e.g. ToIA, Pal, YbgF.
For instance, mutants need to be generated lacking these proteins and the experiment would be
repeated to see if susceptibilities have changed. Further work also needs to be done on transformant
susceptibilities to biocides and antiseptics, because although there are no specific resistance genes
on the plasmids for tolerance to antiseptics, the PM results show the transformants have an
advantage in the presence of certain agents. It would also be pertinent to elucidate whether different
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plasmids can confer similar phenotypes and protein profiles and requires testing of a much larger
panel of transform ants carrying a range of plasm ids, all in J53.
One control which was never implemented in the E. coli experiments was to compare J53
(with no plasmid) against electroporated J53 (with no plasmid), to see if the stress of
electroporation had any residual effect on OMP composition of transformants. Quantification
experiments on these isolates to ascertain the subtler changes caused by plasmid acquisition would
also have been valuable, but due to time constraints, they were never undertaken.
From the investigation into the K. pneumoniae pair of isolates, the identification of OmpK26 in 1B
poses as a potential marker for OmpK35/36 porin loss. To further investigate this requires
screening for the presence of OmpK26 in other non-carbapenemase-mediated carbapenem
resistance isolates. Related to this protein is the expression of the Tog multi-component membrane
complex, which is as yet unknown to be involved in antibiotic resistance and also requires further
study. Many proteins functioning as virulence factors were not identified in 1B such as FhuA and
fimbrial proteins FimA, B, C, F. It would be worth testing whether IB is outcompeted by lA in an
infection model, to see if this particular mechanism is an advantage or disadvantage in vivo. With
the lack of these factors in additiono to the Klebicin B protein, IB may be outcompeted by other
isolates and could be tested by co-infection in an in vivo model.
As described previously, this pair would ideally be sequenced allowing higher-confidence
proteo-genomic comparisons. This should allow the confirmation of the origin of the protein
changes between the pair e.g. whether they are protein expression differences or genetic changes.
Also, analysis of the whole-cell extracts of transformants and K. pneumoniae isolates should be
repeated on a newer, more sensitive LC-MSIMS. It is thought that a more sensitive analytical
instrument would be able to detect the peptides required (those containing the amino acid change or
changes) to comprehensively differentiate resistance enzymes. For example, to discern CTX-M
enzymes from one another, which would provide further evidence for the application of LC-
MSIMS in the resistance profiling of isolates.
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To complete the comprehensive analysis of the A. baumannii isolates, AB210-6 and AB211tJ.adeB
should be submitted for genome sequencing, allowing genetic confirmation of protein changes and
consistency (in terms of genetic conformation) across the four isolates used.
Specific further tests include in vivo infection models to test if AB211 could outcompete
AB210, with its increase in virulence-associated factors expressed. More specifically, to see if
these expression changes actually translated into a phenotypic difference, the identified virulence
factors should be tested with assays for iron acquisition (investigate growth in broth with an iron
chelator); cell attachment assays (incubate labelled bacteria with eukaryotic cells, compare
attachment levels of clinical pair of isolates); and biofilm formation (measure levels of biofilm
growth and integrity by challenging the biofilm with antibiotics and measuring cell death). A
similar approach should be taken with AB210-6, whereby these assays are repeated to confirm
whether AB210 has a similar phenotype to AB211, if so, then it is more likely that efflux
upregulation is responsible for the observed changes.
It was observed that many of the changes between the AB21 0 and AB211 were in proteins
residing on the OM, the next step in their proteome characterisation should be OMP analysis. It
was successfully utilised when analysing the OMPs of K. pneumoniae isolates and identified a
large proportion of the proteins as virulence-associated. Given that many differences between the
A. baumannii pair were also virulence associated, OM analysis would provide additional
information on the differences between the isolates.
As with other isolates in this research project, the E. cloacae pair and mutants should have their
genomes sequenced to confirm changes in protein expression. It would also be worth comparing
knockout mutants of OmpD to determine its function in this pair, to investigate whether a TGC-
MompD mutant would have the same level of resistance as TGC-S, which could suggest if OmpD
is required for efflux-mediated resistance or not. Also, it was hypothesised that modulation of some
proteins identified (OmpA and LuxS) could alter the virulence properties of the isolates. This also
requires investigation, to determine whether the upregulation of AcrAB could give an in vivo
advantage. As well as determining if the resistant organism could outcompete the susceptible
organism, or whether the isolate could be outcompeted.
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The isolates being compared to the tigecycline-resistant clinical isolate SM346 were not
isogenic comparators, so there were few results to interpret and therefore fewer findings to follow
up on. However, comparison with NCTC 10211 and its derivatives revealed changes in protein
expression similar to those seen in previous Acinetobacter comparisons. These include iron
acquisition proteins and biofilm-forming proteins, the role of which should be investigated in a
similar manner to the proteins in Acinetobacter.
8.2 Conclusions
This research project has contributed to the ever-expanding knowledge base of microbial
proteomics, in this case: towards three resistances of clinical relevance, in five pathogenic
organisms with public health importance. It has been demonstrated that some techniques are in-line
with the work of resistance reference laboratories. While many advantages ofproteomics have been
presented, it is clear that proteomics should be used in combination with other approaches. As the
use of genomics, proteomics and metabolomics in tandem will allow global profiling of
microorganisms. This allows a more thorough characterisation of results due to additional
confirmations of protein expression differences through mutations in the genome and altered
metabolome profile.
As the caveats of proteomics are addressed, such as a greater representation of low-
abundance proteins and higher coverage of the expressed proteome, the techniques are becoming
more established. As the sensitivity and resolution of MS instruments improves, the applications of
proteomics technologies will continue to rise.
From all the results obtained, the key findings revealed by this research project are summarised
below:
• Plasmid acquisition has the potential to increase tolerance to certain biocides but may also
increase susceptibility to polymyxin antibiotics and other agents (2-phenylphenol), these
changes are potentially connected with changes found in the OMPs from these isolates.
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• Non-carbapenemase-mediated Carbapenem resistance In Klebsiella pneumoniae has the
potential to reduce virulence factor production but induce additional resistance factors.
Expression of OmpK26 in carbapenem-resistant 1B confirmed by proteomics techniques.
• The GeLC-MSIMS technique identified CTX-M-3 in the plasmid-harbouring J53 isolates and
also CTX-M-15 in the K. pneumoniae isolates. While J499 actually produced CTX-M-15 and
the K. pneumoniae isolates specific CTX-M was not known (the PCR only tested for a group 1
CTX-M enzyme), with more powerful MSIMS instrument, more peptides could be detected
increasing the chances of precise ESBL identification.
• In A. baumannii changes between the pair of isolates were confirmed with the analysis of
mutant derivatives AB2l0-6 and AB2ll~adeB. Proteomics described many changes in the
isolate AB211, potentially conferring greater ability to scavenge iron, form biofilms and cause
infection in a host.
• In E. cloacae, OmpD and SdhA were identified as displaying a positive expression association
with the efflux protein AcrB. These proteins have not previously been identified as displaying
increased expression in tigecycline-resistant E. cloacae and require further testing as potential
markers for this mechanism.
• The DIGE results also identified proteins such as the Min cell division proteins, which
displayed differential expression across comparisons of Acinetobacter, Enterobacter and
Serratia. There were also iron acquisition and biofilm-forming proteins increased in resistant
vs. susceptible isolates in both A. baumannii and S. marcescens.
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